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ABSTRACT 
Low-fat, high-carbohydrate diets are recommended by various scientific bodies for the pre-
vention of coronary heart disease. However, these diets increase postprandial lipaemia and so 
their net benefit for coronary heart disease risk has been the subject of vigorous debate. Exag-
gerated postprandial lipaemia has been implicated in the development of atherosclerosis. Pre-
vious research suggests that physical exercise improves triacylglycerol metabolic capacity. 
The present thesis investigated whether exercise, when simultaneously adopted with a high-
carbohydrate diet, could prevent the augmentation of postprandial lipaemia observed with this 
dietary change. 
The aims of the first study were to establish a three-day dietary intervention model and to 
examine the effects of two extreme isoenergetic diets (high-fat versus high-carbohydrate) on 
the triacylglycerol response to a standard test meal. In the group of healthy young men studied, 
postprandial lipaemia (expressed as the area under the plasma triacylglycerol concentration vs 
time curve) was 90 % higher after the three-day high-carbohydrate diet than after the three-day 
high-fat diet, with major differences in the associated metabolic milieu. 
The second study tested the hypothesis that 30 minutes of daily moderate intensity exer-
cise offsets the augmentation of postprandial lipaemia associated with a high-carbohydrate 
diet. Postprandial lipaemia was 35 % greater after subjects had followed a three-day high-
carbohydrate diet, while refraining from exercise, than after they had followed a typical West-
ern diet. However, the addition of daily exercise to the high-carbohydrate diet significantly 
reduced postprandial lipaemia, almost to the level observed after the Western diet. 
The third study aimed to provide a detailed description of the qualitative changes to post-
prandial triacylglycerol-rich lipoprotein metabolism elicited by a high-carbohydrate diet and 
moderate intensity exercise in a group of healthy postmenopausal women. The postprandial 
triacylglycerol response in the triacylglycerol-rich lipoprotein fraction was 32 % greater after a 
three-day high-carbohydrate diet than after a three-day low-carbohydrate diet. This was asso-
ciated with increases in the numbers of apolipoprotein B48-, apolipoprotein B 100-c0ntaining 
triacylglycerol-rich lipoproteins and their remnants. When subjects had exercised for 60 min-
utes daily whilst consuming the high-carbohydrate diet, none of the above parameters differed 
significantly from the low-carbohydrate diet. 
In conclusion, regular moderate exercise is sufficient to prevent the augmentation of post-
prandial lipaemia and accumulation oftriacylglycerol-rich lipoproteins attributable to a short-
term high-carbohydrate diet. Regular exercise may provide one means for allaying current 
anxieties about high-carbohydrate diets. 
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CHAPTER! 
INTRODUCTION 
Coronary heart disease (CHD) is the leading cause of death in the Western society 
(Murray and Lopez 1997). The main determinant ofCHD is atherosclerosis which is 
the formation of atheroma in the artery wall (Mangiapane and Salter 1999). Athero-
sclerosis involves accumulation oflipids in the intima oflarge elastic and muscular 
arteries. Initially these lipid deposits are known as fatty streaks. At some sites in the 
coronary arteries fatty streaks thicken by continuous, or intermittent, accumulation of 
lipid and connective tissue to form fibrous plaques or atheroma. Over years, these 
atheroma gradually increase in size and can undergo calcification and vascularisa-
tion. Such advanced atherosclerotic lesions can occlude arteries, reduce blood supply 
to the heart and produce severe clinical symptoms. Atherosclerosis begins in child-
hood but clinical manifestations may not occur until late adulthood. Both genetic and 
nongenetic factors are considered to play a causal role for the development of athero-
sclerosis. The nongenetic factors include cigarette smoking, hypertension, obesity, 
physical inactivity and abnormalities in lipid and lipoprotein metabolism. 
Evidence - genetic, laboratory animals, clinical trials, epidemiologic - supports the 
proposition that high levels oflow-density lipoprotein (LDL) cholesterol accelerate 
coronary atherosclerosis and that lowering of LDL-cholesterollevels decreases the 
risk of CHD (The Expert Panel 1988). Epidemiologic and experimental studies have 
demonstrated that saturated fatty acids consistently raise serum total (Keys et al. 
1957; Hegsted et al. 1965; Grundy and Denke 1990; Caggiula and Mustad 1997) and 
LDL (Mensink and Katan 1992; Hegsted et al. 1993) cholesterol levels. Also, cross-
and within-population studies have shown that intake of saturated fatty acids is 
strongly and positively associated with CHD incidence and mortality (Caggiula and 
Mustad 1997). This relation is generally believed to be mediated in part by effects of 
dietary saturated fat on total and LDL cholesterol concentrations and, for this reason, 
public health strategies are being developed and examined (Gibney 1999), aiming to 
reduce the consumption of saturated fat in the population. The existing dietary target 
in the United Kingdom is 33 % of the daily energy from fat, with only 10 % from 
saturated fatty acids (Department of Health 1991). 
2 
Despite the general acceptance of the atherogenic properties of saturated fatty acids, 
the desirable macronutrient replacement for saturated fat in the diet is an area of 
continuing debate. The two main contenders are complex carbohydrates and unsatu-
rated fat. Replacement of saturated with polyunsaturated fat has been shown to re-
duce total and LDL cholesterol effectively (Mensink and Katan 1992; Katan 1997) 
and population studies have demonstrated that polyunsaturated fat intake is nega-
tively associated with CHD mortality (Caggiula and Mustad 1997). As a result, early 
recommendations emphasised diets with a high ratio of polyunsaturated to saturated 
fat. However, the long-term safety of polyunsaturated fatty acids has not been con-
firmed by population data and, in the course of time, concerns arose over possible 
adverse effects, focusing initially on cancer risk and later also on the oxidisability of 
polyunsaturated fatty acids. Such considerations, along with epidemiologic evidence 
from the Mediterranean region where the diet contains large amounts of the mono-
unsaturated oleic acid and CHD incidence is low (Keys et at. 1984), led researchers 
to favour replacement of saturated with monounsaturated fat. Indeed, recent reports 
have demonstrated that high-monounsaturated fatty acid diets efficiently lower total 
and LDL cholesterol levels (Mensink and Katan 1992; Kris-Etherton et al. 1999) 
and, therefore, these diets would be expected to reduce CHD risk. 
However, distrust of the strategy to replace fat with fat (Connor and Connor 1997; 
Omish 1998; Rude11998) and some, albeit inconsistent, epidemiologic evidence 
supporting the notion that high-fat diets promote the development of obesity (Seidell 
1998) have favoured the replacement of saturated fat with carbohydrate, shifting the 
focus of recommendations to diets low in fat and high in carbohydrates. This ap-
proach was based on the fact that low-fat, high-carbohydrate diets have traditionally 
been consumed in Asia, and in this region, rates ofCHD are low (Keys et al. 1984). 
Dietary fat restriction and consumption of high-carbohydrate diets have been widely 
recommended for the prevention of obesity (Schaefer et al. 1995), certain types of 
cancer (Butrum et al. 1988) and CHD (Krauss et al. 1996; The Expert Panel 1993). 
Most recommendations restrict consumption of total fat to an upper limit of30 % of 
daily energy intake. 
3 
Low-fat, high-carbohydrate diets are effective in lowering total and LDL cholesterol 
levels and this has been demonstrated by a number of studies in both men and 
women (Clevidence et al. 1992; Kasim et al. 1993; Dengel et al. 1995; Kasim-
Karakas et al. 1997; Turley et al. 1998; Yu-Poth et al. 1999). These favourable al-
terations to lipoprotein metabolism by high-carbohydrate diets provided evidence 
that this type of diet may help CHD prevention. However, these diets have recently 
come under scrutiny because they also increase plasma triacylglycerol (TAG) and 
decrease high-density lipoprotein (HDL) cholesterol concentrations (Mensink and 
Katan 1992). 
The observation that high-carbohydrate diets induce fasting hypertriacylglycerolae-
mia was made as early as in the 1950s (Hatch et al. 1955; Ahrens et al. 1957). Since 
then, numerous studies have confirmed this "paradoxical" observation (Antonis and 
Bersohn 1961; Mancini et al. 1973; Jones et al. 1987; Mensink and Katan 1987; 
Ullmann et al. 1991; Retzlaff et al. 1995; Flynn et al. 1999; Parks et al. 1999). One 
theoretical argument in favour of the anti-atherogenic utility oflow-fat, high-
carbohydrate diets has been that postprandial lipaemia will be lower during these di-
ets as the amount of ingested dietary fat is reduced (Connor and Connor 1997). How-
ever, studies in healthy men and women and non-insulin dependent diabetes mellitus 
patients suggest that postprandial lipaemia and diumal TAG levels are increased, 
rather than decreased, during the consumption of high-carbohydrate diets compared 
with diets higher in fat (van Gent et al. 1979; Coulston et al. 1983; Jeppesen et al. 
1997; Chen et al. 1993; Chen et al. 1995; Blades and Garg 1995). In addition, con-
trolled-feeding studies (Gonen et al. 1981; Mensinkand Katan 1987; Kasim-Karakas 
et al. 1997; Berglund et al. 1999) as well as intervention studies conducted in free-
living populations (Kasim et al. 1993; Yu-Poth et al. 1999) showed that high-
carbohydrate diets also decrease high-density lipoprotein (HDL) cholesterol concen-
tration. These fmdings suggest that low-fat, high-carbohydrate diets may not reduce 
overall CHD risk. Accordingly, the wisdom of recommending them as one means for 
CHD prevention has been an issue of vigorous debate by many reputable scientists 
(Crouse ill 1989; Connor and Connor 1997; Katan et al. 1997; Reaven 1997; Omish 
1998; Rude11998; Strain 1998; Connor and Connor 1998; Katan et al. 1998; Grundy 
1999). 
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Fasting TAG (Hokanson and Austin 1996) and HDL-cholesterol (NllI Consensus 
Conference 1993) concentrations are independent risk factors for CHD. Plasma TAG 
concentrations show considerable diurnal variation (van Gent et al. 1979). Ingestion 
ofa fat-rich meal results in postprandial elevation of TAG levels lasting for 6 to 8 
hours in healthy normolipidaemic individuals. As people in Western Society tend to 
eat plentiful meals at regular intervals, postprandial lipaemia occurs several times per 
day, so that most individuals spend -80 % of their lives in the postprandial, rather 
than the fasted state. From a metabolic point of view, postprandial lipaemia can be 
considered as a transient or aggravated hypertriacylglycerolaemia and, therefore, 
augmented and protracted postprandial elevations of triacylglycerol may enhance the 
development of CHD. Indeed, a number of case-control and descriptive studies have 
related the magnitude and duration of postprandial lipaemia (Groot et al. 1991; 
Patsch et al. 1992; Ryu et al. 1992; Nikkilii et al. 1994; Karpe et al. 1998; Karpe et 
al. 1999; Boquist et al. 1999) and impaired postprandial metabolism ofTRL particles 
(Simons et al. 1987; Karpe et al. 1994; Meyer et al. 1996; Karpe et al. 1999; Ra-
jaratnam et al. 1999) to the presence of CHD and early atherosclerosis. The case-
control difference in the postprandial TAG response is very consistent among stud-
ies. Usually, cases have higher plasma TAG concentrations in the late postprandial 
phase or a generally elevated TAG area under the curve even after correction for the 
fasting level. In addition, the prospective Physician'S Heart Health Study demon-
strated that raised non-fasting plasma TAG concentration was a strong and independ-
ent predictor of future myocardial infarction (Stampfer et al. 1996). Collectively, 
these fmdings suggest an association between postprandial TAG metabolism and 
CHD and, therefore, the augmentation of postprandial lipaemia with high-
carbohydrate diets may indicate an atherogenic impairment of lipid profile. Further-
more, since HDL-cholesterol concentration is, at least partly, dependent on the effi-
ciency of postprandial TAG metabolism (Patsch et al. 1983; Patsch et al. 1987), it 
may be that the reduction in HDL-cholesterol observed as a response to high-
carbohydrate diets is a later secondary event associated with the impairment in TAG 
metabolism. 
However, the current anxieties about high-carbohydrate diets may be allayed if ways 
are found to introduce such diets without adversely affecting plasma TAG metabo-
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lism. Physical exercise may be a means of achieving this. Both exercise conditioning 
(Weintraub et al. 1989) and acute bouts of exercise (Aldred et al. 1994; Tsetsonis et 
al. 1997; Gill and Hardman 2000) have been shown to reduce postprandial TAG or 
TRL concentrations, at least when subjects are on their "normal" Western diets. It 
may be, therefore, that exercise, when simultaneously adopted with a high-
carbohydrate diet, could prevent the impairment of TAG metabolism observed with 
this dietary change and, in this way, optimise the effects of high-carbohydrate diets 
on lipoprotein lipid markers with regard to CHD risk. An important issue is that in-
activity is endemic in Western countries, including the UK (Sports Council and 
Health Education Authority 1992), and it is unrealistic to expect previously sedentary 
people to increase their exercise levels dramatically. Moderate exercise is probably 
less daunting than vigorous activity and this is acknowledged in current exercise 
guidelines, which recommend that adults should participate in exercise of moderate 
intensity on most, or preferably all, days of the week (Pate et al. 1995). Thus, with 
regard to public health, what needs to be investigated is the possibility that exercise 
of moderate intensity and duration, can attenuate or negate the hypertriacylglyc-
erolaemia observed with a high-carbohydrate diet. 
While a small number of studies have looked at the combination of high-
carbohydrate diet and exercise interventions, all of them have studied subjects at the 
fasted state (Liebman et al. 1983; Ullrich and Albrink 1986; Szostak and Cybulska 
1987; Thompson et al. 1988). To the best of the author's knowledge there is no in-
formation in the postprandial state. This state is particularly critical and dynamic 
(MiesenbOck and Patsch 1992) and could also be a determinant ofHDL-cholesterol 
concentration (Patsch et al. 1987; Patsch et al. 1992) and the size of population of 
small dense LDL particles (Karpe et al. 1 993b) that are potentially atherogenic 
(Griffin 1999). 
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AIMS OF THESIS 
The main aim of the research presented in this thesis was to investigate whether 
moderate intensity exercise, when combined with a low-fat, high-carbohydrate, can 
prevent the impairment of postprandial TAG metabolism which is usually observed 
with this dietary change. The specific aims of the individual studies were: 
Study 1 (Chapter 4) 
• To compare the effects of a short-term, low- and high-carbohydrate diet on 
postprandial TAG responses to a standard test meal. 
• To establish a short-term dietary intervention model for study of the hypertria-
cylglycerolemic effect of high-carbohydrate diets and thus its prevention. 
Study 2 (Chapter 5) 
• To test the hypothesis that daily moderate intensity exercise offsets the aug-
mentation of postprandial plasma TAG response associated with a high-
carbohydrate diet. 
Study 3 (Chapter 6) 
• To assess the effects of a high-carbohydrate diet with or without exercise on the 
TRL particles of exogenous (intestinal) and endogenous (hepatic) origin and 
their remnants. 
2.1 Introduction 
CHAPTER 2 
REVIEW OF LITERATURE 
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The aim of this chapter is to describe the scientific background to the studies pre-
sented later in this thesis. The first part of the review considers the metabolism of 
TAG and TRL particles in the postprandial state, its regulation and association with 
atherosclerosis. The second and third parts deal with the literature regarding the ef-
fects of high-carbohydrate diets and exercise, respectively, on TRL metabolism. Po-
tential mechanisms by which TRL metabolism is affected by high-carbohydrate diets 
and exercise are also discussed. 
2.2 Lipids and iipoproteins 
Lipids are essential for all living cells and have several important functions: as fuel 
molecules; as concentrated energy stores; as structural components of ceIJ mem-
branes; and as precursors for steroid hormones. The major lipids circulating in blood 
are TAG, non-esterified fatty acids (NEFA), phospholipids, cholesterol and choles-
terol esters. These lipids differ in their chemical and physical properties. Non-
esterified fatty acids, cholesterol and phospholipids are amphiphilic molecules with 
both hydrophilic and hydrophobic properties, whereas TAG and cholesterol esters 
are non-polar neutral molecules essentiaIJy insoluble in water. 
Plasma lipoproteins represent a variety of particles that have the major function of 
transporting the water-insoluble lipids in the blood. Lipoproteins are particles with a 
highly hydrophobic lipid core and a relatively hydrophilic outer surface. A typical 
lipoprotein particle consists of a core of TAG and cholesteryl ester, with an outer sur-
face layer of phospholipid and unesterified cholesterol. Each particle has associated 
with it one or more protein molecules, the apolipoproteins (apo), which have hydro-
phobic domains, which "dip into" the core and anchor the protein to the particle, and 
hydrophilic domains which are exposed at the surface of the particle (Frayn 1996). 
Lipoproteins consist of a heterogeneous group of particles with different lipid and 
protein compositions, and different sizes. They have been separated into groups or 
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fractions on the basis of hydrated density, flotation in an ultracentrifuge or electro-
phoretic mobility. Today, lipoproteins are most commonly classified according to 
their hydrated density or Svedberg flotation (Sr) value. Svedberg flotation value-
index is an operational index calculated from the density (11), viscosity (p) of plasma 
and the total centrifugation force (g x time) necessary to float a particle to the top by 
analytical ultracentrifugation (Chen and Reaven 1991). The higher the Srvalue, the 
more buoyant the particle and the greater its TAG content. It should be noted that 
lipoproteins do not form discrete fractions and each fraction may consist of a range 
of particles with somewhat different characteristics. The composition and character-
istics of the major lipoprotein fractions are presented in Table 2.1. There are four 
major fractions: Chylomicrons, very-Iow-density lipoproteins (VLDL), low-density 
lipoproteins (LDL) and high-density lipoproteins (HDL). This classification also in-
cludes chylomicron renmants and intermediate-density lipoproteins (IDL). Chylomi-
cron renmants have similar physical properties to VLDL particles and fall into the 
VLDL density and flotation rate. IDL particles occupy the 1.006-1.019 g·mL·1 den-
sityrange and have a Srvalue of 12-20. VLDL particles can be subdivided into two 
groups: VLDLl (large) with Srvalue of60-400 and VLDL2 (small) with Srvalue of 
20-60. 
Chylomicrons and VLDL particles are relatively rich in TAG and are usually re-
ferred to as the TAG-rich Iipoproteins (TRL); they are mainly concerned with deliv-
ery of TAG from the intestine (chylomicrons) or the liver (VLDL) to tissues. LDL 
and HDL are smaller particles and are more involved with transport of cholesterol to 
and from cells (LDL and HDL, respectively). 
Density range 
(g·mr1) 
Flotation value Diameter Composition (% by weight) 
Fraction (Sf) (nm) Major Iipids Major apolipoproteins Protein TAG C PL 
Chylomicrons < 0.950 >400 80-1000 Dietary TAG B48, AI, All, Cl, Cll, cm, E 1 90 5 
VLDL 0.950-1.006 20-400 30-80 Endogenous TAG BI00, Cl, Cll, cm, E 10 65 13 
LDL 1.019-1.063 0-20 20-22 CandCE BlOO 20 10 45 
HDL 1.063-1.090 0-9 9-15 CE and PL AI, An, Cl, cn, cm, E 50 2 18 
Abbreviations used: Sf, Svedberg flotation index*; C, cholesterol; CE, cholesteryl ester; PL, phospholipid. 
*Svedberg flotation index is an operational index calculated from the density (Jl), viscosity (p) of plasma and the total centrifugation force (g 
x time) necessary to float a particle to the top by analytical ultracentrifugation. The higher the Srvalue, the more buoyant the particle and the 
greater its TAG content. 
Table 2.1. Characteristics of the major lipoprotein classes. Adapted from Frayn (1996) and Mangiapane and Salter (1999). 
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2.3 Metabolism of postprandial lipid and TRL particles 
Most studies on lipid transport have been perfonned in the postabsorptive state, when 
TAG metabolism and lipid transport have reached equilibrium. Studies in the postab-
sorptive state monitor the endogenous pathway oflipid metabolism, whereas studies 
in the postprandial state monitor the exogenous pathway of lipid metabolism super-
imposed on that of the endogenous pathway (Kirchmair et al. 1995). 
2.3.1 Metabolism of chylomicrons and their remnants: the exogenous pathway 
Chylomicrons are secreted by the intestine after fat intake (Green and Glickman 
1981, for review) and provide the means to introduce newly absorbed dietary fat into 
the body. Most dietary lipid (-95 %) is in the fonn of TAG and under nonnal condi-
tions absorption offat is almost complete. The flux oflipid from the gut to the 
plasma compartment is highly efficient. A meal including about 100 g of fat is easily 
absorbed in 5 hours (Karpe 1992). 
The assembly and secretion of TAG-rich chylomicrons in the intestine are absolutely 
dependent on the presence of one molecule of apo B48 as the structural protein 
(Chen and Reaven 1991), which in human subjects is fonned exclusively in the in-
testine after tissue-specific editing of the apo BI00 mRNA (Chan 1992). This apo B 
variant comprises the N-terminal 48 % of the liver-derived variant of apo B, apo 
Bl 00, and hence its name (Kane et al. 1980). Synthesis of apo B 1 00 has also been 
described in the human intestine, the quantitative significance of this is however still 
unknown (Hoeg et al. 1990). It seems that apo B48-containing particles are continu-
ously secreted from the enterocyte and at times of excessive TAG availability (i.e. 
after fat ingestion) lipid droplets fuse with nascent particles resulting in secretion of 
very large chylomicrons (Hayashi et al. 1990) containing -90 % TAG. In addition to 
apo B48, nascent chylomicrons also contain apo AI, All and AIV that are de novo 
synthesised by intestinal cells (Green and Glickman 1981). The chylomicrons se-
creted by the intestine are transported into the systemic circulation via the Iymphatics 
and enter the blood stream via the thoracic duct in the left subclavian vein. The heart 
and lungs are the first organs exposed to chylomicrons (Goldberg et al. 2000). 
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Once the chylomicron has reached the blood stream several compositional changes 
take place. Apo AI is transferred to circulating HDL particles with reciprocal transfer 
of apo Cl, Cll, cm and apo E. In conditions oflow HDL concentrations apo Cs and 
apo E may be transferred to nascent chylomicrons from resident VLDL particles 
(Karpe 1999). Apo Cll is the essential activator of lipoprotein lipase (LPL) (Cryer 
1981), the key-enzyme for the hydrolysis of the massive TAG content of chylomi-
crons. LPL is located on the surface of capillary endothelial cells of a number of tis-
sues such as heart muscle, lungs, adipose tissue and skeletal muscle (EckeI1989). 
The roles of apo Cl and apo cm in the metabolism of TRL are not well understood. 
Apo Cl seems to inhibit the uptake ofTRL remnant particles by receptors 
(Weisgraber et al. 1990) whereas apo cm seems to inhibit both hydrolysis of TRL-
TAG by LPL (Ginsberg et al. 1986) and the removal ofTRL by hepatocytes 
(Windier and HaveI1985). Some TAG is also transferred to LDL and HDL particles 
in exchange for cholesteryl esters, catalysed by cholesteryl ester transfer protein 
(CETP) (Miesenhiick and Patsch 1992). During the time they spend in the circula-
tion, chylomicrons lose 80 % to 90 % of their TAG content and are subsequently 
smaller in size (Cohn 1998). During this catabolism, the surface apo As and almost 
all apo Cs, together with cholesterol and phospholipids, are released and transferred 
to HDL (Chen and Reaven 1991). The depletion from phospholipids is essential for 
unmasking ofapo E on the surface of the particle, by which the TAG-depleted parti-
cle - chylomicron remnant - binds to lipoprotein receptors in liver (Jansen et al. 
1998). The chylomicron remnant is rich in cholesteryl ester and contains two major 
protein components: apo B48 and apo E. 
The chylomicron remnant is, under normal conditions, subsequently taken up by spe-
cific receptors in the liver. Two receptors appear to have a significant role in the re-
moval process in the liver in vivo: the LDL receptor and the LDL receptor-related 
protein (LRP) (BeisiegeI1995). For both receptors, apo E is the key ligand mediating 
the binding and subsequent endocytosis of the particle (Curtiss and Boisvert 2000). 
The binding of the remnant particle to the LRP may be with direct interaction or, to a 
much greater extent, by initial binding to heparan sulfate proteoglycans on the hepa-
tocyte surface and subsequent presentation of the particle to the LRP (Beisiegel 
1995). Even in the absence of apo E there is hepatic remnant removal which, al-
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though it is slow, can clear the particles with some efficiency (Cooper 1997). In the 
absence of apo E, hepatic lipase may serve as a ligand for the LRP (Cooper 1997; 
Jansen et al. 1998). LRP could bind chylomicron remnants also through LPL 
(BeisiegeI1995; Jansen et al. 1998). It has been suggested that, during degradation 
of chylomicrons by LPL, some LPL remains associated with the chylomicron rem-
nants and is released from its endothelial binding site, subsequently mediating the 
uptake of remnants by the liver (Jansen et al. 1998). Proteoglycan-bound hepatic li-
pase on the hepatocyte surface may also serve as a binding site for sequestration, 
further lipolysis and subsequent direct internalisation of the remnant particle lacking 
apo E (Cooper 1997; HaveI1998). Alternatively, this particle could be internalised 
after binding to proteoglycans directly (Cooper 1997; HaveI1998). The last two pro-
cesses constitute non-receptor mediated uptake of chylomicron remnants by the liver. 
Once within the hepatocyte, chylomicron remnants are subject to lysosomal degra-
dation, which releases their components for further degradation, storage or resynthe-
sis. Recently, removal oflarge chylomicron remnants by adipose and muscle tissues 
has been demonstrated in humans in vivo (Karpe et al. 1997b). This removal may be 
mediated by the recently discovered VLDL receptor (Wyne et al. 1996; Multhaupt et 
al. 1996), which recognises apo E as a ligand and is most abundant in skeletal muscle 
and adipose tissue. The VLDL receptor may be important for delivering offatty ac-
ids from TRL remnants to peripheral tissues, such as muscle and adipose tissue, al-
though this remains to be elucidated. 
The half-life of chylomicron-TAG in healthy subjects is only 5-10 minutes (Havel 
1994). The capacity ofLPL to hydrolyse chylomicron-TAG is very high, so that 
TAG clearance is not normally saturated even by large fat loads (HaveI1994). This 
is probably achieved by binding oflarge chylomicrons to the vascular endothelium 
i.e. margination (Karpe et al. 1997a; Hultin and Olivecrona 1998). In this way, each 
particle interacts with several LPL molecules, yielding very rapid catalysis. By con-
trast, removal of chylomicron remnants by the liver is relatively slow, occurring over 
15 minutes or more and remnant clearance is generally saturated after a fat-
containing meal (HaveI1997). Thus, the intestinally derived (apo B48-containing) 
TRL particles found in blood in the postprandial and postabsorptive states can be 
considered to be remnants, in the sense that they are at least partially hydrolysed 
(HaveI1994). 
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2.3.2 Metabolism ofVLDL and their remnants: the endogenous pathway 
VLDL, which is synthesised in the liver, is the transporter of endogenous TAG in 
plasma. Hepatic VLDL production is primarily substrate driven, the most important 
regulatory substrate being fatty acids. Fatty acids may be derived from at least four 
sources: de novo lipogenesis; cytoplasmic TAG stores; fatty acids derived from cir-
culating lipoproteins taken up by the liver; or exogenous (non-esterified) fatty acids 
(Lewis 1997). The nutritional and honnonal state of the organism detennines the rate 
ofVLDL secretion. Therefore, it is the balance between oxidation of fatty acids in 
the liver and the relative contribution of all of these TAG/fatty acids flux rates, all 
regulated to a greater or lesser extent by insulin, which ultimately detennines the 
availability of hepatic TAG for VLDL secretion (Karpe 1999). The insulin regulation 
ofVLDL production will be discussed in section 2.4.1. 
VLDL particles are secreted continuously from the liver in size and density that 
ranges across the full Sf 20 to 400 spectrum (Packard and Shepherd 1997). When se-
creted they contain, as well as TAG (the main lipid), a single molecule ofapo BlOO 
together with other apolipoproteins, including apo AI, All, AIV, the three apo Cs and 
apo E (Havel 1997). Newly secreted VLDL particles acquire additional apo E and C 
from circulating lipoproteins, mainly HDL. The catabolism ofVLDL is similar to 
that of chylomicrons, with the TAG undergoing hydrolysis by LPL (facilitated by 
apo CII) and the redundant surface material being passed to other particles, mainly 
HDL. Exchange of lipoprotein core lipids between cholesterol-rich particles (LDL 
and HDL) and VLDL is catalysed by CETP. VLDL remnants are produced at a con-
siderable slower rate than chylomicron remnants and, therefore, VLDL may circulate 
normally without appreciable hydrolysis for several minutes or more (HaveI1997). 
As the VLDL particle becomes more delipidated, the remnants can either be taken up 
by the liver or they can continue through a "cascade" of delipidation to form IDL and 
fmally LDL. The ultimate remnant ofVLDL is LDL. 
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There is evidence to suggest that the majority ofthe largest, VLDL1 particles, after 
hydrolysis are cleared directly from plasma and only a minor fraction (-10 %) ap-
pears in the LDL pool (packard et al. 1984). There is even evidence that an apprecia-
ble proportion ofVLDL1 is directly removed from the circulation without appearing 
in the VLDL2 fraction (packard and Shepherd 1997). On the contrary, the smaller, 
VLDL2 particles which contain products ofVLDL1 delipidation and newly-secreted 
VLDL particles, are rapidly and substantially (> 40 %) converted to LDL, suggesting 
that the major precursor of the latter is to be found in the VLDL2 subfraction 
(packard et al. 1984). Interestingly, substantially metabolic heterogeneity is observed 
even within the VLDL2 fraction. VLDL2 particles that are derived by catabolism of 
VLDL1 are catabolised slowly within their flotation interval without being signifi-
cantly transferred to LDL. Conversely, directly synthesised VLDL2 are rapidly con-
verted into LDL (Packard et al. 1984). Similar processes to those for chylomicron 
remnants are likely to mediate the clearance ofVLDL1 and VLDL2, although the 
LDL receptor pathway seems to be the most important in the catabolism ofVLDL2 
(packard and Shepherd 1997). 
IDL are only present in low concentration in normal human plasma as it represents 
an intermediate stage in the formation ofLDL from VLDL. It has a low TAG and a 
high cholesteryl ester content than the VLDL and retains the apo B1 00 and apo E. 
IDL can either be uptaken by liver or become LDL particle through the action of 
LPL and mainly hepatic lipase and with loss of apo E. LDL consists of a cholesteryl-
ester enriched core with a shell containing phospholipid, free cholesterol and apo 
BIOO (Frayn 1996). It is removed from the circulation after binding to LDL receptors 
either in the liver (80 %) or in extrahepatic tissues 20 % (Mangiapane and Salter 
1999). The half-life ofLDL is several days. 
2.3.3 Integration ofTRL metabolism in the postprandial state 
In the postprandial state, chylomicrons and VLDL mix in blood and the two TRL 
species compete for the same lipolytic pathway, the action of LPL (Brunzell et at. 
1973; Karpe and Hultin 1995; Bjorkegren et al. 1996). During this period, there is an 
increase in the concentration of TAG and TRL particles in plasma but the contribu-
tion of each TRL species to these increases is largely different. The postprandial in-
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crease in plasma TAG concentration seems to be predominantly (-80 %) due to TAG 
contained within apo B48-containing 1RL particles (Cohn et al. 1993). Conversely, 
the increase in apo BI00-containing 1RL observed postprandially (Cohn et al. 
1988a; Karpe et al. 1993a; Schneeman et al. 1993) can account for as much as 80 % 
of the postprandial increase in the total apo B-containing 1RL particles (Schneeman 
et al. 1993). Thus, postprandiallipaernia predominantly represents the presence in 
plasma oflarge 1RL from the intestine (chylomicrons). but also reflects the plasma 
accumulation of1RL particles of hepatic origin. It has been calculated that endoge-
nous (apo B I 00) 1RL constitute 96-97 % and 91-96 % of all1RL particles in the 
fasted and postprandial state, respectively (Karpe 1999). Hence, the number of ex-
ogenous 1RL particles appearing postprandially is small and the basal production 
rate and turnover of endogenous 1RL are important factors determining the total 
lipoproteinaemic rise after fat intake. 
The postprandial accumulation of apo B 1 00 1RL particles has been a subject of re-
search and two main explanations have been given for this phenomenon: i) reduced 
clearance and/or ii) increased hepatic secretion. The rationale behind the first expla-
nation is that chylomicrons and VLDL compete postprandially for a common re-
moval pathway through LPL (Brunzell et al. 1973), which seems to hydrolyse chy-
lomicron-TAG in preference to VLDL-TAG (Ports et al. 1991). Therefore, in the 
postprandial state chylomicrons may be preferentially hydrolysed leading to accu-
mulation ofVLDL patricles. A number of studies have supported this speculation 
(Schneeman et al. 1993; Karpe et al. 1993a; Karpe and Hultin 1995; Bjorkegren et 
al. 1996). Schneeman et al. (1993) observed a remarkably close correlation between 
the average concentration, as well as the increment in concentration of1RL apo B48 
and apo B 1 00 postprandially. They concluded that these results were consistent with 
impairment of hydrolysis ofVLDL-TAG as a result of preferential hydrolysis of 
chylomicron-TAG by LPL, leading to VLDL accumulation. This line of reasoning 
was also followed by Karpe et al. (1993a) who presented the important fmding that 
postprandial increases in the concentration of apo B48 1RL was accompanied by 
elevation ofVLDL1 and reduced concentration ofVLDL2 particles. Additionally, the 
peak plasma level of the VLDL1 seemed to coincide with that for large chylomicron 
remnants, arguing for an impeded degradation ofVLDL particles. Karpe and Hultin 
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(1995) showed that endogenous TRL accumulate in rat plasma due to a failure to 
compete with a chylomicron-like TAG emulsion for a common lipolytic pathway. 
This contention was subsequently supported in humans by Bjorkegren et al. (1996) 
who, using a short-term intravenous infusion and stable isotope techniques, demon-
strated that the emulsion caused a 75-90 % block of the conversion ofVLDL1 to 
VLDL2 and there was no sign of enhanced synthesis ofVLDL1 after infusion of the 
TAG-emulsion. The implication of this finding is that VLDL1lipolysis does not 
"compete" effectively with chylomicron clearance and so is virtually suspended 
when the plasma content of chylomicrons is high, resuming when lipid absorption is 
complete. 
It has been suggested that substrate delivery to the liver is the major determinant for 
VLDL secretion (Sniderman and Cianflone 1993). Therefore, hypothetically an in-
crease in postprandial hepatic secretion ofVLDL particles might occur because of 
increased substrate availability, for example fatty acids derived from partially hy-
drolysed lipoproteins taken up by the liver, or lipids reaching the liver via the portal 
vein. Furthermore, LPL-derived fatty acids that are not efficiently entrapped by the 
adipose tissue (Frayn et al. 1997) may also serve as a substrate for VLDL secretion. 
In line with this reasoning, Cohn et al. (1990) studied the effect offasted and fed 
conditions on the synthetic rate ofVLDL apo BlOO using a stable isotope (deuterated 
leucine) dilution technique. They reported that secretion of apo VLDL apo Bl 00 is 
increased by -50 % in the fed state over that observed in the postabsorptive state. 
However, it was also reported that the rate of secretion ofapo BI00 in VLDL was 
-50 % of the rate of production of LDL apo B 1 00 in the fasted state, which raises 
some question about the method used (HaveI1994). Specifically, it has been reported 
that a patient homozygous for LPL deficiency who was heterozygous for familiar 
hypercholesterolaemia had very low LDL-cholesterollevels (Zambon et al. 1993), a 
fmding inconsistent with appreciable direct secretion ofLDL particles from the liver. 
In summary, the majority of the evidence indicates that the postprandial accumula-
tion ofVLDL particles is due to competition with chylomicrons for hydrolysis of 
TAG by LPL rather than increased VLDL secretion from the liver. 
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2.4 Regulation of postprandial TAG metabolism 
Postprandial TAG metabolism is regulated by a number off actors. The hormone in-
sulin and the enzyme LPL are discussed in this section. 
2.4.1 Insulin 
Insulin is an important regulator not only of carbohydrate but also of TAG metabo-
lism as well. In the postprandial state, insulin regulates both VLDL production and 
TRL-TAG hydrolysis byLPL (Frayn 1993). In vivo evidence suggests that acute hy-
perinsulinaemia suppresses VLDL-apo B and VLDL-TAG production by about 50 % 
in humans (Lewis et al. 1993; Lewis et al. 1995). This effect seems to be due to a 
number of mechanisms. First, insulin decreases NEFA availability for VLDL-TAG 
synthesis by decreasing intracellular hormone-sensitive lipase (HSL) activity in adi-
pose tissue (Coppack et al. 1994; Frayn et al. 1994) by dephosphorylation. Second, it 
appears that insulin (maybe in combination with the acylation-stimulating protein 
(Sniderman et al. 1997; Sniderman et al. 2000)} exerts a direct effect on the esterifi-
cation of fatty acids in adipose tissue and thus maintenance of a concentration gradi-
ent for the flow offatty acids from the site of LPL action to the adipocytes (Frayn et 
al. 1994). This effect is particularly important in the postprandial state when a major 
proportion of LPL-derived fatty acids may escape retention into the adipose tissue, 
accumulate in the capillary microenviroment and finally enter the plasma NEFA pool 
(Frayn et al. 1997). These fatty acids may have a negative effect on LPL activity 
(Eckel 1989), impairing TRL-TAG hydrolysis, and after entering the NEF A pool, 
may serve as an excellent substrate forVLDL-TAG synthesis. Insulin action, there-
fore, is to enhance entrapment of LPL-derived fatty acids into adipose tissue by 
stimulating their reesterification. Finally, insulin suppresses VLDL-TAG production, 
even in the presence of elevated NEF A, indicating that its suppressive effect is partly 
due to an NEFA-independent process (Lewis et al. 1995). A recent study 
(Malmstrom et af. 1997) demonstrated that VLDL secretion is under complex regu-
lation as insulin acutely suppresses VLDL1-apo B production but has no effect on 
VLDL2-apo B production from the liver. VLDL1 and VLDL2 production is, there-
fore, independently regulated. In the postprandial state this makes sense in that, with 
an ample supply of chylomicron-TAG for muscle and adipose tissue to utilise, there 
is little need for the liver to secrete large TRL particles. 
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Insulin also directly stimulates LPL in adipose tissue (Eckel 1989), which is a major 
site ofTRL-TAG hydrolysis. The stimulation of adipose tissue LPL by insulin is a 
complex and not well defined process and seems to involve increased transcription as 
well as post-transcriptional (probably changes in LPL mRNA stability) and post-
translational mechanisms (Braun and Severson 1992). Elucidation of the precise bio-
chemical mechanism is difficult as in vitro studies the cellular preparation may mat-
ter. A study in diabetic subjects treated with insulin (Simsolo et al. 1992) showed 
that adipose LPL activity increased without change in mRNA levels, suggesting 
post-transcriptional events. In skeletal muscle of healthy subjects, insulin has a sup-
pressive effect on LPL activity (Kiens et al. 1989; Y ost et al. 1995). The tissue spe-
cific regulation ofLPL by insulin has been clearly demonstrated by Farese et al. 
(1991). These authors showed that, in normal-weight subjects, insulin infusion, under 
conditions of euglycaemia, has a stimulatory effect on adipose LPL but an inhibitory 
effect on skeletal muscle LPL activity. However, these findings should be extrapo-
lated to the more realistic situation of the postprandial state with caution as it has re-
cently been reported (Y ost et al. 1998) that both skeletal and adipose tissue LPL ac-
tivity (assessed in biopsy tissue samples) increase significantly from fasted to post-
prandial state. 
2.4.2 Lipoprotein lipase 
LPL is synthesised in parenchymal cells of several tissues. Under processing in the 
endoplasmic reticulum and Golgi complex is translocated, by presently unknown 
mechanisms, to functional heparan sulphate proteoglycan binding sites on the lumi-
nal surface of the capillary endothelium, where the hydrolysis of TRL particles takes 
place (Braun and Severson 1992). The LPL activity of the white adipose tissue and 
muscular tissues (skeletal muscle and cardiac muscle) accounts for a high proportion 
of the total activity of the body and these tissues are most important, therefore, in the 
bulk removal of TAG from plasma (Cryer 1981). LPL is considered as the rate-
limiting step for plasma TRL-TAG hydrolysis. However, it is important to appreciate 
that several factors other than LPL are also critical modulators of this process in-
cluding the apolipoprotein composition of the particles, the size of the lipoproteins 
and how LPL is displayed along the endothelial luminal surface (Goldberg 1996). 
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LPL activity can be altered in a tissue-specific manner, which is physiologically im-
portant, because it directs fatty acid utilisation according to the metabolic demands of 
individual tissues. For example, fasting results in a reduction in LPL activity in adi-
pose tissue but stable or increased levels ofLPL in muscle whereas feeding has ex-
actly the opposite effects, at least in the adipose tissue (EckeI1989). These effects 
are probably orchestrated by insulin that is normally secreted after consumption of a 
mixed meal. Adipose tissue LPL action (measured as TAG extraction across subcu-
taneous adipose tissue) is low (but not completely inactive) in the fasted state and 
rises postprandially to fmal values two to three times those in the fasted state (Frayn 
et al. 1994; Fielding and Frayn 1998). Adipose tissue LPL action reaches its peak at 
four to five hours postprandially (around three to four hours of insulin stimulation), 
which coincides with the peak levels of TAG in plasma (Coppack et al. 1992; Frayn 
et al. 1994). Taking into consideration that adipose tissue appears to have a predomi-
nant role in postprandial clearance of circulating TAG, at least in sedentary subjects 
(Coppack et al. 1990, Ports et al. 1991), this represents a remarkable way in which 
TAG metabolism is regulated. However, as already mentioned in section 2.4.1, mus-
cle LPL activity probably also increases postprandially (Y ost et al. 1998) and, there-
fore, muscle tissue contributes to TAG hydrolysis after the consumption ofa meal. 
2.5 Factors affecting postprandial lipaemia 
Several factors, of which the postabsorptive plasma TAG concentration, preceding 
diet, age, gender and exercise seem to be the most important, affect postprandial 
TAG metabolism. These factors are discussed in this section except exercise, which 
will be discussed separately in section 2.9.2. 
2.5.1 Postabsorptive plasma TAG concentration 
Early studies by Denborough (1963) and Nestel (1964) demonstrated, in both CHD 
and control subjects, a close relationship between the degree of postprandial lipaemia 
and fasting TAG levels. Indeed, the endogenous TAG pool, which mainly represents 
VLDL particles, is an important determinant of the evolution of TAG concentration 
after fat intake (O'Meara et al. 1992; Ports et al. 1994). Since chylomicrons and 
VLDL compete for the same lipolytic pathway (Bnmzell et al. 1973; Bjorkegren et 
al. 1996), an increase in the fasting VLDL concentration leads to competition and 
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subsequent delay in the hydrolysis ofTRL particles postprandially, affecting the 
magnitude of postprandial lipaemia. Thus, when evaluating the postprandial re-
sponse, it is essential to consider the basal levels of TAG and TRL particles. Experi-
mental designs in which subject groups have comparable TAG and TRL levels could 
permit more robust conclusions that those where data have been adjusted to correct 
for differences in the basal state. 
Despite the close relationship between fasting and postprandial TAG levels, post-
prandial TAG response is often independent of basal TAG levels. This has been well 
demonstrated in studies where subjects exhibited higher postprandial lipaemia than 
others with similar fasting TAG concentration (Cohen et al. 1989; Merrill et al. 
1989). More importantly, postprandial TAG and TRL levels appear to be discrimi-
nators for the presence ofCHD, independently of baseline TAG levels. CHD patients 
with normal fasting TAG concentration have been shown to exhibit higher postpran-
dial TAG (Groot et at. 1991) and TRL apo B48 (Rajaratnam et al. 1999) levels than 
controls matched for baseline TAG concentration. The most convincing evidence of 
an association between exaggerated postprandial lipaemia and CHD risk, in the ab-
sence of elevated fasting plasma TAG, was provided by a study of (Uiterwaal et al. 
1994). The postprandial responses of sons of CHD patients were compared with 
those of healthy men. Although there was no difference in postabsorptive plasma 
TAG levels between groups, postprandial TAG concentrations at late time points 
were significantly higher in the sons of men with CHD. Therefore, postprandial TAG 
concentrations may be more closely related to atherogenic risk than those observed 
in the postabsorptive state. 
2.5.2 Preceding diet 
Altering the macronutrient composition of the background diet substantially influ-
ences postprandial TAG metabolism. Despite they contain less fat, low-fat, high-
carbohydrate diets exaggerate postprandial lipaemia. The effects of high-
carbohydrate diets will be discussed in detail in section 2.8.2. A relationship also ex-
ists between postprandial TAG response and saturation of dietary fatty acids. Sup-
plementation oflong-chain ro-3 polyunsaturated fatty acids leads to decreases in both 
fasting and postprandial TAG concentrations, even in doses as low as 1 g per day 
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(Roche and Gibney 2000). Dietary studies in human volunteers generally support the 
view that diets high in polyunsaturated fatty acid, particularly of 00-3 series, result in 
reduced fasting and postprandial TAG concentration and decreased residence time in 
the circulation of both chylomicron remnants and VLDL particles as compared to 
diets rich in saturated fat (Bergeron and Havel (1997) and Williams (1997) for re-
view). These effects are evident in postprandial responses to both polyunsaturated 
fat-rich and saturated fat-rich meals. Diets high in monounsaturated fatty acids seem 
to affect the pattern rather than the magnitude of the response compared to diets en-
riched in saturated fat. A recent cross-cultural study (Zampelas et al. 1998) compar-
ing Northern and Southern Europeans (habituated to saturated fat-enriched and 
monounsaturated fat-enriched diets, respectively) showed that subjects from South-
ern Europe exhibited a pronounced early increase in plasma TAG levels in response 
to fat meal, with a rapid return to fasting concentrations. In contrast, Northern Euro-
peans had a slow rise in TAG levels with sustained elevation beyond the six-hour 
postprandial period. The pattern of the postprandial TAG response in the two groups 
was not influenced by the test meal fatty acid composition (saturated fat-rich and 
monounsaturated fat-rich meal). These fmdings were subsequently confirmed by 
Roche et al. (1998) who conducted a study in which subjects were given a standard 
olive oil test meal twice: at the end of an eight-week monounsaturated fat-enriched 
diet and after an eight-week saturated fat-enriched diet. After subjects had consumed 
the monounsaturated fat-rich diet peak plasma TAG and TRL apo B48 concentra-
tions occurred earlier in the postprandial phase. 
2.5.3 Age and gender 
There is evidence that increasing age is accompanied by a greater postprandial re-
sponse. In a study by Cohn et al. (1988b), younger subjects (29 ± 2 years) exhibited a 
response that was 40 % lower than that of older subjects (66 ± 2 years). However, the 
older subjects also had higher fasting plasma TAG that, as already discussed, may 
have determined the difference in the postprandial response. The same study also 
showed that lipaemia is lower in females than males at all age groups. Tollin et al. 
(1985) reported that TAG clearance was greater in women than men for all age 
groups, although TAG clearance rates decreased with age for the females but not the 
males. 
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2.6 Methods for studying TAG and TRL metabolism 
The TAG metabolic capacity can be examined by a fat challenge, which is usually 
administered orally or intravenously. Presently, there is no consensus of how a stan-
dardised postprandial state should be elicited (for example dose or contents of an ex-
perimental meal), which makes comparisons of results of studies difficult. 
2.6.1 Oral fat tolerance test 
The oral fat tolerance test is an easy way to assess TAG metabolic capacity and 
which mimics the physiological situation. Postprandial lipaemia can be quantified as 
the total area under TAG concentration vs time curve (AUC) or as the incremental 
area, which is the total area normalised for the baseline values (patsch 1987). The 
size and composition of the fat meal utilised vary considerably. The size of the test 
meal can be adjusted according to body surface area, lean body mass, body mass or 
can be the same for all subjects. In a study in healthy young men (Cohen et al. 1988), 
subjects were fed liquid formulas containing 40 g, 80 g and 120 g of cream fat and 
postprandial TAG levels were measured over 8 hours. The lipaemic response (8-hour 
AUC) was proportional to the amount of fat ingested, which may indicate that re-
moval of TAG was not saturated by any of these amounts. Dairy cream is widely 
used despite some possible disadvantages (Karpe 1992). Dairy cream contains me-
dium-chain fatty acids that are not re-esterified in the enterocyte but are transported 
directly to the liver via the portal vein. This might obscure the postprandial plasma 
TAG response. Additionally, dairy cream may vary in fatty acid composition de-
pending on the season. In both these respects, common vegetable oils like corn oil or 
olive oil seem to be suitable although less palatable than dairy cream. Soybean oil 
has also been used by some researchers (Cohn et al. 1988a; Karpe et al. 1993a). 
Cohn et al. (1988a) investigated postprandial TAG and TRL responses in subjects 
who consumed fat as soybean oil or as soybean oil plus cream and found no differ-
ences. 
Both carbohydrate and protein should be supplied together with the fat to resemble 
the physiological situation, especially by eliciting a postprandial insulin response. 
Interestingly, simultaneous ingestion of carbohydrate and fat affects postprandial 
lipaemia. Glucose ingestion along with a fat load has been shown to diminish (Cohen 
• 
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and Berger 1990) or not to affect postprandial lipaemia (Cohen and Schall 1988). In 
contrast, fructose and fructose-containing carbohydrates (e.g. sucrose) augment the 
postprandial lipaemia induced by a fat meal (Cohen and Schalll988; Jeppesen et al. 
1995). The composition of the fat in the meal also has an effect on postprandial 
lipaemia. There is evidence of differences in postprandiallipaemic responses to 
meals containing predominantly saturated, monounsaturated, ro-6 polyunsaturated 
and ro-3 polyunsaturated fatty acids, with levels of TAG response in the order ro-3 
polyunsaturated fatty acids < ro-6 polyunsaturated fatty acids < monounsaturated 
fatty acids < saturated fatty acids (Williams 1997). Since the composition of the test 
meal affects postprandial lipaemia, it is necessary that an identical test meal is used 
when comparing postprandial TAG responses after different interventions, in order to 
be able to isolate the effects of the interventions from the acute effects of the test 
meals. 
2.6.2 Intravenous fat tolerance test 
With this methodology an artificial TAG emulsion (e.g. Intralipid) is injected intra-
venously and venous blood samples are obtained shortly at various intervals (e.g. 5-
minute intervals for 40 minutes). This test provides a measure of TAG clearance, in-
dependent of absorption processes in the gastrointestinal tract and the rate of synthe-
sis and influx of chylomicrons into the circulation. Elimination follows first-order 
kinetics (Le. the clearance rate is directly proportional to the concentration) with a 
constant fraction of the emulsion cleared from the plasma per unit time (Kirchmair et 
al. 1995). The calculated slope is a measure of the TAG-clearance capacity. This 
method assumes that VLDL production and degradation is constant for the duration 
of the test and that the particles in the TAG emulsion behave as chylomicrons . 
2.6.3 Oral retinyl ester assay 
The aim of this test is to distinguish between exogenous and endogenous TRL parti-
cles. The presence of intestinal TRL can be detected by measuring plasma retinyl 
esters (Kirchmair et al. 1995). The rationale for this approach is based on the concept 
that orally ingested vitamin A is esterified in the intestine and is incorporated into the 
core of chylomicron particles. These lipoproteins are secreted into intestinal lymph, 
and their component TAG is hydrolysed by LPL in peripheral tissues. Retinyl esters 
24 
are believed to remain associated with chylomicrons during lipolysis, not to be ex-
changed between lipoproteins in plasma and to be taken up by the liver within chy-
lomicron remnant particles. Evidence suggests that the liver does not resecrete these 
retinyl esters and that they are either stored in liver or resecreted as unesterified reti-
nol bound to retinol binding protein. Therefore, they have been used as markers in 
plasma for lipoproteins of intestinal origin. It is clear that in the hours immediately 
after vitamin A and fat ingestion, the maj ority of plasma retinyl esters are indeed as-
sociated with apo B48-containing TRL particles (Cohn et al. 1993). However, later 
after a meal, a significant proportion of plasma retinyl esters is associated with apo 
BIOO lipoproteins within the TRL as well as the LDL fraction (Krasinski et al. 
1990). Furthermore, the retinyl palmitate does not provide uniform labeling of chy-
lomicrons as it is probable that the larger species carry more retinyl palmitate than 
the smaller ones (Karpe et al. 1995). 
2.6.4 Direct measurement of apo B48 and apo BIOO in the TRL fraction 
This is the most accurate way for quantification ofTRL particles of exogenous and 
endogenous origin, although it is a major methodological challenge. The determina-
tion of apo B48 and apo B 100 in TRL fraction is difficult for several reasons (Karpe 
and Hamsten 1995). First, the amino acid sequence of apo B48 is identical to the N-
terminal 48 % of apo BlOO. Second, apo B48 is present at very low concentrations in 
plasma compared with apo B I 00. Third, the expression of apo B epitopes may vary 
depending on the lipid content of the particle. These circumstances restrict the basis 
for using immunochemical techniques to quantify the two apo B species accurately. 
Thus, attempts to measure TRL apo B48 and apo B I 00 concentrations have focused 
on analytical sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS 
PAGE). A method by Karpe and Hamsten (1994) allows the sensitive quantification 
of TRL apo B48 and apo B 1 00 concentrations in plasma, without differences in 
chromogenicity between apo B48 and apo B 1 00, by applying restricted masses of 
apo B on the gel. In addition, plasma and TRL-apo B48 concentrations have been 
determined using a competitive enzyme-linked immunosorbent assay (ELISA) 
(Love grove et al. 1996). With this method, a specific polyclonal anti apo B48 antise-
rum is used, which recognises the C-terminal region of the protein on the surface of 
lipoprotein particles, showing no cross-reaction with apo BI00 (Peel et al. 1993). 
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2.7 Postprandial TAG metabolism and atherosclerosis 
Relationships between plasma TAG concentration and CHD have largely been de-
scribed in the fasted state (Hokanson and Austin 1996). Triacylglycerol itself is not a 
component of plaques and there is a debate as to whether the effects of TRL particles 
on atherosclerosis are direct or indirect (Grundy and Vega 1992). Postprandial 
lipaemia is transient hypertriacylglycerolaemia, which affects the physical charac-
teristics and particle composition of all major plasma Iipoproteins in a way that it 
may contribute to the initiation and progression of atherosclerosis and CHD. In the 
past decade, there is a wealth of evidence for a potential link between postprandial 
TAG metabolism and the development of atherosclerosis. 
An independent association between increased postprandial TAG levels and CHD 
has been demonstrated by Patsch et al. (1992) in a study investigating 61 male nor-
molipidaemic subjects with severe CHD and 40 control subjects as verified by angi-
ography. Patients with CHD exhibited a higher and prolonged postprandial TAG re-
sponse compared to controls. By multivariate logistic-regression analysis, including 
HDL cholesterol, postprandial TAG concentrations were independently associated 
with the disease, whereas fasting TAG level was not. Notably, postprandial TAG 
concentration (6 hours) predicted the presence or absence ofCHD with accuracy (68 
%) which was higher than that ofHDL2-cholesterol (64 %). In another study, post-
prandial TAG response was again pronounced and late in normolipidaemic patients 
with severe coronary atherosclerosis compared to matched controls (Groot et al. 
1991). Similar results have also been reported by others (Nikkil1i et al. 1994). 
Postprandial TAG concentrations seem to be a potential discriminator not only for 
the presence of severe CHD but for early atherosclerosis as well. In healthy asymp-
tomatic subjects, a commonly used surrogate marker for early atherosclerosis is the 
intima-media thickness of the common carotid artery, measured by B-mode ultra-
sound. Ryu et al. (1992) reported a strong and independent association between the 
peak postprandial TAG concentration and the carotid artery intima-media thickness 
in 47 healthy middle-aged men and women. In accordance with these results, post-
prandial TAG response (expressed as incremental AUC) in asymptomatic mildly hy-
perlipidaemic individuals (Sharrett et al. 1995) and late (6 hour) postprandial TAG 
26 
concentration in healthy men (Karpe et al. 1998) have been possitively associated 
with early atherosclerosis, independently of both fasting TAG and LDL cholesterol 
levels. Boquist et al. (1999) recently demonstrated an independent association be-
tween early (2 hour), rather than late, postprandial TAG levels and carotid artery in-
tima-media thickness in healthy men. A possible explanation for this rather "un-
usual" finding given by the experimenters was the inclusion of apo E3 homozygotes 
only, because postprandial lipoprotein metabolism is impaired in individuals carrying 
the apo E4 allele (Bergeron and Havel 1996). Notably, in the majority of the above 
mentioned studies (Ryu et al. 1992; Karpe et al. 1998; Boquist et al. 1999), HDL-
cholesterol did not correlate significantly with early atherosclerosis even in univarl-
ate analyses, implying that this lipid may not be a discriminator of the early phase of 
CHD. 
The precise way in which postprandial TAG metabolism affects the pathogenesis and 
progression ofCHD has not been elucidated yet but it seems that it is associated with 
a constellation of potentially atherogenic lipoprotein changes. These include: i) in-
crease in the plasma concentration ofTRL particles and their renmants; ii) decrease 
in HDL-cholesterol due to core lipid exchange between HDL and postprandial TRL; 
and iii) formation of small dense LDL that are potentially atherogenic. 
2.7.1 Postprandial increase in TRL particles and their remnants 
Zilversmit (1979) was the first to propose a link between postprandial TRL renmants 
(principally chylomicron renmants) and atherosclerosis. He proposed that athero-
genesis involved the binding of these renmants to the arterial wall, hydrolysis of their 
TAG by arterial LPL and subsequent internalisation of the renmant by arterial 
smooth muscle cells. Four case-control studies suggest a relationship between ele-
vated postprandial levels of apo B48-containing TRL and the presence of CHD. Two 
of them were performed in women (Meyer et al. 1996; Rajaratnam et al. 1999) and 
two in men (Simons et al. 1987; Karpe et al. 1994). The study by Meyer et al. (1996) 
showed that fasting, but not postprandial, apo B48-containing TRL particles were 
higher in women who had developed CHD in the presence of normal LDL- and 
HDL-cholesterol concentrations, but increased non-HDL-cholesterol, compared with 
matched controls. The authors speculated that this was probably due to increased se-
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cretion of these particles by the intestine in the fasted state. In the study by 
(Rajaratnam et al. 1999), the authors compared postprandial metabolism of TAG and 
apo B48-containing TRL particles between normolipidaemic postmenopausal women 
with CHD and controls. The two groups were matched for age and body mass index 
and had similar fasting plasma and lipoprotein concentrations of major Jipids (except 
lower LDL-cholesterol) and apo E phenotype distribution. There was no difference 
in the plasma postprandial TAG response between cases and controls. However, the 
cases had higher fasting TRL apo B48 levels and incremental AUC than the controls 
even after adjustment for baseline TRL apo B48 and LDL-cholesterol concentrations. 
The authors inferred that the clearance of intestinally derived lipoproteins is dimin-
ished in women with CHD. Unfortunately, in both these studies the apo B 1 00-
containing TRL particles were not measured. 
Simons et al. (1987) demonstrated a higher apo B48 to apo BI00 ratio in the Sf> 60 
fraction at 4 hours postprandial in CHD male patients compared to controls. How-
ever, in this particular comparison, the controls had significantly lower fasting TAG 
concentration, which could have been reflected in their lower apo B48 to apo B 1 00 
ratio at 4 hours (the time of maximal postprandial lipaemia). When the same com-
parison was made with a baseline TAG-matched control group, no difference was 
observed between cases and controls. In a comprehensive study by Katpe et al. 
(1994), small chylomicron remnants (apo B48-containing TRL in the Sf> 20-60 
fraction) correlated positively with the rate of progression of coronary artery athero-
sclerosis, as assessed by coronary angiographies separated by approximately five 
years in 32 male patients with CHD. This relationship was independent ofHDL-
cholesterol and small dense LDL particle levels. Finally, one study which has inves-
tigated cases with early atherosclerosis, rather than CHD, demonstrated a higher TRL 
apo B48 to apo B 1 00 ratio at 8 hours postprandially in cases than in controls who 
were not, however, matched for baseline lipids and other risk factors for CHD 
(Sharrett et al. 1995). 
Although a number of studies have examined the potential involvement of intesti-
nally derived TRL particles in atherosclerosis, as originally suggested by Zilversmit, 
closer examination of lipid metabolism and the interactions between lipoproteins that 
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occur in the postprandial state has directed the interest to apo B lOO-containing TRL 
particles as well. A recent study in humans (Karpe et al. 1997a) showed that a major 
proportion of chylomicron remnants are removed from plasma long before they at-
tain a size at which they may penetrate the arterial wall. Furthermore, recent detailed 
examinations of compositional features of human fasting and postprandial chylomi-
cron and VLDL particles (Bjorkegren et al. 1997; Bjorkegren et al. 1998) have re-
vealed that VLDL particles attain remnant characteristics in the postprandial state. 
Specifically, both large and small VLDL become cholesterol, apo E- and apo Cl en-
riched, but depleted in apo crr in the postprandial state. Large and small chylomicron 
remnants contain significantly more apo CII molecules per particle than VLDL in 
fasted and postprandial states, which helps to explain the reduced efficiency of 
VLDL, and especially VLDLh for lipolysis postprandially. The transient increase (by 
50 %) in cholesterol content (Bjorkegren et af. 1997) and concentration (Karpe et al. 
1993a) ofVLDL1 in the postprandial state could explain why the postprandial TRL 
accumulation of cholesterol is mainly accounted for by VLDL particles (Schneeman 
et al. 1993). Apo E-enriched VLDLl particles can be uptaken by macrophages in the 
arterial wall through rapid, receptor-mediated processes and, therefore, contribute at 
least to the initiation offoarn cells in the arterial wall (Bradley and Gianturco 1994). 
Notably, VLDL1 carry three to six times more cholesterol than one LDL particle 
(Bradley and Gianturco 1994). This may suggest a role for postprandial VLDL in 
atherogenesis. An important contribution to this issue has been made by Rapp et al. 
(1994) who used immunoaffmity chromatography to isolate TRL particles from hu-
man atherosclerotic plaque removed during surgery. They found about one-third of 
the lipoprotein-associated cholesterol in the IDLNLDL fraction. Plaque IDL and 
VLDL were significantly larger than the respective equivalents from plasma and 
were substantially apo E-enriched, i.e. they had remnant characteristics. Apo B48 
was not found. Indirect evidence for a link between VLDL and CHO is also given by 
Karpe et al. (1999) who recently compared the pattern ofTRL particles in the post-
prandial state in hypertriacylglycerolaemic subjects with and without manifest coro-
nary atherosclerosis. The postprandial accumulation oflarge VLDL was the most 
pronounced discriminator between these groups whereas there was no disproportion-
ate increase in apo B48-containing particles. 
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At the moment, there is no evidence that the type of apo B itself has an effect on the 
extent of atherosclerosis. A recent study ('l eniant et al. 1997) examined the extent of 
atherosclerosis in apo E knockout mice that synthesise exclusively either apo B48 or 
apo B 1 00. The type of apo B did not have an effect on susceptibility to atherosclero-
sis. In conclusion, it seems that the atherogenic potential of a lipoprotein species de-
pends on its actual concentration in plasma, size and ability to interact with macro-
phage scavenger receptors. All the current data suggest that perturbed postprandial 
TRL metabolism is related to atherosclerosis. However, there is currently limited 
evidence for an association between CHD and a specific accumulation of chylomi-
cron remnants compared to apo B I 00 TRL remnants. 
As the metabolism of exogenous and endogenous TRL particles are so tightly linked 
and remnants of both origins have been implicated in atherosclerosis, it is reasonable 
to discuss studies relating TRL remnants and CHD. Remnant lipoproteins are hard to 
defme and even harder to isolate. They are the products of partial delipidation of 
TRL particles. As such they can exist throughout the Sf 0-400 density range along-
side new secreted particles. Remnants are cholesteryl-ester rich and have a high 
content of apo E and little apo CIl. There is a wealth of evidence linking TRL rem-
nant particles and risk or progression of atherosclerosis (Hodis and Mack 1998; 
Hodis 1999). Small cholesteryl-ester rich VLDL particles have been related to CHD 
severity in young hypertriacylglycerolaemic postinfarction patients (Tomvall et al. 
1993). In vivo measurements offluxes of various lipoprotein species across the in-
tima of human carotid arteries have also shown that elevated plasma concentrations 
of remnant lipoproteins (Sf 12-60) shared with LDL the potential for causing lipid 
accumulation in the arterial intima (Shaikh et al. 1991). Recently, a novel immunoaf-
finity method (Nakajima et al. 1993) has been developed to isolate remnant-like 
lipoprotein particles (RLP) and measure their cholesterol content (section 3.11.6). 
Increased levels ofRLP-cholesterol have been found in normolipidaernic men with 
CHD (Devaraj et al. 1998). RLP-cholesterol concentration has also been more 
strongly related with the severity score of coronary atherosclerosis in cases of sudden 
cardiac death than LDL-cholesterol concentration (Takeichi et al. 1999). Recently 
reference values have been published from the Framingham Study (McNamara et al. 
1998) but quantification of RLP-cholesterol in hard endpoint studies is sti11lacking. 
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2.7.2 Low HDL-cholesterol 
HDL particles are the smallest and densest of the lipoprotein classes. HDL regulates 
the removal and transfer of excess cholesterol from peripheral tissues to the liver, i.e. 
reverse cholesterol transport. According to hydrated density using preparative ultra-
centrifugation, HDL can be separated into mainly two subclasses, the lighter and 
larger HDL2 and the denser and smaller HDL3. HDL2 contains three to four times 
more cholesteryl ester and TAG molecules than HDL3 and is twice as "efficient" as 
HDL3 as a vehicle for fat transport (Eisenberg 1984). 
HDL and TRL metabolism is tightly linked so that constituents (free cholesterol and 
phospholipids) originating from the surface coat oflipolysed TRL particles constitute 
the major, ifnot the only, source ofHDL lipids (Eisenberg 1984). Fasting HDL-
cholesterol concentration shows a strong inverse association with plasma TAG levels 
in the fasted state (O'Meara et al. 1992) and postprandially (patsch et al. 1983). It is 
likely that hypertriacylglycerolaemia, either as a metabolic disorder or a transient 
postprandial phenomenon, results in accelerated exchange ofHDL-cholesteryl ester 
for TRL-TAG mediated by CETP. The TAG-enriched HDL particle is eventually 
remodeled by the action of hepatic lipase, which hydrolyses its TAG and phospho-
lipid, leading to the formation of smaller HDL. This remodeling promotes HDL ca-
tabolism, lowering the concentration of the cardioprotective and metabolically active 
HDL2 fraction and thus impairing reverse cholesterol transport (Tall 1992). A recent 
kinetic study (Lamarche et al. 1999) demonstrated directly in normolipidaemic hu-
mans that TAG enrichment ofHDL particles during an Intralipid infusion enhanced 
the metabolic clearance of apo AI (major apolipoprotein component ofHDL particle) 
from the circulation. The authors speculated that the increased susceptibility of TAG-
rich HDL particles to lipolysis by hepatic lipase compared with fasting HDL could 
have accounted for the enhanced catabolism of TAG-enriched HDL apo AI. Large 
VLDL particles seem to be preferentially involved in the core lipid exchange medi-
ated by CETP (Eisenberg 1985) and, therefore, the postprandial accumulation of 
large VLDL (Karpe et al. 1993a) could partly explain the inverse relationship be-
tween magnitude of lipaemia and fasting HDL2 or HDLrcholesterollevels (patsch et 
al. 1987). In line with the above reasoning, it has been suggested that the efficiency 
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of postprandial TRL metabolism determines the plasma level ofHDL cholesterol or 
larger HDL species in the postabsorptive state (patsch et al. 1992; Miesenbiick and 
Patsch 1992). 
An alternative interpretation for the link between HDL cholesterol levels and post-
prandial TRL metabolism has been given by Karpe et al. (1993c) who investigated 
men with previous myocardial infarction. These authors observed that if the subjects 
were arbitrarily divided into two groups according to fasting plasma HDL cholesterol 
concentration below and above 1.2 mmollL, those in the lower HDL cholesterol 
range showed strong, negative and linear relation between postprandial TRL re-
sponses and HDL-cholesterol concentration. In contrast, only a weak but still nega-
tive association was present in subjects in the upper HDL-cholesterol range. The 
authors speculated that low levels of fasting HDL-cholesterol or the larger HDL spe-
cies can limit the rate oflipolytic degradation of postprandial TRL, whereas at high 
levels ofHDL, TRL lipolytic degradation depends on factors other than HDL. This 
impact of a low HDL level may be mediated by decreased availability of apo cn, 
which impairs TRL-TAG lipolysis by LPL. This hypothesis is in a good agreement 
with results from a study in endurance-trained men (Cohen et al. 1991) whose HDL-
cholesterol levels were well above the distribution in the general population. There 
was no relationship between fasting HDL-cholesterol and the postprandial TRL re-
sponse. However, a subsequent study (Cohen and Grundy 1992) demonstrated that 
normolipidaemic men with low (-0.8 mmollL) or normal (-1.2 mmollL) HDL-
cholesterol concentration exhibited similar postprandial lipaemia. Similar results 
have also been reported by O'Meara et al. (1992). These fmdings argue for the dis-
sociation of postprandial TRL metabolism and fasting HDL-cholesterol, even at a 
Iow range of HDL-cholesterol concentration. It may be that high postprandiallipae-
mia is incompatible with high HDL-cholesterol concentrations but that low or normal 
postprandial lipaemia does not automatically confer high HDL-cholesterol. Accord-
ingly, impaired TRL metabolism is not the only cause oflow HDL-cholesterollev-
els. 
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2.7.3 Small dense LDL particles 
LDL particles have been subfractionated with different methods after the discovery 
of their heterogeneous nature. For example, Austin et al. (1988) using gradient gel 
electrophoresis separates LDL according to the size of the particle into two classes, 
pattern A and B. Griffm et al. (1990) separates LDL into three subclasses using den-
sity gradient ultracentrifugation, LDL I, LDL IT and LDL ill. 
The role of small dense LDL (defmed as pattern B, LDL ill or mean diameter of 
major peak < 25.5 nm) as a risk factor for CHD is well established (Austin et al. 
1988; Griffm et al. 1994; Griffm 1995; Gardner et al. 1996). A number of potential 
atherogenic mechanisms have been proposed: (i) lower affmity for the LDL receptor 
which will effectively increase their residence time in circulation for interaction with 
the arterial wall; (ii) smaller size which allows faster rate of infiltration into the en-
dothelium and subendothelial space than larger LDL; (iii) increased affinity for arte-
rial proteoglycans; and (iv) increased susceptibility to oxidation (Griffm 1999). All 
these processes work together in sequence to confer increased risk on small dense 
LDL. 
Although the LDL subclass distribution depends on genetic and environmental fac-
tors, fasting plasma TAG levels also seem to have an important effect. McNamara et 
al. (1992) showed a significant inverse association between change in LDL size and 
change in plasma TAG in a longitudinal study with a follow up period of about three 
years. Griffm et al. (1994) demonstrated a positive association between plasma TAG 
levels and the concentration ofLDL ill, when plasma TAG concentration was> 1.5 
mmollL. Therefore, it has been suggested that when TAG concentration exceeds this 
threshold level, formation of small dense LDL is facilitated (Packard 1999). 
The mechanisms of small dense LDL formation in the presence of high TAG levels 
(Griffin 1997) resembles that ofHDL particles (section 2.6.2). Briefly, it involves 
enrichment ofLDL with TAG from TRL mediated by CETP, followed by remodel-
ing of the TAG-enriched LDL particle by hepatic lipase. As the threshold of 1.5 
mmollL for plasma TAG is breached by postprandial lipaemia, the postprandial state 
could be of great importance for the formation of small dense LDL. As in the case of 
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HDL, large VLDL particles that accumulate postprandially act as an excellent donor 
of TAG to LDL and can enhance the formation of small dense LDL particles. It has 
also been suggested (packard 1999) that an increase in large VLDL levels gives rise 
to a LDL product that has a prolonged residence time in the circulation (-5 days). 
This LDL particle can be then converted to small dense LDL by the action of CETP 
and hepatic lipase (packard 1999). Karpe et al. (1993b) have shown that the magni-
tude of postprandial lipaemia is positively associated with the levels of small dense 
LDL in the fasted state. 
2.8 Effect of high-carbohydrate diets on TAG metabolism 
There has been considerable emphasis recently on reducing the fat content of the 
Western diet as one means to reduce CHD risk. However, low-fat diets that are nec-
essary relatively high in carbohydrate have been implicated in the development of 
hypertriacylglycerolaemia. This section will discuss the effects of high-carbohydrate 
diets on fasting and postprandial TAG level, factors that may influence TAG re-
sponse to this dietary change and potential mechanisms that may contribute to carbo-
hydrate-induced hypertriacylgJyceroJaemia. 
2.8.1 Effect of high-carbohydrate diets on fasting TAG concentration 
A large number of studies have investigated the carbohydrate-induced increase in 
fasting plasma TAG levels. As this thesis is primarily concerned with effects of high-
carbohydrate diets on postprandial lipaemia, the effects on fasted state will not be 
extensively reviewed here. Rather, some representative studies will be discussed. The 
interested reader is directed to the recent review paper by Parks and Hellerstein 
(2000). 
Ginsberg et al. (1976) investigated the effects of a "control" formula diet (40 % car-
bohydrate, 45 % fat) and an isoenergetic high-carbohydrate formula diet (55 % car-
bohydrate, 30 % fat), for a week each, in 24 subjects with different TAG levels. The 
diets were designed to maintain body weight (euenergetic diets). Dietary carbohy-
drate intake was comprised of dextrins, maltose, lactose and sucrose. The same ab-
solute amounts of sucrose were present in both diets. Both diets had a polyunsatu-
rated to saturated fat ratio of I to 1 and contained 300 mg of cholesterol per day. 
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Consumption of the low-fat diet resulted in a mean fasting plasma TAG concentra-
tion of41 % greater than that after one week on the control diet (P < 0.001). When 
the group was divided into thirds on the basis of their plasma TAG concentration on 
the control diet, the per cent increment in all three groups was comparable, suggest-
ing that the relative rise in plasma TAG concentration induced by the high-
carbohydrate diet was not a function of basal TAG levels. 
A meta-analysis of 27 controlled trials published between 1970 and 1991 (Mensink 
and Katan 1992) investigated the effect of exchanging dietary fatty acids for either 
other fatty acids or carbohydrates. The predicted change was that when 1 % of en-
ergy as fat (regardless of saturation) is replaced by carbohydrate, fasting plasma 
TAG concentration would rise by about 0.025 rnrnollL. For an "average" group of 
adult men on women with a daily energy intake of 10 MJ (2,400 kcal), 1 % of energy 
is equivalent to about 6 g of carbohydrate or 2.7 g of fat. In an earlier study (Mensink 
and Katan 1987), the same authors compared the effects on plasma TAG concentra-
tion of a high-carbohydrate diet, rich in fiber (62 % carbohydrate, 22 % fat, 60 g fi-
ber/day) or a high-monounsaturated fat diet (46 % carbohydrate, 41 % fat of which 
24 % monounsaturated, 43 g tiber/day) with a typical Western diet (48 % carbohy-
drate, 38 % fat of which 12 % monounsaturated, 42 g fiber/day). Each diet consisted 
of conventional mixed solid foods and was euenergetic. Subjects consumed the 
Western-type diet for 17 days. Then, two groups were formed (matched for fasting 
TAG concentration) and for the next 36 days one group followed the high-
carbohydrate, high-fiber diet and the other group followed the olive oil-rich diet. 
Compared to the Western diet, fasting TAG concentration rose by 0.19 rnrnollL on 
the carbohydrate-rich diet and fell by 0.06 rnrnollL on the olive oil diet (P < O.oI). 
Ullmann et at. (1991) used a unique design to investigate whether carbohydrate-
induced hypertriacylglycerolaemia can be avoided altogether if the carbohydrate 
content of the diet is increased gradually rather than suddenly in a single large step 
(such as when subjects are switched directly from diets containing 45 % of energy as 
carbohydrate to those containing 65 % of energy as carbohydrate). Eight healthy 
slightly overweight individuals took part and were sequentially fed five euenergetic 
diets: a typical American diet (40 % fat, 45 % carbohydrate and 15 % protein) and 
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four carbohydrate-rich diets that were each 5 % higher in carbohydrate and 5 % 
lower in fat than the preceding diet. Phase I high-carbohydrate diet contained 50 % 
of daily energy as carbohydrate and 35 % as fat. Corresponding values for the phase 
IV diet were 65 % and 20 %. Each dietary period lasted for 10 days. Compared with 
the values during consumption of the typical American diet, plasma and VLDL-TAG 
did not change significantly during the high-carbohydrate diet at any phase. In con-
trast, when six of the subjects switched suddenly from the typical American diet to 
phase IV high-carbohydrate diet, both plasma and VLDL-TAG concentrations in-
creased significantly. The authors concluded that the gradual phased-carbohydrate 
approach presumably allowed metabolic adaptation to occur without the usual 
stimulus of high-carbohydrate diets to enhance VLDL and TAG synthesis. Although 
this study has an attractive design and has been cited frequently to show that carbo-
hydrate-induced hypertriacylglycerolaemia may be avoidable, its interesting results 
were not confirmed by other studies (Kasim-Karakas et al. 1997). Kasim-Karakas et 
al. (1997) adopted a similar design in which dietary fat was decreased stepwise from 
a habitual intake (33 %) to 31 % (phase I), 24 % (phase II) and then to 14 % (phase 
ill). Corresponding values for carbohydrate intake were 51 %, 53 %, 60 % and 67 %. 
Each dietary period lasted four to six weeks (much longer than in the study by UII-
marm et al. 1991). Plasma fasting TAG concentration rose from 1.85 mmollL (phase 
I) to 2.10 mmollL (phase II) to 2.47 mmollL (phase ill) (P < 0.05). These results are 
interesting in that the increase in TAG concentration occurred even though subjects 
were given longer to acclimate to the dietary change than in the study by Ullmarm et 
al. (1991). These results have been confirmed by the same authors in a more recent 
study (Kasim-Karakas et al. 2000). Therefore, even with gradual increases in dietary 
carbohydrate intake on euenergetic diets, some individuals will experience elevations 
in fasting TAG concentration. 
2.8.2 Effect of high-carbohydrate diets on postprandial TAG concentration 
Compared to postabsorptive studies, a small number of studies have examined the 
effect of high-carbohydrate diets on postprandial TAG response. Furthermore, the 
majority of them had a "diurnal" TAG concentration approach rather than an ap-
proach of examining TAG response to a standard test meal. 
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In an early study, van Gent et al. (1979) compared mean diurnal TAG levels in two 
subjects on a high-carbohydrate-rich diet and on a high-fat diet, for two weeks each. 
They found that in both subjects mean diurnal TAG levels were higher after the high-
carbohydrate diet. In fact, TAG levels were higher on the high-carbohydrate diet at 
all time points (9.00, 13.00 and 17.00 hours), regardless of the distribution of meals 
over day. Similar results had previously been demonstrated by Ginsberg et al. 
(1976). These authors found that TAG levels were significantly elevated at 8.00 
hours (fasted state) and noon (prior to lunch) in 27 subjects on a high-carbohydrate 
formula diet (55 % carbohydrate), and although this difference became insignificant 
after the noon meal, postprandial TAG levels were never lower than those observed 
on a high-fat diet (40 % carbohydrate). In a later study (Coulston et al. 1983) ofa 
similar design but using a somewhat more carbohydrate-rich diet (60 % carbohy-
drate), it was shown that plasma TAG concentrations were significantly higher on the 
carbohydrate-rich diet not only in the fasted state and before the noon meal but also 
postprandially (one and three hours after the noon meal). 
A recent study (Jeppesen et al. 1997) investigated the effects ofa high-carbohydrate 
diet (60 % carbohydrate, 25 % fat) and a high-fat diet (40 % carbohydrate, 45 % fat) 
on fasting and day-long TAG levels in ten healthy postmenopausal women. The two 
diets were euenergetic, assigned in random order and lasted for three weeks each. 
The ratio of sugars to starch was identical in the two diets (0.33:0.66) as was the ratio 
of polyunsaturated to saturated to monounsaturated fat (1.0:1.0:1.2). The amount of 
dietary fibre per MJ was 2.2 g for the high-fat diet and 3.25 g for the high-
carbohydrate diet. Fasting plasma and VLDL-TAG concentrations were significantly 
higher after the subjects had consumed the high-carbohydrate diet. Also, day-long 
TAG concentrations in plasma and in the Sf> 400 and Sf 20-400 lipoprotein fractions 
were significantly higher on the high-carbohydrate diet. Vitamin A was given with 
the noon meal in an attempt to quantify intestinally derived TRL particles. Retinyl 
palmitate concentrations in plasma and the two lipoprotein fractions were signifi-
cantly higher after the high-carbohydrate diet with the most substantial increase in 
the Sf 20-400 lipoprotein fraction, indicating postprandial accumulation of chylomi-
cron remnants after this dietary regimen. 
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Using experimental diets of two-week duration and of identical composition with 
these in the study by Jeppesen et al. (1997), the same group reported similar results 
in male non-insulin dependent diabetes mellitus patients (Chen et al. 1993). The 
authors concluded that the postprandial accumulation of chylomicron remnants (as 
assessed with the retinyl palmitate method) after the 60 % carbohydrate diet was pos-
sibly related to the ability of the high-carbohydrate diet to stimulate VLDL-TAG 
synthesis and secretion and increase the endogenous VLDL pool. This, in turn, 
would increase the postprandial competition of intestinal and endogenous TAG for 
the LPL removal pathway, impairing intestinal TAG hydrolysis and increasing the 
accumulation of chylomicron remnants. The same authors in a subsequent study 
(Chen et al. 1995) corroborated this speculation in nine non-insulin dependent dia-
betes mellitus patients, who followed two diets, for six weeks each, in random order: 
a 40 % carbohydrate diet and a 55 % carbohydrate diet. In both fasted and postpran-
dial (over 24 hours) states, plasma TAG concentrations were significantly elevated 
after the 55 % carbohydrate diet. In this study, VLDL-TAG turnover was also meas-
ured after an eight-hour fast by giving an intravenous bolus of [3H]glycerol to label 
endogenous VLDL-TAG. This showed that VLDL·TAG pool size was significantly 
increased after the high-carbohydrate diet, and this resulted from an increase in 
VLDL-TAG production rate as well as a decrease in VLDL-TAG fractional catabolic 
rate. In light of these changes, the authors attributed the augmentation of postprandial 
lipaemia and accumulation of chylomicron remnants observed after the high-
carbohydrate to the increase in endogenous VLDL-TAG pool size and postprandial 
competition ofTRL particles for the TAG removal pathway. 
It should be noted that in all the above-mentioned studies, the test meals that were 
used to compare postprandial TAG responses after different diet regimes reflected 
the composition of the intervention diets. To the author's knowledge, there is only 
one study that has compared postprandial TAG responses after a low- and a high-
carbohydrate diet using an identical test meal (Blades and Garg 1995). In this study, 
ten male non-insulin dependent diabetes mellitus patients were fed an isoenergetic 
high-carbohydrate diet (55 % carbohydrate, 30 % fat) and a high-monounsaturated-
fat diet (40 % carbohydrate, 45 % fat) for six weeks in a randomised, crossover de-
sign. At the end of each dietary intervention, an oral fat tolerance test was performed 
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(50 g offat labelled with retinyl palmitate, no carbohydrate) and (on a separate day) 
postheparin plasma LPL activity was measured after an overnight fast. The high-
carbohydrate diet significantly increased fasting plasma TAG concentration but had 
no effect on postheparin plasma LPL activity. Incremental AUCs for plasma TAG 
concentrations were similar with both diets. However, visual inspection of the total 
AUCs (they were not reported) reveals that the high-carbohydrate diet resulted in 
higher total AUC, implying that this effect was due to the higher fasting TAG levels. 
There was no difference in the plasma retinyl palmitate response between the two 
diets, which, according to the authors, did not support a defect in chylomicron rem-
nant removal. These results may suggest that carbohydrate-induced increase in post-
prandial TAG levels in male non-insulin dependent diabetes mellitus patients was not 
related to an abnormal accumulation of chylomicron remnants. Rather, it may have 
been mediated by an increase in VLDL-TAG secretion in the fasted state. 
2.8.3 Factors affecting TAG response to a high-carbohydrate diet 
The response offasting TAG concentrations to high-carbohydrate diets depends on 
several factors the most important being the energy content, duration and carbohy-
drate composition of the diet. These factors presumably also affect postprandial TAG 
concentrations as fasting and postprandial concentrations are strongly related. Fac-
tors that affect lipaemia, independently of basal TAG concentration, are difficult to 
be elucidated because of the limited information from postprandial studies. One fac-
tor may involve a possible interaction between the chronic effects of the background 
(high-carbohydrate) diet and the acute effects of the test meal. As mentioned in sec-
tion 2.6.1, it has been reported that carbohydrate (fructose and sucrose) added to a fat 
load augments postprandial lipaemia compared to a fat-only meal (Cohen and Schall 
1988; Jeppesen et al. 1995). This effect has been attributed to an increase in VLDL-
TAG secretion by the liver (Cohen and Schal11988; Jeppesen et al. 1995) or/and a 
decrease in TAG clearance (Grant et al. 1994). It may be that this acute effect of the 
carbohydrate in the test meal is amplified after a high-carbohydrate diet. Therefore, 
the composition of test meal could be a factor determining the postprandial TAG ex-
cursion after a high-carbohydrate diet. This is discussed in chapters 4 and 5. 
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2.8.3.1 Energy content of the high-carbohydrate diet 
As discussed in section 2.8.1, controlled euenergetic high-carbohydrate diets, where 
fat is substituted with carbohydrate in order to maintain body weight, are usually as-
sociated with increases in plasma TAG concentration. However, studies in free-
living individuals in which high-carbohydrate diets were consumed ad libitum rather 
than euenergetically, have demonstrated no change (Kasim et al. 1993; Turley et al. 
1998) or significant decrease (Yu-Poth et al. 1999; Flynn et al. 1999) in fasting TAG 
concentration compared to typical Western diets. 
It is well recognised that ad libitum high-carbohydrate diets often cause weight loss 
(Sheppard et al. 1991; Lichtenstein and Van Horn 1998). The lower energy density 
and higher volume oflow-fat, high-carbohydrate diets result in automatic reductions 
in food and energy intakes. It seems that when consumption of high-carbohydrate 
diets is accompanied with weight loss, hypertriacylglycerolaemia is often avoided. A 
recent meta-analysis of 37 National Cholesterol Education Program Step I and Step 
IT dietary intervention studies in free-living subjects (n > 9000), published between 
1981 and 1997, showed by mUltiple regression analyses that for every I kg decrease 
in body weight, plasma TAG concentration decreased by 0.011 mmollL (Yu-Poth et 
al. 1999). Kasim et al. (1993) reported that in 34 free-living premenopausal women 
taking part in a dietary counseling prograrmne, a low-fat, high-carbohydrate diet re-
sulted in an average weight loss of 3.4 kg by the third month, without any further de-
crease until the next nine months of the study. Fasting plasma TAG concentration 
was unchanged during the 12-month study period. A six-week high-carbohydrate diet 
has also been reported to result in a significant decrease in daily energy intake and 
body weight by 1.9 MJ and 1.5 kg, respectively, with no change in plasma fasting 
TAG concentration in young men (Turley et al. 1998). A recent study (Flynn et al. 
1999) showed that an euenergetic National Cholesterol Education Program Step 11 
diet significantly increased plasma fasting TAG concentration in a group of 10 men 
and 10 postmenopausal women but, when the same diet was administered with a 15 
% energy restriction, plasma TAG concentration decreased. 
A recent comprehensive study (Kasim-Karakas et al. 2000) has specifically com-
pared the effects of a low-fat, high-carbohydrate diet under controlled euenergetic 
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and ad libitum conditions in a large group (n = 54) of postmenopausal women. The 
dietary intervention occurred in two phases. For the first four months, participants 
followed a controlled euenergetic diet in which fat intake was reduced in a stepwise 
manner from 31 % to 23 % to 14 % of energy (corresponding values for carbohy-
drate intake were 53 %, 60 % and 67 %). For the next eight months, they followed an 
ad libitum, self-selected, low-fat diet (12 % fat) under free-living conditions. During 
the euenergetic diet, fasting plasma TAG concentration gradually increased and by 
the fourth month, during the 14 % fat diet, it was (2.30 mmollL) significantly higher 
than the value at study entry (1.70 mmollL). However, two months after subjects 
switched to the ad libitum 12 % fat diet, fasting TAG concentration decreased to 1.90 
mmollL and, at the end of the 12-month study, TAG concentration (1.77 mmollL) 
was not significantly different from the baseline value (1.70 mmollL). During the ad 
libitum low-fat diet, subjects decreased their energy intake by 0.64 MJ per day, 
which was accompanied by an average loss of 4.3 kg over the eight-month study pe-
riod. 
2.8.3.2 Duration of the high-carbohydrate diet 
There is universal agreement that euenergetic high-carbohydrate diets induce hyper-
triacylglycerolaemia in the short-term. However, controversy exists on whether this 
effect is transitory or persistent. 
Mancini et al. (1973) reported that the carbohydrate-induced increase in fasting 
plasma TAG concentration peaked within 4-11 days and then diminished after 4-10 
weeks, although it did remain above baseline values. Kashyap et al. (1982) also 
showed that an euenergetic high-carbohydrate diet was associated with a rise and a 
subsequent decline towards baseline in TAG concentration by the third week. An 
early study in South African prisoners (Antonis and Bersohn 1961) has been widely 
cited to show that changing from a low-carbohydrate (45 % carbohydrate, 40 % fat) 
to a high-carbohydrate diet (70 % carbohydrate, 15 % fat) caused a rise in fasting se-
rum TAG concentration, regardless of the type of fat consumed on the low-
carbohydrate diet. TAG concentration reached a maximum (about double the starting 
value) three to five weeks after the dietary change. After 20-32 weeks on the high-
carbohydrate diet most of the subjects had TAG levels similar to initial values. This 
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study supported the concept that carbohydrate-induced elevation in TAG concentra-
tion is a transient phenomenon. 
A study in young healthy individuals (Brussaard et al. 1982) demonstrated that fast-
ing serum TAG concentration rose rapidly after the change-over from a control poly-
unsaturated fat-rich diet (31 % fat, 11 % as polyunsaturated fat) to an isoenergetic 
low-fat, high-carbohydrate diet (21 % fat, 4 % polyunsaturated fat) and remained 
stable afterwards. There was no sign of a decrease during the 13 weeks on the high-
carbohydrate diet. Brussaard et al. (1982) re-examined unpublished details of the 
study by Antonis and Bersohn (1961). This analysis showed that the white prisoners 
who had initially received a 45 % fat diet rich in saturated fatty acids indeed reached 
baseline fasting TAG concentration by the end of the high-carbohydrate diet. In con-
trast, those who had started out on a 45 % fat diet rich in polyunsaturated fatty acids 
had serum fasting TAG concentrations that were still above the baseline value after 
25 weeks on the high-carbohydrate diet, when most of them were taken off the study. 
According to Brussaard et al. (1982), this suggests that fasting TAG levels on a high-
carbohydrate diet will probably not return to baseline level if the baseline control diet 
has been moderate in fat but rich in polyunsaturated fatty acids, which is agreement 
with the results of their own work (Brussaard et al. 1982). Jones et al. (1987) also 
reported significantly higher fasting TAG concentration after four months on a high-
carbohydrate diet (64 % carbohydrate) than that during the baseline diet (45 % car-
bohydrate). 
Some epidemiologic evidence suggests that the rise in plasma TAG levels associated 
with high carbohydrate is not transient. Studies have shown that boys from popula-
tions with high carbohydrate intakes have higher fasting TAG concentration than 
boys from populations with lower carbohydrate intakes (West et al. 1990; Rubinstein 
et al. 1988). However, it has also been reported (Connor et al. 1978) that Tarahumara 
Indians of Mexico have mean plasma TAG levels (-1.4 mmollL) similar to those ob-
served in Western populations, although they are accustomed to a 75 % carbohydrate 
diet. Interpretation of epidemiologic evidence with regard to an association between 
habitual carbohydrate intake and fasting TAG concentration is difficult as TAG lev-
els can also be influenced by genetic factors, levels of physical activity and body fat. 
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2.8.3.3 Carbohydrate composition of the high-carbohydrate diet 
The type of carbohydrate consumed seems to play a role in determining the TAG re-
sponse to high-carbohydrate diets. Digestible forms of carbohydrate include simple 
sugars and starches. Indigestible forms of carbohydrate go under the name of fibre. 
The term "complex carbohydrate" is commonly employed as a category different 
from simple sugars but this term in confusing, as both starch and fibre are complex 
carbohydrates. 
Both sucrose and fructose, given at abnormally high amounts in the diet, have been 
shown to raise plasma TAG concentration (Frayn and Kingman 1995). Macdonald 
and Braithwaite (1964) were probably the first to report that large amounts (500 g) of 
sucrose caused an increase in TAG levels while starch did not. Reiser et al. (1978) 
compared the isoenergetic exchange of sucrose with cooked wheat starch at 30 % of 
daily energy intake (total carbohydrate, 43 %) for six weeks each in healthy indi-
viduals. Plasma TAG concentration was (significantly) higher by 33 % with sucrose 
than with starch. However, from other studies, it seems that isoenergetic exchange of 
sucrose with starch at energy levels < 30 % has often no effect on fasting TAG level 
(TruswellI994). At the moment, there is no hard evidence that simple sugars are 
more hypertriacylglycerolaemic in humans than starches, when they are not con-
sumed at abnormally large quantities. It can be that some subjects are more sensitive 
to dietary sugars than others and this predisposition could be related to the individ-
ual's insulin sensitivity (Frayn and Kingman 1995). It is recommended that the ratio 
of starch to sugars is maintained at 50:50 or higher (Parks and Hellerstein 2000). 
Fibre seems to protect against carbohydrate-induced hypertriacylglycerolaemia, 
when the diet is high in simple sugars (e.g. sucrose) (Albrink and Ullrich 1986). 
Abrink and Ullrich (1986) reported that the increase in fasting plasma TAG concen-
tration, observed after 70 % carbohydrate diets providing 36 % of energy as sucrose, 
was partially prevented by simultaneous consumption of high levels (68 g) offibre. 
Similarly, short-term consumption ofa 72 % carbohydrate, high starch (62 %) diet 
caused increases in fasting plasma TAG concentrations that were significant only 
with a low (22 g), rather than high (59 g) consumption of dietary fibre (Ullrich and 
Albrink 1982). However, the authors concluded that the rise in TAG concentration 
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during the high starch diet was too small and too transient in their healthy young 
subjects to demonstrate a convincing protective effect of fibre against carbohydrate-
induced hypertriacylglycerolaemia. In middle-aged diabetic men, Anderson et al. 
(1980) found a more pronounced protective effect of a high-fibre diet. In conclusion, 
it may be that a population more susceptible to hypertriacylglycerolaemia is more 
appropriate for demonstrating a preventive effect of diets high in starch and fibre. 
2.8.4 Mechanisms for carbohydrate-induced increases in TAG concentration 
In this section, possible mechanisms for the increases in plasma TAG concentration 
in response to high-carbohydrate diets are discussed. More emphasis is given in the 
fasted state as augmentation of postprandial TAG response due to high-carbohydrate 
diets is partly due to elevation of basal TAG concentration. Also, understanding of 
mechanisms in the fasted state (steady state) can increase understanding of me ch a-
nisms involved in the dynamic postprandial state. Potential mechanisms, independent 
of baseline TAG concentration, are discussed in chapters 4 and 5. 
In the fasted state, most plasma TAG is carried in the VLDL fraction and two factors 
determine plasma levels ofVLDL-TAG, namely, rates of hepatic secretion of 
VLDL-TAG and the capacity for hydrolysis of circulating TAG by LPL. Thus, one 
cause ofhypertriacylglycerolaemia could be hepatic overproduction ofVLDL-TAG. 
Another reason could be defective hydrolysis ofTRL-TAG. 
2.8.4.1 Hepatic overproduction ofVLDL-TAG 
It has been suggested that high-carbohydrate diets may increase de novo lipogenesis 
in the liver that, in turn, may increase fatty acid availability for esterification and he-
patic TAG production (Boogaerts et al. 1984). It should be noted that there is a dis-
tinction between net de novo lipogenesis in the whole body (as evidenced by a respi-
ratory exchange ratio> 1.0) and increased hepatic fatty acid synthesis, which may (in 
a net sense) be counterbalanced by fat oxidation in other tissues (for review on he-
patic de novo lipogenesis, Hellerstein 1996). Using a stable isotope technique, 
Hellerstein et al. (1991) estimated that, in humans, de novo synthesised fatty acids 
contribute only approximately 1 % to VLDL-TAG fatty acids during fasting and 2 % 
after a high-carbohydrate mixed-meal breakfast (3.5 g carbohydrate per kg body 
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weight). These are fairly lifelike fasted and feeding conditions. Results from Schwarz 
et al. (1995) do not support a quantitatively important rate of hepatic de novo lipo-
genesis even after massively increased carbohydrate intake (-360 g carbohydrate 
added per day) for five days. Although contribution of de novo synthesised fatty ac-
ids to circulating VLDL-TAG increased more than lO-fold (1.6 % after euenergetic 
diet vs 20.1 % after increased carbohydrate intake), in absolute terms, less than 3.5 g 
fatty acids were de novo synthesised per day, representing about 12 % of the mass of 
VLDL-TAG secreted daily (28 g). These fmdings were subsequently confirmed by 
Aarsland et al. (1996) who investigated the contribution of de novo synthesised fatty 
acids to total VLDL-TAG secretion rate in healthy men in the basal state and after 
one and four days of a hyperenergetic high-carbohydrate diet (-2.5 times energy ex-
penditure). Although the secretion rate of de novo synthesised fatty acids increased 
almost 50-fold from the basal state to day four, the 3.4-fold increase in total VLDL-
TAG secretion rate was primarily due to stimulation of the secretion of preformed 
fatty acids. Looking at more physiological situations, Parks et al. (1999) recently 
demonstrated that fasting hepatic de novo lipogenesis remained low « 5 % of 
VLDL-TAG fatty acids) after five weeks on an euenergetic high-carbohydrate diet 
(68 % carbohydrate), which was rich in complex carbohydrate and comprised whole 
foods. However, as pointed out by these authors, liquid diets, high in simple sugars, 
seem to be more lipogenic (Hudgins et al. 1996) than whole-food high-carbohydrate 
diets. Also, consumption oflonger-chain dietary carbohydrate compared with short-
chain glucose polymers and simple sugars reduce the lipogenic response to low-fat 
feeding (Hudgins et al. 1998). 
Although hepatic de novo lipogenesis is not quantitatively the direct cause of in-
creased VLDL-TAG production associated with high-carbohydrate diets, it may 
serve regulatory functions in the liver. Malonyl-CoA, the first and committed me-
tabolite in the de novo lipogenesis pathway, plays an important role in fuel selection 
(McGarry and Foster 1980; Winder 1996). Specifically, it acts as a potent inhibitor of 
carnitine acyl-transferase I, the enzyme catalysing the transfer oflong-chain fatty 
acids into the mitochondrial matrix for J3-oxidation. In conditions of availability of 
surplus carbohydrate energy (such as during carbohydrate feeding) hepatic glucose 
metabolism is accelerated, namely, glycolytic rate, availability of pyruvate, glucose 
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oxidation and availability of cytosolic acetyl-CoA, which is the substrate for malo-
nyl-CoA (HeIIerstein 1996). In addition, insulin (which accompanies carbohydrate 
feeding) stimulates acelyl-CoA carboxylase (Mabrouk et al. 1990), the enzyme that 
catalyses the synthesis of malonyl-Co A from acetyl-CoA (this is the starting reaction 
in the de novo lipogenesis pathway). As a result, hepatic malonyl-CoA concentration 
increases which, in turn, inhibits p-oxidation in the liver diverting fatty acids into 
esterification, i.e. TAG synthesis (McGarry and Foster 1980). Therefore, the hepatic 
de novo lipogenesis pathway is very important in metabolic regulation because it is 
the source of malonyl-CoA, which determines the balance between fatty acid oxida-
tion and esterification in the liver. If the above scenario hold true, increases in 
VLDL-TAG secretion attributable to a high-carbohydrate diet should be accompa-
nied by decreases in hepatic fatty acid oxidation. Indeed, a recent study (Sidossis and 
Mittenddorfer 1999) demonstrated that a two-week high-carbohydrate diet resulted in 
significant increases in fasting VLDL-TAG production rate by -50 % with con-
comitant -3-fold decreases in hepatic fatty acid oxidation. Similar fmdings have also 
been demonstrated by the same authors as a result of acute hyperglycaemia (Sidossis 
et al. 1998). 
It has been suggested (Sniderman and Cianflone 1993) that hypertriacylglycerolae-
mia due to increased delivery of carbohydrate to the liver is characterised by the se-
cretion of large, TAG-enriched VLDL without increases in the total number of parti-
cles. Mancini et al. (1973) showed that the ratio of TAG to protein in VLDL in-
creased by 230 % after a high-carbohydrate diet suggesting the formation ofVLDL 
molecules of increased TAG content. Using dynamic light-scattering, Kasim-
Karakas et al. (1997) also found a significant increase in VLDL particle size from 
42.7 um during habitual diet to 47.0 nm after a six-week 67 % carbohydrate diet in 
healthy postmenopausal women. MeIish et al. (1980) studied the kinetics ofVLDL-
TAG and VLDL-apo B in men (three healthy and three hypertriacylglycerolaemic) 
after eight days on an euenergetic fat-free liquid formula consisting of 80 % carbo-
hydrate and 20 % protein. In all six subjects, the effect of carbohydrate feeding was 
to produce a significant increase in VLDL-TAGproduction rate with a group mean 
of 60 %, which was not accompanied by an increase in VLDL-apo B production rate, 
suggesting the production ofIarge, buoyant VLDL particles. However, not all studies 
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have found TAG-enrichment ofVLDL as a response to high-carbohydrate diets 
(Kashyap et al. 1982), whereas other studies (Ginsberg et al. 1981; Huff and Nestel 
1982) have reported significant increases of -50 % in the VLDL-apo B production 
rate. It seems, therefore, that high-carbohydrate diets are associated with elevations 
both in the amounts of TAG per VLDL and in the number ofVLDL particles in 
plasma. 
2.8.4.2 Defective hydrolysis ofTRL-TAG 
Using an intravenous fat tolerance test, Mancini et al. (1973) examined the TAG 
clearance capacity from plasma in healthy subjects fed a non-fat euenergetic fonnula. 
They concluded that peripheral hydrolysis of TAG was decreased by the high-
carbohydrate fonnula. Two recent kinetic studies (Aarsland et at. 1996; Parks et al. 
1999) in healthy subjects have reported decreases in the VLDL-TAG clearance rate 
after high-carbohydrate diets. In the latter study, carbohydrate-induced elevation in 
fasting plasma TAG concentration was attributed entirely to reduced clearance of 
VLDL-TAG, as production ofVLDL-TAG was not found to be increased. The 
mechanisms responsible for reduced VLDL-TAG clearance on high-carbohydrate 
diets are not well defmed. Carbohydrate feeding may impair VLDL-TAG catabolism 
by inducing alterations in the apolipoprotein composition or size of the lipoprotein. 
However, most of the research has focused on the effect of high-carbohydrate diets 
on the activity of LPL, the enzyme primarily responsible for TAG hydrolysis in cir-
culation. 
Campos et al. (1995) compared the effect ofa high-carbohydrate diet (60 % carbo-
hydrate) and a low-carbohydrate diet (38 % carbohydrate) for six weeks each on 
heparin-releasable LPL activity in 43 healthy men. Plasma TAG was significantly 
higher by 50 % and heparin-releasable LPL activity significantly lower by 16 % after 
the high-carbohydrate diet. LPL was inversely correlated with fasting TAG on both 
high- and low-carbohydrate diets (r = -0.41 and r = -0.30, respectively, P < 0.05 for 
both). Thompson et al. (1984) also measured heparin-releasable LPL activity and 
fasting plasma TAG concentration in two groups of endurance athletes before and 
after two weeks on either a high-carbohydrate diet (69 % carbohydrate) or a low-
carbohydrate diet (19 % carbohydrate). Plasma TAG concentration was significantly 
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higher and heparin-releasable LPL activity significantly lower after the high-
carbohydrate diet. When the two diet protocols were combined, there was a strong 
inverse relationship between changes in LPL activity and changes in plasma TAG 
levels (r = -0.75, P < 0.01), suggesting that changes in LPL may have mediated some 
of the diet-induced changes. However, two studies in non-insulin dependent diabetes 
mellitus patients (Chen et al. 1995; Blades and Garg 1995) do not support a lowering 
effect of high-carbohydrate diets on heparin-releasable LPL activity. After six weeks 
on a 55 % carbohydrate diet, fasting plasma TAG concentration was significantly 
higher and heparin-releasable LPL activity was either similar (Blades and Garg 
1995) or significantly higher (Chen et al. 1995) than after six weeks on a 40 % car-
bohydrate diet. 
On a tissue level, high-carbohydrate diets are believed to decrease muscle LPL ac-
tivity and increase adipose LPL activity. The decreasing effect of high-carbohydrate 
diets on muscle LPL activity has been suggested mainly by results of two comple-
mentary studies by the same research group (Jacobs et al. 1982; Lithell et al. 1982). 
Subjects were normal-weight men and their diet was changed from an ordinary 
mixed to a high-fat diet (70 % fat, 25 % carbohydrate) for three days, followed by a 
high-carbohydrate diet (-70 % carbohydrate) for another three days. Subjects body 
weight was maintained during the studies. The high-fat diet was preceded by one to 
two-hours of exercise in order to deplete the muscle vastus lateralis of its glycogen 
stores. Fasting biopsy samples were taken from this muscle when subjects were con-
suming their ordinary diet and also, after the high-fat and after the high-carbohydrate 
diets. Fasting serum insulin and TAG concentrations were significantly higher 
whereas muscle LPL activity was significantly lower after the high-carbohydrate diet 
than after the high-fat diet. The authors concluded that the short-term high-
carbohydrate diet down-regulated muscle LPL activity possibly through higher insu-
lin concentration. However, caution should be given before adopting these conclu-
sions. First, the design of these studies seems to have some limitations, namely, there 
was no wash-out period between the experimental diets and the diet order was not 
randomised. Second and more important, these results were achieved under ex-
tremely different conditions of muscle glycogen status after the high-carbohydrate 
and high-fat diets, as a result of the exercise and dietary manipulation. Specifically, 
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muscle glycogen levels were supercompensated after the high-carbohydrate diet (82 
% higher than that on subjects' ordinary diet) whereas they were reduced by more 
than half after the high-fat diet. It is not clear, therefore, whether the observed differ-
ences in muscle LPL activity after the two experimental diets were due to effects of 
the diets per se or muscle glycogen status (as an important form of energy store) or 
interaction of these two. Despite the limitations of these studies, someone might hy-
pothesise that a high-carbohydrate diet can induce a downregulation of muscle LPL, 
secondary to high diurnal insulin concentrations, as insulin has been shown to de-
crease LPL activity in skeletal muscle (Farese et al. 1991). 
The effects oflong-term dietary interventions on fasting skeletal muscle LPL activity 
have been investigated by Kiens et al. (1987) in physically trained men. They re-
ported that a four-week high-fat diet (54 % fat, 29 % carbohydrate) significantly in-
creased muscle LPL activity compared with subjects' ordinary diet (43 % fat, 42 % 
carbohydrate). When the subjects changed to a high-carbohydrate diet (51 % carbo-
hydrate) fasting muscle LPL activity returned to "ordinary" levels and was signifi-
cantly lower than after the high~fat diet. Neither of the diets affected insulin concen-
trations, dissociating changes in muscle LPL activity and changes in insulin levels. 
Serum TAG concentration was also unaffected by the experimental diets but muscle 
TAG concentration was significantly higher after the high-fat diet than after both the 
ordinary and high-carbohydrate diets. A recent report does not support an effect of 
low- and high-carbohydrate diets on fasting muscle LPL activity (y ost et al. 1998). 
These authors showed that a 16-day high-carbohydrate diet (55 % carbohydrate, 25 
% fat) or high-fat diet (30 % carbohydrate, 50 % fat) did not significantly affect adi-
pose tissue and skeletal muscle LPL activity in healthy normal-weight subjects (15 
men, 10 women). In conclusion, more research is needed to determine whether car-
bohydrate-induced hypertriacylglycerolaemia results from impaired TRL-TAG 
clearance due to lower LPL activity or through some other mechanism. 
2.9 Effect of exercise on TAG metabolism 
Strong epidemiologic evidence indicates that there is an inverse relationship between 
physical activity and CHD risk (Whaley and Blair 1995). This relationship could, at 
least partly, be explained by the beneficial effects of exercise on lipoprotein metabo-
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lism (Superko 1995). The best example for this is well-trained endurance athletes 
who exhibit blood lipid and lipoprotein profiles that are consistent with a low risk for 
CHD (Durstine and Haskell 1994). Determining cause and effect as a result of exer-
cise is often complicated by changes in energy intake, diet composition, body fat and 
muscle mass often associated with exercise programmes. However, it appears that at 
least some of the effects of exercise on lipoprotein metabolism result from the exer-
cise per se as they are seen even when exercise is not accompanied by the above 
mentioned changes. Exercise has a potent influence on TAG metabolism. Both re-
peated transitory effects of single, isolated exercise sessions and exercise-training 
effects are likely to be involved. This section will discuss the effects of exercise on 
fasting (only briefly) and postprandial TAG concentration and potential mechanisms 
by which exercise may exert these effects. 
2.9.1 Effect of exercise on fasting TAG concentration 
Endurance athletes and regular exercisers (Wirth et al. 1985) tend to have lower 
fasting TAG concentration than inactive individuals (Durstine and HaskeII (1994), 
for review). In addition, levels of plasma TAG can be reduced after an aerobic train-
ing programme (Holloszy et al. 1964; Tran et al. 1983; Durstine and HaskeII 1994). 
Weintraub et al. (1989) demonstrated a significant reduction in fasting plasma TAG 
concentration from 0.92 mmoIIL to 0.79 mmoIIL after a seven-week exercise condi-
tioning programme in healthy young men. This reduction was accompanied by an 
average 43 % increase in subjects' maximum oxygen uptake (V02 max). Subjects 
performed, in average, four exercise sessions per week and each session consisted of 
30 minutes jogging at the upper end of moderate intensity (80 % of maximum heart 
rate). hnportantIy, the reduction in fasting TAG occurred, even though placing the 
subjects on a metabolic diet and increasing their daily energy intake during the exer-
cise training prevented changes in diet composition and weigh loss. Indeed, a meta-
analysis of 95 exercise training studies showed that significant reductions in fasting 
TAG levels after exercise training occur even in the absence of weight loss (Tran and 
Weltman 1985). 
A single exercise session can also attenuate fasting TAG concentration (AnnuzZi et 
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al. 1987) (for review, Pronk 1993), although further research is needed on the short-
term changes in TAG concentration in women. Generally, it seems that fasting 
plasma TAG concentrations are not usually altered immediately following or in the 
days after exercise sessions at 30-55 % V02 max. In contrast, if exercise is prolonged 
and strenuous, TAG concentration is likely to be lower the day following the exer-
cise session (Lithell 1986). 
2.9.2 Effect of exercise on postprandial TAG concentration 
2.9.2.1 Effect of exercise training 
Several cross-sectional studies have showed that postprandial TAG response (ex-
pressed as AUC) to a test meal (40-140 g) is consistently lower in endurance-trained 
men (Cohen et al. 1989; Merrill et al. 1989) and women (Tsetsonis et af. 1997) than 
in sedentary individuals. At least in men, this was also observed when the relation-
ship between training and postprandial lipaemia was investigated more critically by 
matching subjects for fasting TAG level and body weight (Cohen et al. 1989; Merrill 
et al. 1989). An important contribution has been made by Tsetsonis et al. (1997) who 
investigated differences in postprandial lipaemia between endurance trained and un-
trained middle-aged women in the presence and absence of effects of a recent session 
of moderate intensity exercise (performed -18 hours before ingestion of the test 
meal). When subjects had performed the exercise session, postprandial lipaemia de-
creased (significantly) by 16 % and 30 % in the untrained and trained group, respec-
tively. The greater decrease in the trained group may imply that the chronic and acute 
effects of exercise interact synergistically. Another interesting observation was that, 
after subjects had refrained from exercise for almost three days before the ingestion 
of the test meal, there was no difference in postprandial lipaemia between trained and 
untrained subjects. This may indicate that the residual effects of the last exercise ses-
sion contribute to low postprandial lipaemia observed in endurance-trained individu-
als. 
Cross-sectional studies using intravenous infusion oflipid emulsion to measure TAG 
metabolic capacity have shown that TAG removal rate is significantly enhanced in 
male (Sady et al. 1988; Cohen et af. 1989) and female (Podl et al. 1994) endurance 
athletes than in sedentary controls. Cohen et af. (1989) matched athletes with con-
troIs for fasting TAG levels, however, the half-life of chylomicron-TAG was still 
significantly lower in athletes. 
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Comprehensive longitudinal studies have investigated the effects of training on post-
prandial lipaemia (Weintraub et al. 1989; Aldred et al. 1995) and rate of fat clear-
ance (Wirth et al. 1985; Thompson et al. 1988). In the study by Weintraub et al. 
(1989) discussed in the previous section, the 16 % reduction in fasting TAG concen-
tration was accompanied by a 37 % reduction in the retinyl palmitate AUC in the 
chylomicron fraction, implying less postprandial competition between VLDL and 
chylomicrons and improved clearance of chylomicrons. The authors ascribed these 
reductions to changes in fitness, however, as the post-training fat tolerance test was 
performed 36 hours after the last training session, the possibility of an acute influ-
ence of this exercise session can not be excluded. A longer training study in young 
healthy men by Thompson et al. (1988), with 14 and 48 weeks of training (four to 
five one-hour cycling sessions per week at 80 % of maximum heart rate), investi-
gated the effect of training on TAG clearance rate. Measurement of fasting TAG 
concentration and intravenous fat tolerance test were performed before and after 14 
or 48 weeks of training. In addition, subjects followed a controlled high-carbohydrate 
diet for the last four weeks before the above measurements to avoid changes in body 
weight and composition. After 14 weeks of exercise training, V02 max improved by 
26 %, fasting TAG concentration decreased by 16 % and the rate of TAG clearance 
increased by 24 %, although the latter was not significant. Continuation of training 
for further 34 weeks did not change V02 max or fasting TAG concentration but rate 
of TAG clearance increased by 49 % above pre-training values, which was signifi-
cant. 
The studies by Wirth et al. (1985) and Aldred et al. (1995) have both attempted to 
exclude effects of acute exercise session by examining subjects at least 48 hours after 
the last training session. In the study by Wirth et al. (1985), ten male patients with 
primary hypertriacylglycerolaemia were trained for four months, three times per 
week with one-hour sessions consisting mainly jogging, ball games and callisthenics 
eliciting heart rate between 120 and 150 beats per minute. Body weight remained 
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unchanged throughout the study period whereas maximal physical performance in-
creased after training. Although fasting TAG concentration decreased after training, 
the removal rate of exogenous TAG rose by only 8 %. Seven of nine patients showed 
increased clearance after training and, therefore, the low power to detect a change 
may also have been a factor. In the study by Aldred et al. (1995), healthy middle-
aged women trained over 12 weeks by brisk walking. Despite clear improvements in 
endurance fitness and body composition, there was no change in plasma TAG re-
sponse to an oral fat load, compared with a control group. The authors suggested that 
improved endurance fitness does not necessarily result in changes in the lipaemic 
response above those attributable to the residual effects of the last bout of exercise. 
However, it was also speculated that the intensity of training (60 % V02 max) might 
not have been sufficient to enhance TAG metabolic capacity. Yanes et al. (1989) 
fond no significant difference in postprandiallipaemic response between cardiac pa-
tients who had underwent exercise rehabilitation for at least three months and those 
who had elected not to participate in a regular exercise programme. They attributed 
this to the large variability in Iipaemic response in cardiac patients. 
Detraining studies can be revealing about the nature of exercise training-induced 
changes to postprandial TAG metabolism. Mankowitz et al. (1992) studied eight 
healthy normolipidaemic male runners in the trained state (> 20 hours after exercise) 
and then after 14-22 days of detraining. These authors demonstrated that detraining 
reduced subjects' average V02 max but had no effect on their body composition, body 
mass and fasting TAG concentration. The impressive fmding of this study was the 
deleterious effect of detraining on chylomicron metabolism. The retinyl palmitate AUCs 
in the chylomicron and chylomicron renmant fractions increased after two to three 
weeks of detraining by 41 % (P < 0.05) and 37 % (P = 0.058), respectively. The authors 
concluded that the favorable effects of exercise training on lipoprotein metabolism 
could decline rapidly after detraining. The effects of the early phase of detraining on 
postprandial lipaemia has recently been examined by Hardman et al. (1998). Ten nor-
molipidaemic endurance-trained subjects undertook an oral fat tolerance test 15 hours, 
60 hours and 6.5 days after their last training session, which was more than 30 minutes 
in duration. When compared with values at 15 hours, postprandial lipaemia (expressed 
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as total or incremental AUC) was significantly higher at 60 hours and at 6.5 days with 
most of the increase evident by 60 hours. Postprandial lipaemia was related to fasting 
TAG concentration, which followed a similar pattern over this short detraining period, 
i.e. it increased by an average of 47 % during 6.5 days without exercise and most of this 
increase occurred between 15 and 60 hours after the last exercise session. These fmd-
ings demonstrated the important contribution of a recent session of exercise to the low 
levels of postprandial lipaemia that are characteristic of endurance-trained people. 
2.9.2.2 Effect of a single exercise session 
Although it has been known since the early 1960s that a session of exercise dimin-
ishes postprandial lipaemia (Cohen and Goldberg 1960), it was only recently that the 
optimal timing to exercise (before or after a fat meal) to magnify the effect of exer-
cise was investigated (Zhang et al. 1998). In this study by Zhang et al. (1998), 
twenty-one recreationally active male subjects consumed a high-fat meal on four oc-
casions which were in a randomised order: (i), control (no-exercise, fat meal only); 
(ii) exercise at 12 hours before the meal; (iii) exercise at one hour before the meal 
and (iv) exercise at one hour after the meal. In the exercise trials, subjects performed 
a single exercise session at 60 % of their \T02 max for one hour. Compared with the 
control trial, the AUC for TAG was 51 %,38 % and 5 % lower, when the exercise 
was performed 12 hours before, one hour before and one hour after the meal, respec-
tively. The 5 % reduction with the post-meal exercise session was not significant. 
These fmdings indicated that exercising 12 hours before the meal could magnify the 
lowering effect of exercise on postprandiailipaemia, implying a delayed effect of 
exercise on TAG metabolism. As this exercise timing seems to be the most beneficial 
with regard to reduction in postprandial lipaemia, this review will emphasise on 
studies which have used similar exercise timing. 
In confirmation of the TAG-lowering effect of an exercise session performed several 
hours before a fat challenge (Zhang et al. 1998), Aldred et al. (1994) had previously 
demonstrated that postprandial lipaemia decreased by 31 % when the subjects had 
exercised for 120 minutes at 31 % \T02 max 15 hours before the fat intake. Gill et al. 
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(1998) also reported a significant reduction in postprandial lipaemia when subjects 
had performed 90 minutes of treadmill running at 60 % V02 max the evening prior to 
the test meal. Interestingly, in the study by Gill et al. (1998) the reduction in lipaemia 
was similar when exercise had been performed in continuous (one 90-minute ses-
sion) or discontinuous (three 30-minute sessions) formats. In contrast to the results of 
these studies (Zhang et al. 1998; Aldred et al. 1994; Gill et al. 1998), Cohen et al. 
(1989) investigated the influence of an exercise session (intensity not stated) lasting 
60 minutes and performed 12 hours before a fat meal in 10 sedentary men. He re-
ported that postprandial lipaemia was slightly but not significantly reduced by exer-
cise. This may have been because the duration and/or intensity of exercise were in-
sufficient to induce an effect on postprandial TAG metabolism. 
Tsetsonis and Hardman (1996b) investigated the effect ofa 90-minute exercise ses-
sion (brisk walking) of either moderate (61 % \T02 max) or low (31 % V02 max) in-
tensity, performed 15 hours prior to a fat challenge. It was shown that the postpran-
dial TAG response (expressed as total AUC) was significantly lower (by 26 %) after 
the moderate exercise than in the non-exercise trial but not after the low intensity ex-
ercise. The authors suggested that the total energy expended during exercise could be 
an important determinant of exercise-induced decreases in postprandial lipaemia, as 
twice as much energy was expended during the moderate intensity exercise as during 
the low intensity exercise in their study (3.47 MJ vs 1.73 MJ). Indeed, in a subse-
quent study (Tsetsonis and Hardman 1996a), the same authors demonstrated that ex-
ercise sessions of the same energy expenditure but different intensity elicited similar 
attenuation in postprandial lipaemia. Specifically, they compared the effects of brisk 
walking, for either 90 minutes at 63 % \T02 max or 180 minutes at 32 % \T02 max, 
with a non-exercise trial. The gross energy expenditure was 4.18 MJ for the low in-
tensity and 4.28 MJ for the moderate intensity exercise session (not significantly dif-
ferent). However, substrate utilisation was different between the two intensities, so 
that oxidised fat represented 40 % and 25 % of the total energy produced during the 
low and moderate intensity exercise sessions, respectively (P < 0.05). On the days 
after walking, postprandial lipaemia was reduced by both the low and the moderate 
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intensity walking, the magnitude of these reductions being strikingly similar (-32 
%). These authors were probably the first to suggest that acute exercise-induced de-
creases in postprandial lipaemia could be independent of qualitative differences in 
substrate utilisation during exercise. 
An important contribution to this issue has been made by Malkova et al. (1999). In 
their study, subjects underwent three oral fat tolerance tests in a balanced design. On 
two occasions, subjects ran on the treadmill for 90 minutes at 60 % V02 max the af-
ternoon prior the fat tolerance test, after having ingested 131 mg acipimox (antilipo-
lytic agent) or placebo. On the third occasion they refrain from exercise (control 
trial). As acipimox suppresses the supply of non-esterified fatty acids from adipose 
tissue, NEFA levels remained suppressed during the exercise session in the acipirnox 
trial. Although gross energy expenditure during exercise was identical in the acipi-
mox (4.83 MJ) and placebo (4.86 MJ) conditions, the relative contributions off at and 
carbohydrate was different. The proportion of energy derived from fat during exer-
cise was lower after acipimox (16 %) than after placebo (28 %) whereas the propor-
tion from carbohydrate was correspondingly greater (placebo 72 %, acipimox 84 %) 
(P < 0.05 for both comparisons). Interestingly, even after acipirnox administration, 
fat oxidation contributed 16 % of energy expenditure during exercise, implying that 
intramuscular TAG was the predominant source offatty acids for oxidation in these 
circumstances. Additionally, the compensatory increase in carbohydrate oxidation 
may have reflected a greater rate of muscle glycogen degradation. Despite the sig-
nificant differences in the relative contribution of fat and carbohydrate to energy 
metabolism during exercise and possibly the nutrient status in muscle, postprandial 
lipaemia (total AUC) was strikingly similar in the two exercise trials; in both cases, 
-20 % lower than in the control condition. 
Since the reducing effect of exercise on postprandial lipaemia is closely related to the 
energy expended during exercise (Tsetsonis and Hardman 1996b, a), it is possible 
that the attenuation in postprandial lipaemia by exercise is attributable to the associ-
ated energy deficit rather than to the exercise per se. A recent study (Gill and Hard-
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man 2000) compared the effects on postprandial lipaemia of a moderate intensity ex-
ercise session (60 % of"02 max) and an equivalent energy deficit induced by re-
striction of food intake. Compared with the control trial (no exercise, consumption of 
a diet isoenergetic to subjects' habitual diet), 90 minutes of brisk walking reduced 
postprandial lipaemia by 20 % (P < 0.05), whereas food intake restriction (no exer-
cise, subjects' food intake was restricted to induce the same energy deficit, relative to 
control, as brought about by the 90-minute walk) reduced it by 7 % (not signifi-
cantly). The authors concluded that the effect of exercise on postprandial lipaemia is 
greater than that attributable to the energy deficit incurred. 
Studies that have investigated the effect of a single exercise session on the rate of 
clearance of exogenous TAG showed that clearance rate is increased the day after 
exercise (Sady et al. 1986; Annuzzi et al. 1987). Sady et al. (1986) demonstrated that 
clearance rate ofan intravenous fat emulsion was increased by 76 % (P < 0.01, range 
16 % to 221 %) at 18 hours after a marathon race, compared to values taken 24 hours 
before the race. Annuzzi et al. (1987) subsequently showed that the day after 180 
minutes, but not 90 minutes, of exercise at 77 % of maximum heart rate, clearance 
rate of an intravenous fat emulsion was significantly increased. Gill (1999) also 
found no effect of a 90-minute session of moderate intensity exercise on the clear-
ance rate of intravenous fat emulsion. 
2.9.3 Mechanisms for exercise-induced decreases in TAG concentration 
2.9.3.1 Enhanced hydrolysis ofTRL-TAG 
Studies that have investigated the hypothesis that exercise reduces plasma TAG con-
centration by enhancing the TRL-TAG removal pathway have mostly focused on the 
key enzyme, LPL. Although exercise could also affect other parts of this pathway, 
the existing information is on the effects of exercise on LPL activity. 
Taking into consideration possible residual effects of the last exercise session, cross-
sectional studies have demonstrated that endurance-trained athletes exhibit a higher 
post-heparin plasma LPL activity than sedentary controls (Kantor et al. 1987; Podl et 
al. 1994). On a tissue level, Nikkilli et al. (1978) found that LPL activity of both adi-
pose tissue and skeletal muscle was 2.7- and 1.7-times higher, respectively, in male 
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long distance runners than in controls. The authors concluded that endurance training 
is associated with an adaptive increase in LPL activity not only in skeletal muscle but 
also in adipose tissue, which aims to increase the body capacity to mobilise and util-
ise fat as a fuel. Such an increase can allow rapid restoration of TAG stores in both 
tissues, while increase in adipose tissue LPL activity can also favour release of fatty 
acids directly from plasma TAG to plasma NEFA pool for oxidation in muscles 
(Nikkilli et al. 1978). Higher muscle LPL activity was also present in female long 
distance runners, compared with controls, but there was no difference in adipose tis-
sue LPL activity. 
After seven, 15 and 48 weeks of exercise training, plasma post-heparin LPL activity 
has been shown to increase by 16 %, 33 % and 49 %, respectively (Weintraub et al. 
1989; Peltonen et al. 1981; Thompson et al. 1988). A number of training studies 
have also demonstrated a training-induced increase in skeletal muscle LPL activity 
(Lithell et al. 1981; Lithell et al. 1984; Ong et al. 1995; Seip et al. 1995) but no ef-
fect on adipose tissue LPL activity (Ong et al. 1995; Seip et al. 1995). The majority 
of these studies involved daily, prolonged intense exercise, for example sessions of 
more than 60 minutes duration at an intensity ranging from 60 to 75 % of \102 max 
(Seip et al. 1995). Detraining studies in humans have shown decreases in plasma 
heparin-releasable LPL activity (Mankowitz et al. 1992), decreases in muscle and 
increases in adipose tissue LPL activities (Simsolo et al. 1993). Kiens and Lithell 
(1989) compared muscle LPL activity after an eight-week programme of knee exten-
sion exercise in one leg with that in the untrained leg. After training, muscle LPL ac-
tivity was 70 % higher in the trained muscle compared with the untrained muscle of 
the same individual and this increase was strongly related to an increase in capillary 
density. As the physiological site ofLPL is the luminal surface of the capillary en-
dothelium, the increased number of capillaries around each fibre type in the trained 
compared with the untrained muscle provides more binding sites for the enzyme. 
Furthermore, closer proximity of myocytes to capillaries will improve diffusion con-
ditions; and increased capacity for ~-oxidation due to training may mean more en-
trapment of the fatty acid products of hydrolysis (Hardman 1998). All these training-
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induced adaptations could explain the increased uptake ofVLDL-TAG in the trained 
muscle that was also observed in the study by Kiens and LitheII (1989). 
Acute-exercise studies have shown striking increases in plasma post-heparin LPL 
activity 18 hours after prolonged, intense exercise (Kantor et al. 1984; Sady et al. 
1986). Elevated levels of plasma post-heparin LPL activity have also been observed 
in untrained and trained individuals 24 hours after one and two hours, respectively, 
of moderate intensity cycle ergometer exercise (Kantor et al. 1987). Herd (1997) 
reported a 54 % (non-significant) increase in plasma post-heparin LPL activity, 
measured 18 hours after a two-hour moderate exercise (50 % ofVOz max). On a tis-
sue level, one hour of exhaustive exercise has been shown to increase adipose tissue 
(by 44 %) but not muscle LPL activity (LitheII et al. 1979a), whereas heavy exercise 
ofIonger duration (eight-hour (85 km) cross-country skiing race) did increase muscle 
LPL activity by 238 % (LitheII et al. 1979b). In a subsequent study (Taskinen et al. 
1980), it was shown that after a 20-km run (duration between 85 and 105 minutes) 
muscle and adipose tissue LPL activity increased by 112 % and 20 %, respectively, 
suggesting that increases in the former may be more important. 
Studies that specifically investigated the exercise-induced increase in muscle LPL 
activity have shown that this increase usually occurs over a period of several hours 
(Lithell et al. 1979b) with a lag time of at least one to two hours (LitheII et al. 1979a; 
Kiens et al. 1989; Kiens and Lithell 1989). Kiens et al. (1989) found an increase in 
muscle LPL activity at four hours after 60 minutes of intense exercise, which was no 
longer detectable eight hours after exercise. However, studies that used exercise of 
longer duration (Lithell et al. 198 I) reported that this increase may persist for at least 
12 hours. Exercise appears to raise muscle LPL activity, at least partly, by pretrans-
lational mechanisms, i.e. by increasing LPL mRNA level (Seip et al. 1995; Seip et 
at. 1997). Catecholamines, fatty acids and muscle contraction may be potential 
regulators of exercise-induced LPL gene expression. Epinephrine has been recently 
shown to stimulate human muscle LPL activity in vivo (Pedersen et al. 1999). Cate-
cholamines increase intracellular cAMP, and the LPL promoter has a cAMP respon-
sive element (Deeb and Peng 1989). It has also been speculated that both a fall in in-
tramyofibral concentrations of fatty acids (due to increased p-oxidation) and the 
muscle contractile activity per se may signal the induction of LPL gene expression 
(Seip and Semenkovich 1998). 
2.9.3.2 Reduced hepatic production ofVLDL-TAG 
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The evidence on a possible effect of exercise on hepatic VLDL-TAG production is 
sparse and limited to experimental animals. Using the Triton method, Simonelli and 
Eaton (1978) studied TAG production by the liver. Triton WR-1339 has detergent 
properties that bind plasma TAG, thereby preventing its clearance from the circula-
tion. Hence, increments in circulating TAG after administration of Triton reflect their 
secretion by the liver. This study (Simonelli and Eaton 1978) showed that in obese 
hyperlipidaemic Zucker rats, as well as in their thin normolipidaemic littermates, he-
patic TAG secretion was reduced by approximately 50 % after three weeks of train-
ing (running). The authors speculated that this decrease could have been mediated by 
an associated reduction in the molar ratio of insulin:glucagon after training, consis-
tent with a net catabolic change in the bihormonal state. A study by Mondon et al. 
(1984) has demonstrated similar results. Ten to 12 weeks of training resulted in 50 % 
lower VLDL-TAG secretion rate in vivo. TAG secretion by perfused livers of trained 
and untrained rats were identical in response to given insulin and NEF A levels. This 
indicated that exercise training did not lead to any intrinsic difference in the ability of 
liver to esterify NEFA and secrete TAG, when insulin and NEFA were comparable. 
Rather, the lower TAG secretion rates in vivo observed in trained rats seemed to have 
been due to a reduction in substrate availability during the training period. In a more 
recent study (Fukuda et al. 1991), it was shown that the training-induced reduction in 
hepatic TAG secretion rate was accompanied by an increase in the production ofke-
tone bodies. The authors concluded that the altered hepatic partitioning oflong-chain 
fatty acids between esterification and oxidation was one of the causative factors for 
the serum TAG-lowering effect of exercise. 
2.10 Summary 
In this chapter an attempt was made to present an overview of the current knowledge 
of lipid and lipoprotein metabolism. In particular, literature concerning the postpran-
dial TAG and TRL metabolism and the link between its impairment and CHD was 
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highlighted. A detailed description of the effects oflow-fat, high-carbohydrate diets 
on TAG metabolism was also given, in the light of the current debate on the wisdom 
of recommending these diets for CHD prevention. The weight of available scientific 
evidence suggests that high-carbohydrate diets induce fasting hypertriacylglyc-
erolaemia, which appears to result from overproduction of both VLDL-TAG and 
VLDL particles and/or an impairment in VLDL clearance. However, limited infor-
mation exists on the effect of high-carbohydrate diets on postprandial TAG and TRL 
metabolism, which can give an insight into the atherogenic potential of these diets. 
Furthermore, there is sparse information on how carbohydrate-induced hypertriacyl-
glycerolaemia can be prevented in order to allow appropriate public health recom-
mendations to be made. The simultaneous adoption of a high-carbohydrate diet and a 
physically active lifestyle could be effective in this regard. Exercise, even of moder-
ate intensity, beneficially affects TAG metabolism and available evidence for this 
was discussed in this chapter. The effect of high-carbohydrate diets on postprandial 
lipaemia and the potential role of exercise in favourably altering this effect are the 
main research questions of the present thesis. 
3.1 Subjects 
CHAPTER 3 
GENERAL METHODS 
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All studies were conducted with the approval of Loughborough University's Ethical 
Advisory Committee. Subjects were recruited from within Loughborough University 
and the Loughborough area by advertising in the local paper and placement of posters 
in the University, local shops and community centres. Volunteers were fully informed 
of the nature and purpose of the studies and provided with written information (Ap-
pendix AI) including possible risks and discomforts. They were also encouraged to 
ask questions and discuss the studies before signing a statement of informed consent 
(Appendix A2). Healthy, normolipidaemic young men (chapters 4 and 5) and post-
menopausal women (chapter 6) were recruited. Subjects were only included in the 
studies if they: 
a) were free of known cardiovascular disease or abnormalities, acute illness or active, 
chronic systemic disease. 
b) had resting arterial blood pressure (mean of three readings) < 160195 mm Hg. 
c) were not taking any medication known to influence carbohydrate or lipid metabo-
lism (except hormone replacement therapy in chapter 6 as long as it was not inter-
rupted during the study). 
d) were amenorrhoeic for> 2 years following the menopause (chapter 6). 
e) were non-smokers. 
f) were sedentary or recreationally active. 
g) had no orthopaedic contra-indications to prolonged running (chapter 5) or walking 
(chapter 6). 
h) had no known coagulation disorders. 
i) had plasma total cholesterol concentration < 7.8 mmol.rl, fasting plasma TAG 
concentration < 2.3mmol.rl, as measured in a fasting blood sample at screening. 
j) had non-extreme dietary habits i.e. proportion of habitual fat intake between 25-45 
% of daily total energy intake. 
k) had stable body mass for the last month before the study. 
I) were non-vegetarians. 
At screening, to ensure they met the inclusion criteria for the studies, volunteers com-
pleted confidential health (Appendix A3) and physical activity (Appendix A4) ques-
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tionnaires with the experimenter and had their arterial blood pressure, fasting plasma 
triacylglycerol and cholesterol concentrations measured. They were also asked to 
weigh and record all their food and drink intake for two week days and one weekend 
day (this is fully described in the "Diet recording" section). 
3.2 Preliminary recording and testing 
3.2.1 Diet recording 
Volunteers' habitual energy intake and diet composition were determined by the 
weighed food inventory method. Specifically, volunteers were asked to complete diet 
records (Appendix A5) by weighing and recording all their food and drink intake for 
two week days and one weekend day. They were specifically instructed to choose 
representative days to record their diet, i.e. avoid recording on days when they are 
involved in activities that would alter their normal diet (e.g. illness, holiday). Volun-
teers received written (Appendix A6) and verbal instructions and observed visual 
demonstrations on how to use the weighing scales and complete the diet records accu-
rately. 
3.2.2 Exercise tests 
Several exercise tests were conducted in the studies described in chapters 5 and 6. Some 
involved running (chapter 5) and some walking (chapter 6) on a calibrated motorised 
treadmill (Quinton Q65 Series 90, Quinton Instrument Company, Seattle, USA). During 
these tests, oxygen uptake (V02) and carbon dioxide production (VC02) were deter-
mined and heart rate and perceived rates of exertion were recorded (all these procedures 
are fully described in sections 3.3, 3.4 and 3.5, respectively). All subjects were familiar-
ised with treadmill running or walking prior to testing. During the familiarisation session 
the subjects ran or walked on the treadmill at different speeds and gradients and their 
heart rate was monitored. 
3.2.2.1 Submaximal exercise testing 
There is a linear relationship between V02 and intensity of exercise at submaximal 
exercise intensities. Near maximum effort, V02plateaus and reaches the highest 
achievable level which is the V02 max (Brooks et al. 1996). In the studies reported in 
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chapters 5 and 6, subjects undertook a four-stage incremental submaximal exercise 
test to determine the relationship, for each individual, between increasing treadmill 
speed (chapter 5) or gradient (one subject of chapter 5 and all subjects of chapter 6) 
and V02. From this relationship, a linear regression equation was derived for each 
subject, which was used to calculate the speed or gradient necessary to elicit intensity 
corresponding to 60 % V02 max, as described below. 
In chapter 5, the duration of this continuous submaximal test was sixteen minutes -
four stages offour minutes each. The initial speed was 2.24 mls (5 mph). Throughout 
the test, the treadmill's gradient remained unchanged (zero inclination) whilst the 
speed increased by 0.45 mls (1 mph) after each four-minute stage. The speed of the 
treadmill was elevated such that the exercise intensity increased gradually from ap-
proximately 50 % to 80 % V02 max. Expired air samples were collected and heart 
rate and rate of perceived exertion were recorded during the last minute of each stage 
The first three minutes of every stage constituted a period of adjustment for a steady-
state to be achieved. Each individual's regression equation describing the linear rela-
tionship between V02 and speed was determined and, together with the measured V 
O2 max (see section 3.2.2.2), the speed necessary to elicit intensity corresponding to 
60 % V02 max was calculated. This calculated value was then used for the exercise 
sessions during the high-carbohydrate plus exercise intervention in chapter 5. 
One subject (male) from chapter 5 who suffered from a knee injury and the subjects 
(postmenopausal women) in chapter 6 undertook a four-stage submaximal walking 
test during which the treadmill speed was kept constant and the gradient was in-
creased in each stage. The duration of this test was 20 minutes - four stages of five 
minutes each. The speed was selected on an individual basis in order to give a com-
fortable, brisk walking pace. This was 2.10 mls (4.7 mph) for chapter 5 and 1.21-1.57 
mls (2.7-3.5 mph) for chapter 6. The first stage of the test was on a level treadmill 
with gradient increasing by 4 % (chapter 5) or 1.5-2.5 % (chapter 6) in each subse-
quent stage. The increase in gradient was established on an individual basis, based on 
the subject's heart rate response in the familiarisation session. Expired air samples 
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were collected during the last minute (chapter 5) or two minutes (chapter 6) of each 
stage and heart rate and rate of perceived exertion were recorded. A two-minute, 
rather than one-minute, expired air collection was taken in chapter 6 as the subjects 
were older females and their ventilation rates were relatively low. Each individual's 
regression equation describing the linear relationship between V02 and gradient was 
determined and, together with the predicted V02 max (see section 3.2.2.2), the gradi-
ent necessary to elicit intensity corresponding to 60 % predicted V02 max was cal-
culated. This calculated value was then used for the exercise sessions during the high-
carbohydrate plus exercise intervention in chapter 6. 
3.2.2.2 Maximal exercise testing 
In chapter 5, the subjects' V02 max was directly determined using a modified version 
of the protocol devised by Taylor et al. (1955). This involved an incremental running 
test divided into three-minute stages, all at a constant running speed, which ranged 
from 2.69 mls (6 mph) to 3.36 mls (7.5 mph). The speed was determined individually, 
based on each subject's ability to elicit test duration of between seven and twelve 
minutes. The starting gradient was 3.5 % and increased by 2.5 % in each subsequent 
stage. An expired air collection was taken from 1 :45 to 2:45 minutes of each stage 
and the heart rate and perceived rate of exertion were recorded. The test was open-
ended and concluded with a final expired air collection, when the subject signaled 
that he could only manage one more minute. The highest V02 achieved during the 
test (usually the fmal collection) was accepted to be the subject's V02 max. Other 
criteria for achievement ofV02 max, besides volitional exhaustion, included at least 
three of: a respiratory exchange ratio greater than 1.1; a small or nil increase in V02 
from the penultimate to the fmal expired air sample « 0.15 Llmin (Taylor et al. 
1955)); attainment of maximum heart rate, determined as the mean of the low esti-
mate (220 - age) and the high estimate [210 - (0.5 x age)] (American College of 
Sports Medicine 1995); ventilatory equivalent for oxygen greater than 30. 
In chapter 6, the subjects were women 51-66 years and had not undertaken any clini-
cal exercise stress test to ensure no contraindications to maximal exercise. For this 
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reason, their V02 max was not directly measured - as in chapter 5 - but was esti-
mated by extrapolation of the V02 / heart rate relationship obtained during the sub-
maximal exercise test (see section 3.2.2.1) up to the subject's predicted maximum 
heart rate. The maximum heart rate was estimated as described above. 
3.3 Measurement of oxygen uptake and carbon dioxide production 
V02 and VC02 were determined during all exercise tests and sessions (chapters 5 and 
6) and at rest in the fasted and postprandial states (chapter 5 and 6). 
Samples of expired air were collected into 50 L (for resting samples and exercise 
samples when volumes of expired air were low) or 150 L (for large volume samples) 
Douglas bags (Plysu protection Systems, Milton Keynes, UK). Subjects, whilst 
wearing a nose clip, breathed through a mouthpiece (Harvard Apparatus, Edenbridge, 
UK) fitted to a lightweight one-way respiratory valve (Jakeman and Davies, 1979), 
which in turn was connected to a 1.5 m length of 30 mm bore lightweight tubing 
(Falconia flexible ducting, Baxter, Woodhouse and Taylor Ltd., Macclesfield, UK) 
(exercise samples in chapters 5 and 6) or a 1.52 m length of35 mm tubing (Hans 
Rudolph, inc, Kansas City, USA) (resting samples in chapters 5 and 6). The tubing 
terminated at a two-way valve which opened and closed the Douglas bag. 
A known volume of expired air was removed from each sample to determine the per-
centage of oxygen using a paramagnetic oxygen analyser and of carbon dioxide using 
an infra-red carbon dioxide analyser (Servomex, Series 1400, Crowborough, UK). 
The analysers were calibrated before each sample analysis with certified reference 
gases (Cryoservice Ltd., Worcester, UK or Air Products, Crewe, UK). 
The remaining volume of expired air in each Douglas bag was measured by evacua-
tion through a dry gas meter (Harvard Apparatus, Edenbridge, UK). The temperature 
of the air in the Douglas bag was measured during evacuation using a thermistor 
(Edale, type 2984, Model C, Cambridge, UK) placed in the air outlet tubing of the dry 
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gas meter. The temperature was read from a thermometer to which the thermistor was 
connected. 
Barometric pressure was measured using a Fortin barometer (F.D. and Company, 
Watford, UK) and the measured expired gas volumes were corrected to standard tem-
perature and pressure for a dry gas (STPD) using the universal gas equation. Inspired 
gas volumes were derived using the Haldane transformation and V02 and VC02 were 
calculated. From these values, carbohydrate and fat utilisation rates were calculated 
using indirect calorimetry and the equations described by Frayn (1983) without 
measurement of urinary nitrogen excretion (for the estimation of protein oxidation). 
The contribution of amino acids to the substrate supply is normally relatively small 
(Brooks et al. 1996), maybe apart from during prolonged heavy exercise, and so the 
error in calculating carbohydrate and fat utilisation rates without measurement of uri-
nary nitrogen excretion is probably small. Energy expenditure was determined by 
multiplying the calculated mass of substrates used by their respective energy densities 
(17 kJ/g and 39 kJ/g for carbohydrate and fat, respectively). 
3.4 Heart rate 
Heart rate was monitored during the preliminary tests and exercise sessions using 
short range telemetry (Polar PE 3000 Sport Tester or Polar Favor, Polar Electroky, 
Kempele, Finland). 
3.5 Perceived rate of exertion 
The Borg scale (Borg 1982) of perceived exertion, with numbers ranging from 6 to 
20, was used to obtain each subject's own assessment of exercise intensity. This scale 
enabled the subjects to express their own perceived rate of exertion during the pre-
liminary tests and exercise sessions. 
3.6 Anthropometry 
Anthropometric measurements were made in all studies of this thesis. These meas-
urements were obtained according to the techniques described in The Oxford Text-
book of Sports Medicine (Jones and Norgan 1994) and the Applied Body Composi-
67 
tion Assessment (Heyward and Stolarczyk 1996). The same experimenter obtained all 
measurements in each study. 
3.6.1 Body Mass Index 
Body Mass Index (BMI) was calculated according to the formula, weight (kg) di-
vided by the square of height (m). 
Body weight to the nearest 0.05 kg was measured using a level platform beam bal-
ance (A very Industrial Ltd., Leicester, UK), with subjects barefoot and wearing light 
clothing. The body mass was also taken prior to each exercise test and session for 
the calculation ofV-02 per kg of body mass. 
Height to the nearest 0.1 cm was also measured (with the subjects barefoot) using a 
Holtain fixed-wall stadiometer (Seca; Germany). The subjects stood with their heels 
together at a 60° angle to each other. The head was placed in the Frankfort Plane, 
with the line between the lower orbits of the eyes and the external auditory meatii 
perpendicular to the vertical board. They were instructed to inhale deeply and a 
moveable headboard was lowered onto the top of the head with enough pressure to 
compress the hair. The experimenter applied vertical traction under the mastoid pro-
cess and height was then measured. 
3.6.2 Waist and hip circumferences 
Waist and hip circumferences were measured as described by Jones and Norgan 
(1994) using a flexible, inelastic Fibron tape measure (eMS Weighing Equipment, 
London, UK). For the waist circumference measurement, the landmark was the mid-
axillary line at the midpoint between the costal margin and iliac crest. This is often 
the natural waist. For the hip circumference measurement, subjects stood with feet 
together and at an angle of approximately 15°. The tape was lowered to the level of 
the trochanters, which is used as a guide for location of the maximum hip circumfer-
ence. This measurement was made with the tape remaining horizontal, while the tape 
was raised and lowered until the maximum circumference was found. The waist-to-
hip ratio was also calculated as an index of "body shape" by simply dividing waist by 
hip circumference. 
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3.6.3 Percentage body fat - skinfold thickness 
Measurements of subcutaneous skinfold thickness were made to estimate body fat-
ness using skinfold calipers (HoJtain Ltd., Crymmych, UK) and applying the predic-
tion equations ofDurnin and Womersley (Dumin and Womersley 1974). These equa-
tions are age- and sex- specific and predict body density from the logarithm (base 10) 
of the sum of the four skinfold thicknesses (biceps, triceps, subscapular and suprail-
iac). All measures were taken with the subject standing. They were repeated twice 
and the mean was taken as the value for the particular site. 
a) Biceps - With the elbow flexed at an angle of 90°, the mid point between the lat-
eral projection of the acromial process and the inferior margin of the olecranon 
process was marked. The arm was allowed to hang loosely with the palm facing 
forward and the measurement was made at the level of the mark over the belly of 
the biceps muscle above the centre of the cubital fossa. 
b) Triceps - This measurement was at the same level as the biceps measurement on 
the midline of the posterior aspect of the arm. 
c) Subscapular - This measurement was made along the natural cleavage line of the 
skin just inferior to the inferior angle of the scapula with the subject's arms 
hanging loosely by the sides of the body. 
d) Suprailiac - This skinfold was measured vertically in the mid-axillary line, half 
way between the costal margin and the superior iliac crest. 
Each skinfold was lifted between the thumb and index fmger of the experimenter's 
left hand, 1 cm above the site of the measurement. The calipers were applied and the 
measurement was taken after 5-8 seconds of caIiper pressure. 
3.7 Diet analysis 
Weighed food inventories were analysed using a computerised version (Comp-Eat 
5.0, Nutrition Systems, London) ofUK food composition tables (Holland et al. 1991). 
The same software was used for the prescription of the experimental diets. One limi-
tation of this nutrient database is that, because of incomplete information, the satu-
rated, monounsaturated and polyunsaturated fatty acid contents of many food items 
are estimates. For this reason, the dietary intakes of these fatty acids often did not add 
to 96 % by weight of the total fat intake (dietary fat contains, on average, 96 % by 
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weight as fatty acids; the other 4 % is glycerol and other lipids (Mensink and Katan 
(1992». Since the present research was designed to manipulate the intake of total fat, 
rather than that of fatty acids of specific saturation, the above limitation was not con-
sidered major problem. Instead, the estimates of fatty acid intake (g), as reported in 
the nutrient analysis, were adjusted to add to 96 % by weight of the total fat intake. 
The percentage of energy derived from saturated, monounsaturated and polyunsatu-
rated fatty acids was then calculated using the adjusted fatty acid intake values. These 
percentages are presented in chapters 4, 5 and 6. 
3.8 Experimental design and main interventions 
The main aim of the studies presented in this thesis was to investigate the effect of 
high-carbohydrate diets on postprandial TAG metabolism and how daily exercise can 
alter this. Postprandial TAG metabolism was studied using the oral fat tolerance test 
method, i.e. after the consumption of a standardised high-fat, mixed meal. In each 
study, the same group of subjects consumed a standardised high-fat, mixed meal on 
two or three (depending on the study) occasions after different interventions. These 
interventions involved short-term manipulation of the carbohydrate and fat, but not 
energy, content of subjects' diets. Specifically, for the three days preceding each oral 
fat tolerance test, subjects followed a prescribed diet either high or low in carbohy-
drate, which was isoenergetic to their habitual diet. Subjects refrained from exercise 
during these interventions. The prescribed high-carbohydrate diet was also followed 
with the addition of daily exercise of moderate intensity (high-carbohydrate plus ex-
ercise intervention) (chapters 5 and 6). In order to remove any "order of testing" ef-
fect, a counterbalanced design was adopted, i.e. individuals in each study were ran-
domly assigned to the interventions so that the sequence in which these were under-
taken was different for different subjects. A short-term (three-day) dietary interven-
tion model was employed because the lipoproteinemic changes are likely to be more 
marked shortly after the initiation of a high-carbohydrate diet than after longer peri-
ods of intervention during which adaptive processes may counterbalance the initial 
effects. Therefore, the initial, dynamic period of dietary change, when effects on 
lipoprotein metabolism are becoming manifest, may be revealing with regard to car-
bohydrate-induced hypertriacylglycerolaemia and its potential prevention by exer-
cise. There was a 10-day wash-out interval between interventions. Full details of the 
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experimental design and main interventions are presented in the methodology section 
of each experimental chapter. 
3.8.1 Experimental diets 
All experimental diets employed in this thesis were designed to be isoenergetic, on an 
individual basis, to subjects' previously determined habitual energy intake (section 
3.2.1), in order to maintain subjects' body mass. In an attempt to ensure this, subjects 
were specifically instructed to record their habitual diet on representative days and 
explained in detail how to complete the diet records accurately (section 3.2.1). It is 
known that under-recording often occurs when the self-reported energy intake method 
is used (Livingstone et al. 1990; Kasim-Karakas et al. 2000). For this reason, daily 
energy intake values determined from the subjects' diet records were compared with 
those obtained using energy requirement prediction equations which take into consid-
eration subjects' gender, age, body mass and physical activity level (Department of 
Health 1991). For a few subjects who reported unrealistically low daily energy intake, 
the predicted, rather than self-reported, daily energy requirement was used for pre-
scription of the experimental diets. 
All experimental diets comprised normal foods, excluding alcohol. The sources of 
carbohydrates were cereals, pasta, rice, fruits, breads, vegetables, honey, jam, and 
biscuits. The sources of fat were commercial margarines, oils, avocado pears, nuts, 
dairy products, and meats. In chapter 4, as the composition of the diets was particu-
larly extreme, the food items were prescribed on an individual basis based on each 
subject's preferences. Subjects in chapters 5 and 6 consumed the same food items. A 
spreadsheet (Microsoft Excel 97) was used to establish the amount in grams for each 
food item according to each subject's previously determined daily energy intake. The 
experimenter kept in close contact with subjects, who were encouraged to contact her 
if they had any questions at all concerning the experimental diets. 
Three meals and one or two snacks were consumed each day, prepared by the sub-
jects themselves. The food items were provided by the researchers (apart from chap-
ter 4), together with detailed instructions about the mass of each item to be consumed 
and methods of preparation and cooking. Subjects were instructed to follow the ex-
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perimental diets "to the gram" and weigh and record each item consumed. Full de-
scription of the composition of the diets is presented in the methodology section of 
each experimental chapter. 
3.8.2 Exercise sessions 
In the high-carbohydrate plus exercise intervention, subjects performed an exercise 
session on the treadmill of either 30 (chapter 5) or 60 minutes (chapter 6) daily. Each 
exercise session was carried out in the laboratory at an intensity of about 60 % \T02 
max, which is considered as moderate by most classifications. For instance, according 
to the American College of Sports Medicine exercise intensity classification system 
(American College of Sports Medicine 1995), exercise within the range of 50 to 74 % 
\T02 max is moderate. Regular exercise of moderate intensity confers significant 
health benefits and is recommended by various scientific bodies for the prevention of 
CHD and for cardiac rehabilitation programmes (American College of Sports Medi-
cine 1995; Nlli Consensus Conference 1996). In addition, exercise at this intensity is 
associated with a lower risk of injury, acute cardiac events during exercise or discon-
tinuation of activity than vigorous exercise (NIH Consensus Conference 1996). 
For the group of young men studied in chapter 5, exercise at 60 % \T02 max meant 
running. For the group of older postmenopausal women studied in chapter 6, exercise 
at this intensity meant brisk walking. The treadmill speed and gradient necessary to 
elicit intensity corresponding to 60 % \T02 max was calculated during the preliminary 
testing, as described in section 3.2.2. The intensity of exercise was monitored by col-
lecting one- (chapter 5) or two-minute (chapter 6) expired air samples (section 3.3) 
every 15 minutes. Heart rates (section 3.4) and perceived rates of exertion (section 
3.5) were also recorded during exercise. 
3.8.3 Preparation for the main interventions 
In all studies, preceding each three-day intervention, subjects' diets and physical ac-
tivity were standardised as described in the individual chapters. 
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3.9 Test meal protocol 
Subjects arrived at the laboratory after a 12-hour overnight fast, at approximately 
08:00 hours. A cannula was introduced into a forearm or antecubital vein and the 
subject rested quietly in a supine position for 10 minutes, after which a baseline 
blood sample was obtained. The test meal (see section 3.9.1) was then consumed 
over a median of 11 (range 9 - 14) minutes. Further blood samples were obtained 
(with subjects in the supine position) 15,30,45,60 and 90 minutes after completion 
of the meal, and then hourly until 6 hours. The cannula was kept patent by flushing 
with non-heparinized saline (9 gIL). Expired air samples were also collected (chap-
ters 5 and 6) for 6-minute periods in the fasted state and postprandially (every hour) 
using Douglas bags, for measurement of oxygen uptake and carbon dioxide produc-
tion (see section 3.4). Subjects rested or performed sedentary activities (working qui-
etly, watching television, reading, etc.) during the observation period and consumed 
only mineral water. This was provided ad libitum on the first test and replicated dur-
ing subsequent tests. 
3.9.1 The test meal 
The test meal employed in the studies of this thesis was a high-fat, mixed meal and a 
modification of the meal described previously by Schlierf et al. (1987). It was given 
according to body mass (Table 3.1) and its macronutrient composition is shown in 
Table 3.2. Table 3.3 presents the energy and macronutrient content of the test meal 
(chapters 4 and 5) for a subject of77.3 kg. 
The reproducibility of this test meal has recently been examined (Gill 1999). It was 
shown that the mean difference ± SD in the postprandial TAG response (total AUC) 
on a test-retest basis was 2.0 ± 13.3 %. This indicates that this test has probably 
enough precision to detect exercise-induced decreases in postprandial lipaemia, 
which are often more than 20 % when for instance a 90-minute exercise session of 
moderate intensity is employed 15 hours prior to the test meal (Gill 1999). 
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Chapters 4 and 5 Chapter 6 
(per kg body mass) (per kg body mass) 
Whipping cream (g) 2.53 2.11 
Oats (g) 0.75 0.63 
Brazil nuts (g) 0.15 0.12 
Milk chocolate (g) 0.13 0.11 
Sultanas (g) 0.13 0.11 
Desiccated coconut (g) 0.07 0.06 
Granny Smith apple (g) 0.67 0.56 
Banana (g) 1.13 0.94 
Table 3.1. Quantities of ingredients of the test meal, administered per kg body mass. 
All ingredients were purchased from J Sainsbury's. 
Chapters 4 and 5 Chapter 6 
(per kg body mass) (per kg body mass) 
Energy (kJ) 65.8 54.6 
Fat (g) 1.22 1.01 
Carbohydrate (g) 1.11 0.92 
Protein (g) 0.18 0.15 
Fat (% energy) 69 69 
Carbohydrate (% energy) 26 26 
Protein (% energy) 5 5 
Table 3.2. Macronutrient composition of the test meal. 
Energy(MJ) 
Carbohydrate (g) 
Sugars 
Starch 
Fat (g) 
Saturated 
Monounsaturated 
Polyunsaturated 
Cholesterol, mg 
Protein (g) 
Fibre, g 
Test meal for an example subject, 
body mass 77.3 kg 
5.08 
85 
54 
31 
93 
57 
26 
6 
205 
14 
14 
Table 3.3. Energy and macronutrient content of test meal for an example subject, 
body mass 77.3 kg. 
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3.9.2 Preparation for the test meal 
Subjects were instructed to come to the laboratory for the test meal after a 12-h fast. 
They were also instructed to drink plenty of water the evening prior to the test meal 
to prevent dehydration. They arrived at the laboratory by car to ensure they were at 
the rested state. 
3.10 Blood sampling 
Venous blood samples were obtained via an indwelling cannula (Venflon 2, 18G/45 
mm: BOC Ohmeda AB, Helsingborg, Sweden) placed in an antecubital or forearm 
vein or occasionally by venopuncture of an antecubital vein. For cannulation, sub-
jects lay on an examination couch and a small volume oflocal anaesthetic (1 % w/v 
lignocaine hydrochloride; Antigen Phannaceuticals Ltd., Roscrea, Ireland) was in-
jected subcutaneously. The cannula was then introduced and a IO-cm three-way 
stopcock (Connecta, BOC Ohmeda AB, Helsingborg, Sweden) was attached for 
blood sampling. The cannula was kept patent by flushing with saline solution (0.9 %; 
B. Braun Ltd., Buckinghamshire, UK). All blood samples were obtained with sub-
jects in the supine position (for at least 15 minutes) and were collected directly into 
Monovettes (Sarstedt Ltd., Leicester, UK) via a "multi-adaptor" (Sarstedt Ltd., 
Leicester, UK). Different types ofMonovettes were used depending on the subse-
quent analysis. Serum Monovettes were used to collect samples for determination of 
insulin and 3-hydroxybutyrate. Samples to be analysed for glucose and lactate were 
collected into pre-chilled sodium-fluoride Monovettes. All other blood samples were 
collected into pre-chilled potassium ethylenediamine tetra-acetic acid (EDTA) 
Monovettes. Sodium-fluoride and potassium-EDTA Monovettes were kept chilled 
until centrifugation. 
Blood samples collected into sodium-fluoride and potassium-EDTA Monovettes 
were centrifuged (Koolspin; Burkard, Scientific Ltd., Uxbridge, UK) within 15 min 
of collection for 15 minutes at 1,250 g at 4'C. Blood collected into serum Monovet-
tes was allowed to clot for 1 h at room temperature before centrifugation for 15 min-
utes at 1,250 g at 4'C. Plasma aliquots were stored at -20'C and serum aliquots at -
70'C for later analysis. In chapter 6, one plasma aliquot (4 mL) was kept at 4'C, until 
a TRL fraction was separated and apo B48 and BIOO concentrations were deter-
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mined. To minimise proteolytic degradation of apo B in this aliquot, 1.0 ~L per mL 
plasma ofphenylmethylsulfonylfluoride (pMSF, Sigrna) 10 mM dissolved in iso-
propanol and 5 JlL per mL plasma of aprotinin (Trasylol, Bayer, Leverkusen, Ger-
many) 1.4 Jlg/L were added. 
3.11 Analysis of blood samples 
These analyses were conducted in the Biochemistry Laboratory in the Department of 
Physical Education, Sports Science and Recreation Management unless otherwise 
stated. 
3.11.1 Spectophotometric assays 
Concentrations of TAG in plasma (all chapters) and the TRL fraction (chapter 6) 
were measured enzymatically using a commercially available kit (Roche Diagnostics 
Ltd., Lewes, UK) (chapter 4) or the method described by the Oxford Lipid Metabo-
lism Group (Humphreys et al. 1990) with correction for free glycerol (Appendix B 1) 
(chapters 5 and 6). In all studies, plasma was also analysed for total cholesterol, glu-
cose, lactate (Roche Diagnostics Ltd., Lewes, UK) and non-esterified fatty acids 
(NEFA) (Wako, Wako Chemicals GmbH, Neuss, Germany) by standard enzymatic, 
colorimetric methods. A magnesium chloride/phosphotungstic acid precipitation 
method (Roche Diagnostics Ltd., Lewes, UK) was used to isolate an HOL-containing 
supematant from plasma which was subsequently analysed for cholesterol. Serum 3-
hydroxybutyrate concentrations were determined by an enzymatic method (Sigrna 
Diagnostics, Poole, Dorset, UK). All spectophotometric assays were performed on an 
automated analyser (Cobas Mira Plus, Roche Diagnostic Systems, Hertfordshire, 
UK). The plasma TAG concentrations in chapter 4 were determined on Cobas Bio, 
Version 8326. 
3.11.2 Radioimmunoassays 
Concentrations of serum insulin were determined using a solid-phase 12'Iodine ra-
dioimmunoassay (COAT-A-COUNT; Diagnostic Products, Los Angeles, CA, USA). 
Radioactivity was measured using an automated gamma counting system (Cobra IT, 
Packard Instrument, Downers Grove, IL) (Appendix B2). This analysis was con-
ducted in the Chemistry Department, Loughborough University. 
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3.11.3 Apolipoprotein E phenotyping 
Apolipoprotein E phenotype was determined by Dr SJ Mastana and Mrs A Pacynko 
in the Human Genetics Laboratory (Department of Human Sciences, Loughborough 
University), by isoelectric focusing using Western blot techniques (Eichner et al. 
1991). 
3.11.4 TRL fractionation 
The TRL fraction (Sf> 20) was separated by preparative ultracentrifugation. The 
TRL fractionation was conducted on fresh plasma the day after the samples were 
collected. The plasma had been mixed with a preservative cocktail (see section 
3.11.4) and stored overnight at 4·C. During the analyses the samples were chilled in 
ice trays. 
Approximately 4.2 mL of 1.006 g/mL density solution (prepared by dissolving 11.0 
g NaCI in 995 ml distilled water and adding 0.1 mL of 0.1 mmollL EDTA) was in-
jected at the bottom of bell-topped centrifuge tubes (13 x 51 mm) (Quick-Seal, 
Beckman Instruments Ltd., High Wycombe, Bucks, UK) using a 21G x 3.81 cm 
needle (Sabre International Products Limited, Reading, UK) attached to a 5-mL sy-
ringe (plastipak, Becton Dickinson, Oxford, UK). The tubes were weighed. Ap-
proximately 2 mL of plasma was then carefully layered underneath the density solu-
tion using a cannula-needle (Venflon 2, 18G/45 mm: BOC Ohmeda AB, Helsing-
borg, Sweden) attached to a 2 mL syringe (Plastipak, Becton Dickinson, Oxford, 
UK) and the tubes were re-weighed and topped up with density solution. The tubes 
were then sealed with a Beckman tube topper kit (Beckman Instruments Inc., Lon-
don, UK) and gently placed in a fixed-angle rotor (Beckman, TLA 100'4). They were 
centrifuged for ISO min in an Optima TLX (Beckman Instruments Ltd.) at 100,000 
rpm (average 543,000 g) at 4·C. The tubes were then placed in a Beckman Centri-
Tube slicer (Beckman Instruments Ltd.) and sliced at 3.5 cm from the bottom to iso-
late the TRL fraction. This was aspirated into pre-weighed 3 mL polycarbonate tubes 
(Fisher Scientific, Loughborough, UK) using a 21 G x 3.81 cm needle attached to a 2 
mL syringe. The tube slice and the tube slicer blade were then rinsed with density 
solution to dislodge TRL particles which were stuck to the walls of the tube slicer 
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and this liquid was added to the TRL suspension in the polycarbonate tube. The tube 
was then re-weighed to detennine the mass of the TRL suspension. 
The concentration (mrnollL) of TAG in the TRL fraction suspension was then deter-
mined. This concentration was multiplied by the mass of the fraction (assuming the 
density of the fraction to be I glmL) and divided by 1000 to give the mrnolar quan-
tity of TAG in each fraction. This was then multiplied by 1000 and divided by the 
original volume of plasma used to generate the fraction to give the concentration 
(mmollL) ofTRL-TAG in the plasma sample. 
3.11.5 Determination ofTRL apo B48, apo BIOO and apo E concentrations 
Apo B48, apo B I 00 and apo E in the TRL fraction were quantified using analytical 
SDS-PAGE as described by Karpe and Hamsten (1994). This is a type of electropho-
resis used to separate proteins by molecular weight. The proteins are reduced and de-
natured and SDS is used to give proteins a consistent charge-to-mass ratio. These 
analyses were conducted by the author under the supervision of researchers in the 
Oxford Lipid Metabolism Group. 
Aliquots of the TRL fraction were delipidated in a methanol-diethyl ether solvent 
system. The delipidations were always performed immediately after ultracentrifuga-
tion. A volume of 3.0 mL of methanol (99.8 %, BDH Analar) was vigorously added 
to 200-300 JlL ofTRL fraction in a 7 mL round-bottom glass tube with a polyethyl-
ene stopper (Vacutainer,® Vacutainer Systems, Becton Dickinson, UK). A volume of 
3.0 mL diethyl ether (99.5 %, BDH Analar) was then vigorously added to the tube , 
and the delipidation mixture was centrifuged (GS-15R, Beckman Instruments Ltd.) 
for 25 minutes in a swing-out rotor (S4180, Beckman Instruments Ltd.) at 4·C. After 
gentle removal of the solvent, another 3.0 mL diethyl ether was immediately added 
and the sample was centrifuged for another 25 minutes under the same conditions, 
whereafter the diethyl ether was discarded. The tube was allowed to dry until a whit-
ish haze was seen at the bottom of the tube. The protein sediments were solubilised in 
50 JlL of sample buffer (2 % SDS, 0.15 M sodium phosphate, 12.5 % glycerol, 5 % 
mercaptoethanol, and 0.001 % bromphenol blue at pH 6.8) by mixing for 3x3 min-
utes at room temperature. The dissolved protein mixture was subsequently denatured 
79 
at 80'C for 10 min. After denaturation the tubes were immediately centrifuged (GS-
15R, Beckman Instruments Ltd.) for 2 minutes in a swing-out rotor (S4180, Beckman 
Instruments Ltd.). Samples were then frozen at -20'C until analytical SDS-PAGE was 
performed. 
Gradient SDS gels (3-27 %) (lCN Biomedicals, Inc, Ohio, USA) were used for elec-
trophoresis and apo BlOO from LDL (0.2IlglIlL) (provided by the Oxford Lipid Me-
tabolism Group) was used as a reference protein and for standard curve dilutions. 
When gels were run simultaneously and thereafter fixed, stained, and destained in the 
same bowl, a standard curve was applied to only one of these gels. For the construc-
tion of the standard curve, five amounts of the apo BlOO standard were applied (0.1 
Ilg, 0.2 Ilg, 0.5 Ilg, 1 Ilg and 1.5 Ilg). Electrophoresis was performed using a vertical 
BioRad Miniprotean IT apparatus connected to a BioRad Power Pack 300 supply. The 
upper and lower electrophoresis buffers contained 25 mM Tris, 192 mM glycine, and 
0.2 % SDS adjusted to pH 8.5. Pre-electrophoresis was performed for 15 min at 60 V. 
Normally, both 2 ilL and 10 IlL of each sample were applied to obtain at least one 
protein band within the range of the apo BI00 standard curve. Gels were run first at 
60 V for 15 min and then at 100 V for approximately 1 hour until the bromophenol 
blue bands reached the lower end of the gel. After electrophoresis, gels were fixed in 
12 % trichloroacetic acid for 30 min, then stained in 0.2 % Coomassie G-250 (Merck, 
Poole, UK), 40 % methanol, and 10 % acetic acid for 3 hours, and fmally destained in 
12 % methanol, 7 % acetic acid for 48 hours with four to five changes of destainer. 
Gels were scanned using BioRad GS700 Imaging Densitometer. The background was 
subtracted by scanning an empty lane. 
The apo B 48 and B 1 00 mass in the 10 ilL and 2 ilL application, respectively, were 
calculated using the apo B 1 00 standard curve, as the chromogenicity of these apo-
Iipoproteins has been found to be equal (Karpe and Hamsten 1994). For the calcula-
tion of TRL apo B48 and B 1 00 concentrations in the plasma sample, several dilution 
factors were taken into consideration: (i) the total volume of sample buffer ( 50 ilL) 
that the delipidated TRL fraction was dissolved in divided by the sample volume ap-
plied to the gel; (ii) the volume of the TRL fraction recovered divided by the volume 
ofTRL fraction delipidated (usually 0.3 mL for fasting samples and 0.2 mL for post-
80 
prandial samples); and (iii) I divided by the volume of plasma ultra-centrifuged to 
get TRL apo B48 and B 1 00 concentrations in the plasma sample in mgIL. Apo E was 
quantified using the apo Bl 00 standard curve by taking account of the difference in 
chromogenicity by multiplying with 2.6 (Bjiirkegren et al. 1997). 
3.11.6 Determination of remnant-like lipoprotein particle cholesterol concentra-
tion 
The RLP-cholesterol was determined in serum samples using a novel immunosepa-
ration kit technique (Jirnro-II) made available from the Japanese Immunoresearch 
Laboratories Company (Nakajima et al. 1996). This analysis was conducted by the 
author under the supervision of researchers in the Oxford Lipid Metabolism Group. 
Serum was mixed with a lipoprotein separation medium consisting of a Sepharose gel 
suspension to which monoclonal (Mab) antibodies directed against apo BlOO (HR) 
and apo AI had been attached (Nakajima et al. 1993). The Mab JIH recognises an 
epitope in the region of apo BSI (Nakajima et al. 1996). It binds to all apo BI00-
containing particles (Le. VLDL and LDL) but not to a minor fraction ofVLDL that is 
enriched in apo E and has remnant characteristics (Campos et al. 1992). This anti-
body also fails to recognise apo B48-containing particles. When the kit is used, all 
HDL and (newly-secreted) chylomicrons containing apo AI are precipitated. The un-
bound fraction contains chylomicron remnants and apo E-enriched VLDL particles 
that have properties resembling VLDL remnants. In normolipidaemic subjects likely 
to have low levels ofTRL remnants, apo E-containing HDL-sized lipoproteins may 
also be found in the unbound fraction (Marcoux et al. 1998). It may be that these 
lipoproteins do not contain neither apo B nor apo AI and thus are not recognised by 
the immunoaffinity gel antibodies (Marcoux et al. 1998). The unbound fraction there-
fore contains a large proportion ofRLP particles and, in some conditions, lipoprotein 
particles of smaller size that may not be direct products of TRL lipolysis. The subse-
quent measurement of the cholesterol content of the unbound fraction is likely to 
provide a good estimate of remnant cholesterol levels in serum and could be used as a 
marker for RLP. The best diagnostic marker for RLP has been evaluated and among 
cholesterol, triacylglycerol, phospholipids and apo B measurements, cholesterol was 
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found to be the most sensitive, precise and convenient (Nakajima et al. 1993). In ad-
dition, cholesterol measurement is widely used to estimate atherosclerotic risk. 
Fasting RLP-cholesterol concentration has been shown to be strongly associated with 
serum TAG concentration (Nakajima et al. 1993) and the concentration of apo B48 
and apo B 1 00 TRL particles (Karpe et al. in press). The increase in RLP-cholesterol 
after fat intake has been correlated with the increase in TRL apo B48 and large apo 
B 1 00 TRL particles (Karpe et al. in press). Despite the strong association between 
plasma TAG and RLP-cholesterol concentrations, there is considerable interindi-
vidual variability in RLP-cholesterollevels and subjects with the same TAG concen-
tration often have very different RLP-cholesterollevels (Nakajima et al. 1993). 
Age, gender and menopausal status have significant effects on RLP-cholesterol con-
centrations. RLP-cholesterol concentrations increase with age in both men and 
women (Nakajima et al. 1993; McNamara et aI.1998). Data from the Framingham 
Heart Study (McNamara et a1.1998) also showed that postmenopausal women (n = 
718) had significantly higher mean RLP-cholesterollevels than premenopausal 
women (n = 667) (0.188 mmollL vs. 0.163 mmollL). However, women (n = 1385) 
consistently had lower mean concentrations than men (n = 1436) (0.176 mmollL vs. 
0.208 mmollL). From the data that were generated, ranges for low, normal and in-
creased RLP-cholesterol concentrations were calculated for fresh samples. These 
were: low, < 0.15 mmollL; normal, 0.15-0.25 mmollL; and increased, > 0.25 
mmollL. 
The RLP-cholesterol kit consists of the following reagents: 
• Immunoaffmity gel (30 mL): mouse monoclonal antibodies to anti-human apo 
BlOO (n-H) and anti-human apo AI (H-12) conjugated to Shepharose 4B beads 
as the solid phase. 
• Wash buffer (750 mL): 0.01 M Tris-HCL buffer with 0.01 % EDTA, 0.02 % so-
dium azide, pH 7.4. 
• Cholesterol reagent RI (40 mL) containing ascorbate oxidase, cholesterol esterase 
and cholesterol oxidase. 
• Cholesterol reagent R2 (10 mL), containing horseradish peroxidase, 4-amino-
antipyrine and N-ethyl-N-(3-methylphenyl)-N' -succinyl-ethylenediamine. 
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• Cholesterol-ester calibrator 1.292 mmollL (2 mL). 
According to the manufacturer's instructions, serum is the preferable sample for the 
assay but EDTA or heparin plasma may also be used. Concentrations in fasting or 
non-fasting EDTA plasma samples have reported to be higher than in serum or hepa-
rinised plasma (Leary et al. 1998). Freezing may result in higher RLP-cholesterol 
concentration. It has been calculated that at an RLP-cholesterol concentration of 0.25 
mmollL, there was a positive bias of 0.023 mmollL, producing a concentration of 
0.273 mmollL (McNamara et al. 1998). The separation of the RLP fraction is suffi-
cient provided the total TAG concentration in the sample is < 11.3 mmollL; HDL-
cholesterol, < 2.3 mmollL; and LDL-cholesterol; < 5.2 mmollL. The detection limit 
of the assay is estimated to be 80 !illlollL or 0.080 mmollL. 
The immunoaffmity Sepharose gel was prepared (after inversion to ensure complete 
suspension) by centrifuging the required amount for 1 min at 800 rpm at 4' C. The 
supematant was removed and equal volume of wash buffer was added and the tube 
was suspended. The tube was again centrifuged for 1 minute under the same condi-
tions, the supematant was removed and equal volume of wash buffer was added. The 
tube was suspended and the immunoaffmity gel suspension was ready for use. 
Two Hitachi micro-sample cups (supplied by JIMRO) were labeled for each sample. 
A 3.2-mm diameter steel bead (provided by JIMRO) was added to each cup using a 
bead dispenser (provided by JIMRO). A total of300 J.1L of the inununoaffinity 
Sepharose gel suspension and 10 J.1L of serum were then added to each cup. The 
separation medium was gently mixed (RLP Mixer, J-l 00, Photal, Otsuka Electronics, 
Japan) for 120 minutes at room temperature. The RLP mixer has a series of magnetic 
bars driving the steel bead up and down in each cup to ensure mixing during the in-
cubation (Nakajima et al. 1996). The RLP separation gel was then allowed to settle 
for at least 20 minutes, but less than 30 minutes. 
The cholesterol content in the supematant was assayed in dublicate enzymatically 
using a centrifugal autoanalyser (Monarch, Instrumentation Laboratory, Warrington, 
UK). Calibrators of different concentrations (103 /lmollL, 52 /lmollL, 26 !illlollL, 13 
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J.lffiollL, 6.5 J.lffiollL and 3.2 flmollL) were used for construction of a calibration 
curve. These were prepared by serial dilutions of the cholesterol ester calibrator 
(1292 flmollL) in wash buffer. For the calculation ofRLP-cholesterol concentration 
in the serum sample, the cholesterol in the supernatant was multiplied by 31 to cor-
rect for the dilution of serum sample at the immunoseparation step. 
3.12 Calculations and statistics 
Plasma, TRL and serum concentrations measured in the fasted state were compared 
using Student's t-test(chapter 4) or one-way analysis of variance (ANOVA) for re-
peated measures (chapters 5 and 6) when two or three interventions were employed, 
respectively. Summary measures (Matthews et al. 1990) of the postprandial re-
sponses were calculated as the total areas under plasma, TRL fraction and serum con-
centration vs time curves (AUC) using the trapezoidal rule. The AUC is a useful way 
of summarising the postprandial response for each individual from the series of 
measurements before and after the meal. Summary measures were compared using 
student t-test or one-way ANOV A, again depending on the number of interventions 
employed. In addition, when the pattern of change over time in the postprandial re-
sponse seemed different, the interaction effect of intervention and time was deter-
mined using two-way ANOV A for repeated measures. This analysis was proven par-
ticularly important in situations where the AUCs after different interventions were 
similar but there was a clear difference in the pattern of the response, indicating a 
qualitative, rather than quantitative, effect of the interventions on the postprandial re-
sponse. Data were checked for normality before statistical analyses were performed 
using the Kolmogorov-Smimov test. When data were not normally distributed, they 
were transformed to their natural logarithm. Normal distribution of transformed val-
ues was confirmed before statistical testing. If significant differences were identified 
by ANOV A, Tukey post hoc comparisons were performed to determine where these 
differences occurred. Relationships between variables were evaluated using Pear-
son's product moment correlation coefficient. A 5 % level of significance was 
adopted throughout. Statistical procedures were performed using Statistica for Win-
dows, version 5.0 (Tulsa, OK, USA). 
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3.13 Accuracy and precision 
The accuracy and precision of the assays described in the sections above were moni-
tored using quality control sera; for glucose and lactate, Precirorm U (Roche Diag-
nostics Ltd., Lewes, UK); for TAG, Precirorm L (Roche Diagnostics Ltd., Lewes, 
UK) and Control Serum N (Human) (Roche Diagnostics Ltd., Lewes, UK); for total 
and HDL-cholesterol, Precirorm L (Roche Diagnostics Ltd., Lewes, UK); for NEFA, 
Seronorm Lipid (SERO AS, Asker Norway); for 3-hydroxybutyrate, ~-HBA Control 
Normal (Sigma Diagnostics, Poole, UK). 
All samples from each subject were analysed in the same batch, except for TAG de-
termination in the TRL fraction (chapter 6), where analyses were performed in fresh 
plasma. Within-batch coefficient of variations were 1.3 % for plasma TAG with cor-
rection for free glycerol (Humphreys et al. 1990) (chapters 5 and 6) and 1.2 % using 
the commercially available kit (Roche Diagnostics Ltd., Lewes, UK) (chapter 4),0.7 
% for cholesterol, 1.8 % for HDL cholesterol, 0.8 % for glucose, 1.3 % for lactate, 
0.9 % for NEFA, 1.4 % for 3-hydroxybutyrate and 4.2 % for insulin. The within-
batch coefficient of variation for TRL-TAG detennination was 5.4 % and for apo B-
48 and apo B-I00 determinations were 4.4 % and 4.2 %, respectively. The between-
batch coefficient of variation for TAG measurement using the method described by 
Humphreys et al. (1990) was 3.3 % at 0.250 mmollL and 1.6 % at 0.9 mmollL. 
Quality control samples (provided by the Oxford Lipid Metabolism Group) prepared 
by human serum were used for the RLP-cholesterol assay. The within-batch coeffi-
cient of variation was 7.7 % at 0.20 mmollL and 6.6 % at 0.64 mmollL. 
CHAPTER 4 
POSTPRANDIAL LIPAEMIAAFrER SHORT-TERM VARIATION IN 
DIETARY FAT AND CARBOHYDRATE 
4.1 Introduction 
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There is divergence of opinion on the optimal macronutrient recommendation for 
protection against CHD. Whereas the reduction of dietary saturated fat forms a well-
accepted tenet, the controversy focuses on which macronutrient can be the best re-
placement. The two main contenders are complex carbohydrates and unsaturated fat. 
Replacement of saturated with unsaturated fat has been shown to have effects on 
lipoprotein metabolism which would be expected to reduce the risk ofCHD (Katan 
1997; Katan et al. 1997). However, distrust of the strategy to replace fat with fat 
(Connor and Connor 1997; Omish 1998; Rude11998) has shifted the focus ofrec-
ommendations to diets low in fat and high in carbohydrates. In the UK, for example, 
a desirable level likely to decrease the incidence of diet-related chronic disease has 
been set at 33 % of energy from fat (Department of Health 1991), a reduction of 5 % 
compared with figures for 1996 (Ministry of Agriculture Fisheries and Food 1997). 
Replacement of fat with carbohydrates has been recommended because this reduces 
plasma total and LDL-cholesterol concentrations (Clevidence et al. 1992). Recently, 
however, concern has been expressed that low-fat, high-carbohydrate diets may not 
confer the anticipated benefits for cardiovascular disease risk (Baum and Brown 
2000) because such diets also increase fasting plasma TAG and decrease HDL-
cholesterol concentrations (Mensink and Katan 1992). According to epidemiological 
evidence, these alterations may be expected to increase the risk of CHD (Hokanson 
and Austin 1996). High-carbohydrate diets have also been associated with the pre-
dominance of small dense LDL particles (Dreon et al. 1999) that are potentially ath-
erogenic (Griffm 1999). 
Despite the fact that they contain less fat, high-carbohydrate diets increase postpran-
dial lipaemia (Jeppesen et al. 1997; Coulston et al. 1983; Chen et al. 1993). This ef-
fect appears to be of great importance. First, an exaggerated TAG response, espe-
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cially at late time points, has been recognized as an independent marker of CHD 
(patsch et al. 1992). Second, the magnitude of postprandial lipaemia shows a strong 
inverse association with fasting HDL-cholesterol concentration (patsch et al. 1983) 
and a positive association with the preponderance of small and dense LDL particles 
(Karpe et al. 1993). As discussed in sections 2.7.2 and 2.7.3, an exaggerated post-
prandial lipaemia probably enhances the opportunity for exchange ofHDL- and 
LDL-cholesterol esters for TAG from TRL particles, resulting in the formation of 
cholesterol-depleted HDL and small dense LDL particles. Thus, one may speculate 
that exaggeration of postprandial lipaemia could, at least partly, explain the reduc-
tion in HDL-cholesterol concentration (Katan 1998) and shift in LDL particle mass 
from predominantly larger to predominantly smaller LDL particles (Dreon et al. 
1999) which have been reported in healthy volunteers in response to a low-fat, high-
carbohydrate diet. 
Consequently, it is important that the links between dietary change and postprandial 
TAG metabolism are understood and their implications for the atherosclerotic proc-
ess explored. In the majority of postprandial studies investigating the effect of high-
carbohydrate diets (Jeppesen et al. 1997; Coulston et al. 1983; Chen et al. 1993), the 
test meals were not standard but reflected the composition of the background diets 
which were compared. Therefore, the test meal on each occasion had different com-
position as it contained different amount of carbohydrate and fat. In this way, these 
studies do not distinguish the acute effects on postprandial lipaemia of the test meal 
from the chronic effects of the preceding diet. 
It has been suggested that carbohydrate-induced hypertriacylglycerolaemia is a short-
term adaptive response to an increase in dietary carbohydrate and that this effect di-
minishes after a couple of weeks (Bierman 1995; TruswellI994). On the other hand, 
results from experimental (Brussaard et al. 1982) and epidemiological (West et al. 
1990) studies show that this can be a long-lasting phenomenon. Either way, the lipo-
proteinemic changes are likely to be more marked shortly after the initiation of a 
high-carbohydrate diet than after longer periods of intervention during which adap-
tive processes may counterbalance the initial effects. Carbohydrate-induced hyper-
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triacylglycerolaemia may thus be best examined through study of the initial responses 
to a switch to a high-carbohydrate diet. 
The present study was, therefore, designed to investigate the effects of short-term 
manipulation of the fat and carbohydrate content of isoenergetic diets on the meta-
bolic responses to a standard test meal. An additional objective was to establish a 
short-term dietary intervention model for future investigations of the hypertriacyl-
glycerolaemic effect of high-carbohydrate diets and, importantly, its prevention. In 
order to provide a clear picture of differences in postprandial events, the experimen-
tal diets employed had distinctly different composition. 
4.2 Subjects and methods 
4.2.1 Subjects 
Nine normolipidaernic men took part in the study, which was approved by the 
Loughborough University Ethical Advisory Committee. All subjects were fully in-
formed of the procedures and risks involved and gave their written consent. Some 
physical characteristics and plasma concentrations of TAG, total cholesterol and 
HDL-cholesterol of subjects as measured after an over-night fast on recruitment, 
whilst subjects were following their habitual lifestyle are presented in Table 4.1. All 
subjects were non-smokers and none had any physician-diagnosed cardiovascular or 
metabolic disease or was taking drugs known to influence lipid or carbohydrate me-
tabolism. To exclude individuals with extreme habitual dietary practices, only non-
vegetarian subjects and subjects with habitual fat intakes constituting between 25 % 
and 45 % of energy intake were accepted. Subjects' habitual diet was assessed by the 
weighed food inventory method over two weekdays and one weekend day, as de-
scribed in section 3.2.1. Information about the energy content and macronutrient 
composition of subjects' habitual diets is presented in Table 4.2. Seven subjects were 
recreationally active in moderate exercise (e.g. fast walking, easy cycling) three times 
per week. Two also engaged in more strenuous exercise, again around three times per 
week. Five subjects possessed the E3/3 phenotype, two the E3/2 and two E4/3. 
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Age, year 26.7± 3.8 
Body mass, kg 79.6± 8.2 
Height, m 1.78 ± 0.04 
BMI,kglm2 25.1 ± 1.8 
Waist, cm 84.0± 6.7 
Waist to hip ratio 0.86 ±0.05 
Body fat, % 18.9 ± 4.3 
TAG,mmoIIL 0.93 ±0.29 
Total cholesterol, mmoIIL 4.18 ± 0.94 
HDL-cholesterol, mmoIIL 1.08 ± 0.19 
Table 4.1 Physical characteristics of subjects and plasma concentrations of lipo-
protein Iipids measured in the fasted state. n = 9 men, mean ± SD. 
89 
4.2.2 Study design 
Each subject consumed a standardised high-fat, mixed meal, with an interval of 13 
days, after two different interventions. These interventions comprised: (i) three days 
on a high-fat diet and (ii) three days on a high-carbohydrate diet. The order of the 
interventions was counterbalanced. 
4.2.3 Experimental diets 
The experimental diets were isoenergetic and their energy value approximated, on an 
individual basis, subjects' previously determined energy intake (sections 3.2.1 and 
3.8.1). They were based on normal foods, excluding alcohol, and their energy and 
macronutrient contents are shown in Table 4.2. Three meals and one or two snacks 
were consumed each day. Subjects prepared these themselves, to a menu agreed with 
the experimenters. This included detailed instructions about the mass of each item to 
be consumed and methods of preparation and cooking. Subjects were instructed to 
follow the experimental diets ''to the gram" and were also asked to weigh and record 
each item consumed. Examples of the prescribed high-carbohydrate and high-fat di-
ets are presented in Table 4.3 and Table 4.4, respectively. Subjects refrained from 
exercise during the three-day interventions; only activities of daily living and slow 
walking for personal transport were permitted. Caffeine consumption was not re-
stricted during the interventions but subjects were instructed to standardise it for the 
day prior the oral fat tolerance tests. 
During the three days leading up to the first intervention period, diets were unre-
stricted but subjects weighed and recorded all foods consumed, replicating this prior 
to the subsequent intervention. During these three days, they also refrained from ex-
ercise and from alcohol consumption. Otherwise, subjects returned to their usual Iife-
style during the IO-day wash-out interval. 
4.2.4 Diet analysis 
Weighed food inventories were analysed for energy and major nutrients using a com-
puterised version (Comp-Eat 5.0, Nutrition Systems, London) ofUK food composi-
tion tables (Holland et al. 1991). 
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4.2.5 Test meal protocol 
Full details of the test meal protocol were given in section 3.9. Briefly, subjects ar-
rived at the laboratory after a 12-h fast at approximately 0800 h. A cannula was in-
troduced into a forearm or antecubital vein and the subject rested quietly in a supine 
position for 10 minutes, after which a baseline blood sample was obtained (details on 
blood sampling are given in section 3.10). The test meal (described in detail in sec-
tion 3.9.1) was then consumed. The meal was given according to body mass (per kg 
of body mass: 1.2 g fat, 1.1 g carbohydrate, 0.2 g protein). For these subjects, this 
meant 96 ± 3 g fat, 93 ± 3 g carbohydrate, 14 ± 1 g protein and 5.54 ± 0.19 MJ of 
energy, 69 % of which came from fat. Further blood samples were obtained (with 
subjects in the supine position) 15,30,45,60 and 90 minutes after completion of the 
meal, and then hourly until 6 hours. Subjects rested or worked quietly during the ob-
servation period and consumed only water. This was provided ad libitum on the first 
trial and replicated during the second trial. 
4.2.6 Analytical methods 
At each sampling point in the fasted and postprandial states, blood samples for 
plasma preparation were separated within 15 minutes of collection, divided into ali-
quots and were stored at -200 C. At most time points, separate samples were collected 
for serum preparation. These were allowed to clot at room temperature before sepa-
ration and were stored at -700 C. Plasma samples were analysed for total and HDL-
cholesterol (fasted and 6-h samples only), TAG, NEFA, glucose and lactate, and se-
rum samples for 3-hydroxybutyrate (all by enzymatic, colorimetric methods). Serum 
samples were also analysed for insulin using a solid-phase 1251 radioimmunassay. 
Details of these analyses have been given in section 3.11. Phenotypes of apolipopro-
tein E were determined by isoelectric focusing, using Western blot techniques. 
Habitual diet High-carbohydrate diet High-fat diet 
Energy,MJ 11.7± 1.7 12.2 ± 2.1 11.9 ±2.l 
Carbohydrate, % 50±9 68±3 18±4 
Sugars 20±6 35 ± 5 6±2 
Starch 30±9 33±4 12±2 
Fat, % 35±9 18±3 66±5 
Saturated 13 ± 5 8±1 24±3 
Monounsaturated 13±4 6±1 22±2 
Polyunsaturated 8±4 3 ± 1 17±2 
Cholesterol, mg 319 ± 140 200± 89 352± 74 
Protein, % 15 ± 3 14 ± 1 16± 3 
Fibre, g 25 ± 11 22± 8 18 ± 5 
Table 4.2 Energy content and composition of the habitual and experimental (high-carbohydrate and high-fat) diets. Each 
experimental diet was consumed for three days. n = 9 men, mean ± SD. 
High-carbohydrate diet 
Total energy: 11.3 MJ 
CHO FAT 
69% : 18 % : 
PROTEIN 
13% 
Breakfast Amount, g 
Bran flakes 90 
Semi-skimmed milk 200 
White bread 80 
Jam 30 
Orange juice 240 
Coffee with semi-skimmed 50 (milk) 
milk 
Lunch 
White bread 160 
Flora, 38 % vegetable fat 20 
Lean ham 90 
Orange juice, unsweetened 240 
Banana lOO 
Snack 
Swiss roll 50 
Orange juice, unsweetened 240 
Dinner 
White spaghetti, boiled 260 
Cheddar cheese, medium 30 
Flora 38 % vegetable fat 10 
Swiss roll 25 
Snack 
Tango orange drink 660 
Digestive biscuits, plain 45 
DATE: 
Actual Notes 
amount,g 
Please eat and drink everything that has been prescribed for the three days of the 
high-carbohydrate diet. Please refrain from exercise on these three days and do not 
eat or drink anything else (except water). 
92 
Table 4.3 An example of the prescribed high-carbohydrate diet. It was consumed 
for three days. 
High-fat diet 
Total energy: 11.3 MJ 
CHO FAT 
20% : 69% : 
Breakfast 
Bran flakes 
Semi-skimmed milk 
Coffee with semi-skimmed 
milk 
Snack 
Potato crisps 
Peanuts 
Lunch 
Wholemeal bread 
Flora, 70 % vegetable fat 
Cream cheese 
Diet 7UP 
Cucumber, lettuce 
Peanuts 
Dinner 
Tuna, canned in oil, drained 
White spaghetti, boiled 
Mayonnaise 
Cheddar cheese, medium 
Cucumber, lettuce 
Snack 
Semi-skimmed milk 
PROTEIN 
11% 
Amount,g 
60 
200 
50 
30 
30 
75 
20 
60 
Free 
Free 
20 
75 
130 
140 
20 
Free 
150 
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Actual Notes 
amount, 
g 
Please eat and drink everything that has been prescribed for the three days of the 
high-fat diet. Please refrain from exercise on these three days and do not eat or drink 
anything else (except water). 
Table 4.4 An example of the prescribed high-fat diet. It was consumed for three 
days. 
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4.2.7 Calculations and statistics 
Plasma and serum concentrations measured in the fasted state were compared using 
Student's Hest for correlated means. Total postprandial responses were calculated as 
the AUC using the trapezoidal rule. The incremental postprandial TAG response was 
calculated as the total AUC minus the fasting value extrapolated over six hours. 
These summary measures (section 3.12) were compared between interventions using 
Student's Hest for correlated data. In addition, the interaction effect of intervention 
and time was determined using two-way ANOV A for repeated measures. Relation-
ships were evaluated using Pearson's Product Moment correlation coefficient. A 5 % 
level of significance was adopted throughout and results are expressed as mean ± 
SEM, unless otherwise stated. 
4.3 Results 
4.3.1 Experimental diets and test meal 
Both experimental diets were well tolerated, aside from a common complaint by the 
subjects offeeling excessively full during the high-carbohydrate diet. Most subjects 
also complained for the high-fat diet being excessively rich. Compliance, assessed by 
food inventories and detailed discussions with subjects, was high. The test meal was 
also well tolerated by all subjects without any sign of nausea or other gastrointestinal 
discomfort. It was consumed over an average of 11.4 minutes (both interventions). 
4.3.2 Plasma and serum concentrations in the fasted state 
Plasma concentrations of TAG, lactate and serum concentration of insulin were sig-
nificantly higher, whereas HDL-cholesterol and NEF A were significantly lower after 
the high-carbohydrate diet than after the high-fat diet, (Table 4.5). No significant dif-
ferences were found for glucose or total cholesterol. Serum 3-hydroxybutyrate con-
centration was somewhat lower after the high-carbohydrate diet (P = 0.06). 
4.3.3 Postprandial responses 
The total AUC (Figure 4.1, upper panel, Table 4.6) was higher after the high-
carbohydrate diet than after the high-fat diet and the pattern of change in TAG con-
centration differed between interventions (interaction of intervention x time, P < 
0.001). Peak concentration occurred later after the high-carbohydrate diet (3-4 h post-
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prandially, compared with 1-2 h) and at 6 h was still significantly higher than the 
fasting value (P < 0.001). The totallipaemic response (AUC) was closely related to 
fasting TAG concentrations in the high-carbohydrate intervention (r = 0.97, P <0.01) 
but not in the high-fat intervention (r = 0.61, NS). The incrementallipaemic response 
(Figure 4.1, lower panel, Table 4.6) was higher after the high-carbohydrate diet and 
the pattern of change over time also differed between interventions (interaction of 
intervention x time, P < 0.001). 
Table 4.5 
High-carbohydrate High-fat Pvalue l 
TAG,mmoIIL 1.18± 0.18 0.62± 0.09 0.02 
Total cholesterol, mmoIIL 3.98± 0.25 3.81 ± 0.25 0.14 
HDL-cholesterol, mmoIIL 1.01 ± 0.08 1.10 ± 0.09 0.002 
Non-esterified fatty acids, mmoIIL 0.21 ± 0.03 0.30± 0.04 0.003 
3-hydroxybutyrate, rrunoIIL 0.02± 0.01 0,07 ± 0.02 0.06 
Insulin, IlIU/mL 10.9± 0.8 9.2±0.6 0,03 
Glucose, mmoIIL 5.13 ± 0.13 5.26 ± 0.13 0.15 
Lactate, rrunoIIL 1.08 ± 0.09 0.73 ± 0.03 0.004 
Concentrations measured in the fasted state for plasma TAG, total cholesterol, HDL cholesterol, non-esterified fatty acids, glu-
cose, lactate, and serum 3-hydroxybutyrate and insulin, after the high-carbohydrate diet and after the high-fat diet. Each diet 
was consumed for three days. n = 9 men, Mean ± SEM. 
I Significance of differences between trials by Student's t-test for correlated means. 
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Total (upper panel) and incremental (lower panel) plasma concentra-
tions of TAG in the fasted state (0 hour) and for six hours following 
consumption of a high-fat, mixed meal after three days on a high-
carbohydrate diet (High-CHO) and after three days on a high-fat diet 
(High-fat). n = 9 men. Mean ± SEM. 
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Postprandial responses of insulin, NEFA and 3-hydroxybutyrate, glucose and lactate 
are shown in Figure 4.2, Figure 4.3 and Figure 4.4, respectively. Summary measures 
of these responses are presented in Table 4.6. The serum insulin response did not dif-
fer between interventions, nor did the change in concentration over time. The plasma 
glucose response was lower (P = 0.009) after the high-carbohydrate diet and the 
plasma lactate response was higher (P = 0.001). The change in plasma concentrations 
of glucose and lactate over time did not differ between interventions. The pattern of 
change ofNEFA over time was clearly different (interaction of intervention x time, P 
<0.001); the concentration was lower after the high-carbohydrate diet in the fasted 
state and for four hours postprandially, but higher thereafter. The serum 3-
hydroxybutyrate response to the high-fat meal was significantly lower (P = 0.02) after 
the high-carbohydrate diet, with a much smaller rise between two and six hours than 
after the high-fat diet (interaction of intervention x time, P <0.001). 
Neither total nor HDL-cholesterol changed over the observation period in either inter-
vention. In the 6-h blood samples, plasma total cholesterol did not differ significantly 
between interventions but, as in the fasted state, HDL-cholesterol was lower after the 
high-carbohydrate diet (1.00 ± 0.08 mmollL vs 1.1 0 ± 0.09 mmollL, P = 0.002). 
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Serum concentrations of insulin in the fasted state (0 hour) and for six 
hours following consumption of a high-fat, mixed meal after three days 
on a high-carbohydrate diet (High-CHO) and after three days on a high-
fat diet (High-fat). n = 9 men. Mean ± SEM. 
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Concentrations of plasma non-esterified fatty acids (NEFA) (upper 
panel) and serum 3-hydroxybutyrate (lower panel) in the fasted state (0 
hour) and for six hours following consumption of a high-fat, mixed 
meal after three days on a high-carbohydrate diet (High-eRO) and after 
three days on a high-fat diet (High-fat). n = 9 men. Mean ± SEM. 
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Time, h 
Plasma concentrations of glucose (upper panel) and lactate (lower 
panel) in the fasted state (0 hour) and for six hours following con-
sumption of a high-fat, mixed meal after three days on a high-
carbohydrate diet (High-CHO) and after three days on a high-fat diet 
(High-fat). n = 9 men. Mean ± SEM. 
Table 4.6 
High-carbohydrate diet High-fat diet P value! 
Total TAG, mmollL x h 12.63 ± 1.64 6.64±0.50 0.003 
Incremental TAG, mmollL x h 5.54± 0.64 2.92 ± 0.47 0.002 
Non-esterified fatty acids, mmollL x h 2.40 ± 0.20 2.80 ± 0.21 0.12 
3-hydroxybutyrate, mmollL x h 0.23 ± 0.06 0.62± 0.11 0.Q2 
Insulin, !lID/mL x h 144 ± 34 143 ± 25 0.99 
Glucose, mmollL x h 31.5 ± 1.0 33.6 ± 1.1 0.009 
Lactate, mmollL x h 6.40 ± 0.43 4.96± 0.22 O.ot 
Six-hour areas under the plasma or serum concentration vs time curves for TAG, non-esterified fatty acids, 3-hydroxybutyrate, 
insulin, glucose and lactate after three days on a high-carbohydrate diet and after three days on a high-fat diet. n = 9 men. 
Mean±SEM. 
! Significance of differences between trials by Student's t-test for correlated means. 
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4.4 Discussion 
This study was designed to investigate the effects of manipulation of the fat and car-
bohydrate content of isoenergetic diets on the metabolic responses to a standard test 
meal. It was conducted during the initial, dynamic period of dietary change when ef-
fects on lipoprotein metabolism are becoming manifest. The fmdings confinn that 
low-fat, high-carbohydrate diets increase fasting (Mensink and Katan 1992) and post-
prandial (Coulston et al. 1983; Jeppesen et al. 1997; Chen et al. 1993) plasma TAG 
concentrations, with a complementary decrease in HDL-cholesterol. However, in the 
postprandial studies just referred to, the test meal employed after each diet interven-
tion was not standardised with regard to its macronutrient composition. Specifically, 
it reflected the composition of the background diet and thus contained different 
amounts of fat and carbohydrate on each occasion. Therefore, the differences in the 
postprandial responses to the test meals encompassed both the acute effects of the 
macronutrients in the meals and the chronic effects of the preceding diets. In the pres-
ent study, the same test meal was used after each dietary intervention and therefore 
the differences in the responses to the meal reflected the effects of the antecedent di-
ets per se and maybe also their interactions with the macronutrients in the standard 
test meal. 
The major new fmding is that postprandial lipaemia in healthy men was 90 % higher 
after the short-tenn high-carbohydrate diet than after the high-fat diet, with differ-
ences in TAG concentration between trials of up to 0.9 mmollL. This fmding, along-
side the marked differences in the associated postprandial metabolic milieu, suggests 
that the present three-day dietary model may be attractive for future investigations of 
carbohydrate-induced hypertriacylglycerolemia and of interventions which might at-
tenuate this. 
In the fasted state, diet-induced differences in VLDL secretion may have contributed 
to the 0.6 mmollL difference between interventions in plasma TAG concentration. 
High-carbohydrate diets have been shown to stimulate hepatic synthesis and secretion 
ofVLDL-TAG (Sidossis and Mittenddorfer 1999), generating an expansion of the 
fasting TAG pool (Jeppesen et at. 1997; Gonen et at. 1981). Increased hepatic de 
novo lipogenesis may occur during high-carbohydrate feeding but is not likely to be 
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bohydrate content of isoenergetic diets on the metabolic responses to a standard test 
meal. It was conducted during the initial, dynamic period of dietary change when ef-
fects on lipoprotein metabolism are becoming manifest. The findings confirm that 
low-fat, high-carbohydrate diets increase fasting (Mensink and Katan 1992) and post-
prandial (Coulston et al. 1983; Jeppesen et al. 1997; Chen et al. 1993) plasma TAG 
concentrations, with a complementary decrease in HDL-cholesterol. However, in the 
postprandial studies just referred to, the test meal employed after each diet interven-
tion was not standardised with regard to its macronutrlent composition. Specifically, 
it reflected the composition of the background diet and thus contained different 
amounts of fat and carbohydrate on each occasion. Therefore, the differences in the 
postprandial responses to the test meals encompassed both the acute effects of the 
macronutrients in the meals and the chronic effects of the preceding diets. In the pres-
ent study, the same test meal was used after each dietary intervention and therefore 
the differences in the responses to the meal reflected the effects of the antecedent di-
ets per se and maybe also their interactions with the macronutrients in the standard 
test meal. 
The major new fmding is that postprandial lipaemia in healthy men was 90 % higher 
after the short-term high-carbohydrate diet than after the high-fat diet. This fmding, 
alongside the marked differences in the associated postprandial metabolic milieu, 
suggests that the present three-day dietary model may be attractive for future investi-
gations of carbohydrate-induced hypertriacylglycerolemia and of interventions which 
might attenuate this. 
In the fasted state, diet-induced differences in VLDL secretion may have contributed 
to the 0.6 mmollL difference between interventions in plasma TAG concentration. 
High-carbohydrate diets have been shown to stimulate hepatic synthesis and secretion 
ofVLDL-TAG (Sidossis and Mittenddorfer 1999), generating an expansion of the 
fasting TAG pool (Jeppesen et al. 1997; Gonen et al. 1981). Increased hepatic de 
novo lipogenesis may occur during high-carbohydrate feeding but is not likely to be 
the main determinant of increased VLDL-TAG secretion. As discussed in detail in 
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section 2.8.4.1, results from several studies do not support a quantitatively important 
rate of hepatic de novo lipogenesis, even after massively increased carbohydrate in-
take (Schwarz et al. 1995). However, de novo lipogenesis due to surplus carbohydrate 
energy plays an important role in fuel selection (McGarry and Foster 1980; Winder 
1996) through malonyl-CoA which inhibits ~-oxidation in the liver, channeling fatty 
acids into esterification, i.e. TAG synthesis (McGarry and Foster 1980). It has, there-
fore, been proposed that carbohydrate-induced hypertriacylglycerolaemia occurs be-
cause of increased intracellular hepatic availability offatty acids for TAG synthesis, 
stemming from inhibition of their oxidation by high glucose uptake (Sidossis and 
Wolfe 1996). This hypothesis is in line with the four-fold decrease in hepatic fatty 
acid oxidation that has been reported after a high-carbohydrate diet, alongside a 50 % 
increase in VLDL-TAG production rate (Sidossis and Mittenddorfer 1999). 
In addition to the potential effects of the high-carbohydrate diet on VLDL, suppressive 
effects of the high-fat diet on VLDL secretion may have contributed to the difference 
between interventions in fasting TAG concentration. Studies in rat hepatocytes have 
found that a high-fat diet decreases VLDL production, partly because increased oxida-
tion offatty acids decreases their availability for VLDL-TAG synthesis (Francone et al. 
1992; Oussasou et al. 1996). Both mechanisms, i.e. suppression of hepatic fatty acid 
oxidation after a high-carbohydrate diet and/or enhancement after a high-fat diet, 
would be consistent with the observed difference between interventions in fasting 
serum 3-hydroxybutyrate (Table 4.3). 3-Hydroxybutyrate (a ketone body) is produced 
by the liver and, since ketone bodies production, under normal conditions, occurs dur-
ing increased hepatic fatty acid ~-oxidation, serum 3-hydroxybutyrate concentration 
can be used as a marker of hepatic fatty acid ~-oxidation. However, the higher serum 
3-hydroxybutyrate concentration after the high-fat diet could reflect, in addition, re-
duced availability of oxaloacetate, which is required for the acetyl-CoA to enter into 
the tricarboxylic acid cycle (Stryer 1995). Oxaloacetate can be used as a gluconeogenic 
precursor during carbohydrate restriction, and subjects in the present study could be 
considered as carbohydrate-restricted after the high-fat intervention. Their daily carbo-
hydrate intake during the high-fat intervention was on average 135 g, which is less than 
the minimum amount of carbohydrate required daily (200 g) (Macdonald 1999) and 
also about 2.5-fold less than their habitual carbohydrate intake (369 ± 93 g). 
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In the fasted state the hydrolysis ofVLDL-TAG may also have been influenced by the 
experimental diets, amplifying differences in TAG concentration between interven-
tions. In line with this hypothesis, it has recently been reported (Parks et al. 1999) 
that VLDL-TAG clearance in humans in the fasted state was reduced after a low-fat, 
high-carbohydrate diet. As discussed in section 2.8.4.2, there are also reports which 
demonstrated that increases in fasting plasma TAG concentration due to high-
carbohydrate diets were accompanied by significant decreases in plasma heparin-
releasable LPL activity (Thompson et al. 1984; Campos et al. 1995), implying a de-
fect in plasma TAG hydrolytic capacity after this dietary regime. 
In the postprandial state, an exaggerated and protracted lipaemic response was ob-
served after the high-carbohydrate diet. This will have been partly due to the ex-
panded fasting TAG pool as chylomicrons compete with VLDL for the same, rate-
limiting enzyme (LPL) for hydrolysis of their core TAG (Brunzell et al. 1973; Karpe 
and Hultin 1995; Bjorkegren et al. 1996). Therefore, an increase in the fasting VLDL 
concentration due to the high-carbohydrate diet would increase the competition be-
tween TRL particles of exogenous and endogenous origin postprandially, leading to 
impaired hydrolysis of their TAG content and an exaggeration in TAG response to 
the test meal. This however may not be the sole explanation for the difference in 
postprandial lipaemia. 
The composition of the test meal employed may have also been a factor determining 
the difference in postprandial TAG response after the two interventions. This may 
involve an interaction between the high-carbohydrate diet and the carbohydrate con-
tent of the test meal. As mentioned in section 2.6.1, it has been demonstrated that 
carbohydrate (fructose and sucrose) added to a fat load augments postprandial 
lipaemia compared to a fat-only meal (Cohen and SchaIl 1988; Jeppesen et al. 1995). 
This effect of acute carbohydrate ingestion on TAG response has been attributed, at 
least partly, to an increase in VLDL-TAG secretion by the liver (Cohen and Schall 
1988; Jeppesen et al. 1995). One of several mechanisms may be that carbohydrate 
ingestion accelerates hepatic glycolytic rate, availability of pyruvate and formation 
of malonyl-CoA, which in turn inhibits hepatic fatty acids oxidation, diverting them 
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towards TAG synthesis and the secretory pathway (McGarry and Foster 1980; Sidos-
sis et al. 1998). These responses to the carbohydrate in the meal could have been 
amplified after the high-carbohydrate diet, priming the liver to secrete more VLDL-
TAG postprandially - as well as in the fasted state. This, in turn, would increase the 
total TAG response. The high TAG concentrations during the late postprandial pe-
riod (Figure 4.1) after the high-carbohydrate diet are consistent with this explana-
tion, as is the low 3-hydroxybutyrate concentrations (implying lower hepatic fatty 
acid ~-oxidation) and the high NEFA concentrations which could have served as a 
substrate for hepatic TAG synthesis (Figure 4.3). 
Plasma NEFA concentrations were higher after the high-fat diet during the early part 
of the observation period (Figure 4.3). In the postprandial state, the release ofNEFA 
into the circulation is determined by the activity of intracellular hormone sensitive 
lipase in the adipose tissue and the extent to which lipoprotein lipase-derived fatty 
acids are not entrapped in tissues (Fielding and Frayn 1998). Therefore the accentu-
ated NEFA response observed after the high-fat diet could reflect an impairment of 
the normal postprandial suppression of hormone sensitive lipase by insulin and/or a 
greater "spillover" offatty acids from the action of lipoprotein lipase. 
In the fasted state, glucose homeostasis was well-maintained after the high-fat diet. 
However, the postprandial plasma glucose response was much greater after the high-
fat diet, despite a similar insulin response. This may reflect impaired uptake of glu-
cose by muscle and other tissues due to the greater availability for oxidation of 
plasma fatty acids (Randle et al. 1963). According to what has been proposed by 
Randle et al. (1963), high NEFA concentration leads to increased fatty acid oxida-
tion, resulting in inhibition of glycolysis and glucose uptake. This, in turn, leads to an 
increase in blood glucose concentration. 
The high plasma TAG concentrations after the carbohydrate-rich diet may enhance 
the opportunity for reciprocal transfer of cholesterol and TAG between HDL and 
TAG-rich lipoproteins (Miesenbock and Patsch 1992), explaining the observation 
that HDL-cholesterol was lower. However, the lower HDL-cholesterol concentration 
after a high-carbohydrate diet could also simply reflect lower requirements for HDL-
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mediated cholesterol removal at lower intakes of dietary fat CV 6lez-Carrasco et al. 
1999). It is interesting that the three-day intervention was enough to provoke the ex-
pected lowering of HDL-cholesterol by the high-carbohydrate diet. As modulation of 
HDL-cholesterol is likely to be slower than changes in TAG after the initiation of a 
carbohydrate-rich diet, this supports the validity of the present dietary intervention 
model. 
In conclusion, the short-term consumption of a high-carbohydrate diet reduced 
plasma fasting HDL-cholesterol, increased fasting TAG concentrations and elevated 
the postprandial TAG response to a standard meal, compared with an isoenergetic 
high-fat diet. These findings complement earlier studies (Jeppesen et al. 1997; Chen 
et al. 1993; Coulston et al. 1983), which employed test meals with the same macro-
nutrient composition as the preceding diet interventions. However, in order to pro-
voke clear metabolic changes, extreme dietary interventions were employed in the 
present study. A high-carbohydrate diet was employed in which 70 % of energy came 
from carbohydrate, a more extreme dietary change than that recommended for the 
population at large. The high-fat diet was very high in fat and associated with meta-
bolic changes observed in a state of insulin resistance, i.e. higher plasma glucose and 
NEF A concentrations. For these reasons, the present findings should not be inter-
preted as providing guidance on dietary recommendations. 
The potential atherogenicity of carbohydrate-induced hypertriacylglycerolemia and 
concomitant decreases to HDL-cholesterol are the subject of current debate (Katan et 
at. 1997; Bierman 1995; Connor and Connor 1997; Omish 1998; Connor and Connor 
1998; Katan et al. 1998). Most of these discussions have so far been based on obser-
vations of fasting plasma lipids. However, postprandial plasma TAG concentration in 
the late postprandial phase (6 hours after fat intake) constitutes an independent risk 
marker for CHD (patsch et al. 1992). Interestingly, augmented late postprandial TAG 
concentrations were observed after the carbohydrate-rich diet. It is not known, how-
ever, whether or not this carbohydrate-induced postprandial elevation of TAG is 
likely to confer a level of atherogenic risk similar to that evident in individuals con-
suming diets higher in fat. 
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In the present study, two extreme diet interventions were employed, with regard to 
their carbohydrate and fat contents. Thus, this study did not provide any information 
on the magnitude of postprandial lipaemia after a diet of typical Western composition 
in comparison to after the high-carbohydrate diet. Data from other studies (Chen et al. 
1993; Jeppesen et at. 1997) which have used diets ofless extreme composition than 
those in the present study suggest that postprandial lipaemia is higher after a 60 % 
carbohydrate diet than after a 40 % carbohydrate diet, the latter diet being fairly close 
to a typical Western diet (46 % carbohydrate). Another important issue in relation to 
CHD risk is whether carbohydrate-induced hypertriacylglycerolaemia can be avoided. 
As discussed in section 2.9.2, exercise even of moderate intensity (Aldred et al. 1994; 
Tsetsonis et al. 1997; Gill and Hardman 2000) beneficially affects postprandial TAG 
metabolism, at least when subjects are on their "normal" diet. Hypothetically, daily 
exercise during a high-carbohydrate diet could offset the effects of this diet on TAG 
metabolism. Thus, a study examining the effect of exercise on postprandial lipaemia, 
as one means to prevent carbohydrate-induced hypertriacylglycerolaemia, is consid-
ered in the chapter that follows. 
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CHAPTER 5 
EXERCISE PREVENTS THE AUGMENTATION OF POSTPRANDIAL 
LIPAEMIA ATTRIBUTABLE TO A LOW-FAT, mGR-CARBOHYDRATE 
DIET 
5.1 Introduction 
A number of studies (Coulston et af. 1983; Chen et al. 1993; Chen et af. 1995; Jep-
pesen et al. 1997) have demonstrated that high-carbohydrate diets (55-60 % carbo-
hydrate) augment postprandial lipaemia compared to diets lower in carbohydrate (40 
% carbohydrate). However, in all postprandial studies just referred to, the test meal 
employed after the interventions was not standardised with regard to its macronutri-
ent composition. The findings of the previous study (chapter 4) complemented those 
of the above-mentioned studies by demonstrating that the augmentation of postpran-
diallipaernia after a high-carbohydrate is due to the effect of this diet per se and 
maybe also its interaction with the macronutrients in the standard test meal. 
A sluggish postprandial TAG metabolism constitutes an independent risk marker 
for CHD (Patsch et al. 1992; Karpe et al. 1998). In addition, the magnitude of post-
prandial lipaemia could be a determinant of the population of small dense LDL par-
ticles (Karpe et al. 1993) and of HDL-cholesterollevels (Lechleitner et al. 1990). It 
is, therefore, important that the effects of high-carbohydrate diets are investigated in 
the postprandial state and that ways are found to introduce such diets without ad-
versely affecting plasma TAG concentrations. An increase in physical activity may 
be effective in this regard, as it has been shown to reduce postprandial lipaemia, at 
least when subjects are on ''normal'' Western diets (Aldred et al. 1994; Tsetsonis et 
al. 1997; Gill and Hardman 2000). It may be therefore that the simultaneous adop-
tion of a low-fat, high-carbohydrate diet and a physically active lifestyle can offset 
the potentially deleterious effects of this diet on TAG metabolism and optimise, in 
this way, effects on lipoprotein lipid markers with regard to CHD risk. 
A small number of studies in human volunteers have looked at the effect of exercise 
as one means to prevent carbohydrate-induced hypertriacylglycerolaemia (Liebman 
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et al. 1983; Ullrich and A1brink 1986; Szostak and Cybulska 1987; Thompson et al. 
1988) but, without exception, these studies were undertaken in the fasted state. In 
the study by Liebman et al. (1983), exercising and sedentary groups were requested 
to consume their usual diets with the exception that isoenergetic amount of either 
white bread or white bread containing wheat bran was substituted for their normal 
bread consumption and lor incorporated into at least two meals per day for 12 
weeks (on average, four to six slices of bread were incorporated into the subjects' 
diets). Subjects in the exercise groups participated in a 6.4-km (4-mile) walk-jog-
run programme at moderate intensity three times per week. Subjects in the seden-
tary group maintained their normal physical activity levels. The dietary intervention 
resulted in an isoenergetic substitution of carbohydrate for fat. Specifically, the per-
centage of daily energy intake derived from carbohydrate increased from 46 % be-
fore the intervention to 53 % in week 10 of the intervention. Corresponding values 
for fat intake were 38 % and 31 %. In sedentary and exercise groups, total and 
VLDL-TAG concentrations increased by week 6 of the intervention and, in the sed-
entary groups, they continued to rise between week 6 and 12. In contrast, in the ex-
ercise groups, the increases in total and VLDL-TAG concentrations observed by 
week 6 were reversed between week 6 and 12. This last observation was attributed 
to the exercise regimen as well as the 1.2 kg reduction in mean body weight that oc-
curred during this time period. In a subsequent cross-sectional study (Ullrich and 
Albrink 1986), subjects followed an euenergetic 70 % carbohydrate diet for seven 
days while either refraining from exercise (non-exercisers) or performing at least 
11.3 km (7 miles) over these days. Although both groups exhibited a significant in-
crease in plasma TAG concentration following the high-carbohydrate diet, the in-
crease was significantly lower for the exercisers (0.36 mmollL) than for the non-
exercisers (0.84 mmollL). Thus, although baseline TAG concentration was not dif-
ferent between the groups, following the high-carbohydrate diet, the non-exercisers 
had significantly higher fasting TAG concentration (2.17 mmollL) than the exercis-
ers (1.40 mmollL). Szostak and Cybulska (1987) also observed that physical exer-
cise, 45 minutes of gymnastic exercises and 15 minutes of swimming three times in 
a week, reduced or entirely abolished the hypertriacylglycerolaemic effect of a 
seven-day high fructose intake (80 g per day) in patients with endogenous hyper-
triacylglycerolaemia. Finally, Thompson et al. (1988) observed that increases in 
plasma TAG concentration on a 56 % carbohydrate diet were blunted by physical 
activity. 
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To the author's knowledge, there is no information on the effect of exercise during 
a high-carbohydrate diet on postprandial lipaemia. The present study was designed 
to test the hypothesis that daily moderate intensity exercise offsets the augmentation 
of postprandial plasma TAG response associated with a high-carbohydrate diet. A 
short-term dietary intervention model was employed, in an attempt to investigate 
whether exercise can prevent the development ofhypertriacylglycerolaemia during 
the initial, dynamic period of change to a high-carbohydrate diet. Exercise was of 
moderate intensity for 30 minutes daily, as recommended by the Centers for Dis-
ease Control and Prevention and the American College of Sports Medicine (Pate et 
al. 1995). 
5.2 Subjects and methods 
5.2.1 Subjects 
Nine normolipidaemic men took part in the study, which was approved by the 
Loughborough University Ethical Advisory Committee. All subjects were fully in-
formed of the procedures and risks involved and gave their written consent. Some 
physical characteristics and plasma concentrations of TAG, total cholesterol and 
HDL-cholesterol of subjects as measured after an over-night fast on recruitment, 
whilst subjects were following their habitual lifestyle are presented in Table 5.1. All 
subjects were non-smokers and none had any physician-diagnosed cardiovascular or 
metabolic disease or was taking drugs known to influence lipid or carbohydrate 
metabolism. To exclude individuals with extreme dietary practices, only non-
vegetarian subjects and subjects with habitual fat intakes constituting between 25 % 
and 45 % of energy intake were accepted. Subjects' habitual diet was assessed by 
the weighed food inventory method over two weekdays and one weekend day, as 
described in section 3.2.1. Information about the energy content and macronutrient 
composition of subjects' habitual diets is presented in Table 5.2. All subjects were 
recreationally active in moderate intensity exercise (e.g. fast walking, easy cycling) 
at least three times per week. Four of them also engaged in more strenuous exercise, 
again around three times per week. Four subjects possessed the E4/3 phenotype, 
three the E3/3, one the E312 and one the E4/4. 
Age, year 33±4 
Body mass, kg 79.0±6.6 
Height,m 1.79 ± 0.06 
BMI, kgfm2 24.4 ± 1.2 
Waist, cm 85.4 ±4.6 
Waist to hip ratio 0.86 ± 0.05 
Body fat, % 16.6 ± 1.9 
V02max, mL/kgfmin 54±7 
TAG,mmol!L 1.10 ± 0.47 
Total cholesterol, mmol!L 4.49 ± 1.02 
HDL-cholesterol, mmol!L 1.17±0.18 
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Table 5.1 Physical characteristics of subjects and plasma concentrations of 
lipoprotein lipids measured in the fasted state. n = 9 men, mean ± SD. 
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5.2.2 Study design 
Each subject consumed a standardised high-fat, mixed meal, with intervals of 13 
days, after three different interventions. These interventions comprised: (i) three days 
on a typical Western diet; (ii) three days on a high-carbohydrate diet; and (iii) three 
days on the same high-carbohydrate diet with one 30-minute session of moderate 
intensity exercise each day. The order of the interventions was counterbalanced. 
5.2.3 Preliminary exercise tests 
Two preliminary exercise tests were conducted. In the first test, the steady-state re-
lationship between submaximal V02 and treadmill speed was established (section 
3.2.2.1). From this relationship, a linear regression equation was derived, for each 
subject, which was used, together with the measured V02 max, to calculate the 
speed necessary to elicit intensity corresponding to 60 % V02 max. In the second 
test, each subject' V02 max was determined during uphill running or walking at a 
constant speed (section 3.2.2.2 for full details). 
5.2.4 Experimental diets 
The experimental diets were isoenergetic and their energy value approximated, on an 
individual basis, subjects' previously determined energy intake (sections 3.2.1 and 
3.8.1). One diet was of similar composition to a typical UK (or Western) diet 
(Ministry of Agriculture Fisheries and Food 1997). It provided 46 % of energy as 
carbohydrate, 38 % as fat, and 16 % as protein. The other diet was high in carbohy-
drate and provided 70 % as carbohydrate, 15 % as fat and 15 % as protein. The diets 
were based on normal foods (that were provided by the experimenter), excluding 
alcohol, and their energy and macronutrient contents are shown in Table 5.2. The 
contributions of saturated, monounsaturated and polyunsaturated fatty acids to the 
total energy intake in the typical Western diet were designed to equal those for Brit-
ish male adults of25-34 years of age (Gregory et al. 1990). These contributions were 
then proportionally reduced for the high-carbohydrate diet. Although the contribu-
tion of simple sugars and starch to the total carbohydrate intake for British male 
adults of25-34 years is approximately 42 % and 58 %, respectively (Gregory et al. 
1990), it was decided that a ratio of50:50 would enhance the effect of the high-
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carbohydrate diet and, therefore, provide a clearer picture of the postprandial TAG 
responses. Three meals and one or two snacks were consumed each day. Subjects 
prepared these themselves, to a menu agreed with the experimenter. This included 
detailed instructions about the mass of each item to be consumed and methods of 
preparation and cooking (these were discussed verbally as well). Subjects were in-
structed to follow the experimental diets "to the gram" and were also asked to weigh 
and record each item consumed. Examples of the prescribed typical Western diet and 
high-carbohydrate diet are presented in Table 5.3 and Table 5.4, respectively. Sub-
jects refrained from exercise during the three-day interventions, except the planned 
exercise session in the high-carbohydrate plus exercise intervention. Only activities 
of daily living and slow walking for personal transport were permitted. Caffeine con-
sumption was not restricted during the interventions but subjects were instructed to 
standardise it for the day prior the oral fat tolerance tests. 
During the three days leading up to the first intervention period, subjects consumed 
a standardised, prescribed diet (46 %, 38 % and 16 % of energy derived from car-
bohydrate, fat and protein, respectively) and refrained from alcohol consumption 
and from exercise. There was a lO-day washout period between interventions, dur-
ing the first seven days of which subjects resumed their usual physical activity and 
dietary habits. During the last three days of this period, i.e. leading up to the next 
intervention, they consumed the same standardised, prescribed diet as prior to the 
first intervention, again refraining from alcohol consumption and exercise. 
Table 5.2 
Habitual diet Western diet High-carbohydrate diet 
Energy, MJ 10.6 ± 2.0 10.9 ± 1.2 10.9 ± 1.2 
Carbohydrate, % 50±5 46 70 
Sugars 22±5 23 36 
Starch 28±7 23 34 
Fat, % 34±6 38 15 
Saturated 13±4 16 6 
Monounsaturated 12 ± 5 12 4 
Polyunsaturated 8±4 9 4 
Cholesterol, mg 298 ± 33 260± 29 159 ± 25 
Protein, % 16±2 16 15 
Fibre, g 22± 11 12 ± 1 12 ± 1 
Energy content and composition of the habitual and experimental (typical Western and high-carbohydrate) diets. Each experi-
mental diet was consumed for three days. Mean or Mean ± SD. 
Typical Western diet 
Total energy: 12.0 MJ 
CHO FAT 
46% . 38% . 
PROTEIN 
16% 
Breakfast Amountg 
White bread 92 
Butter 25 
Jam (not reduced sugar) 40 
Low-fat yogurt, fruit (-lg fat/100g) 180 
Coffee with semi-skimmed milk 46 (milk) 
Sugar 10 
Lunch 
White bread 139 
Flora, 38 % vegetable fat 32 
Ham 104 
Cheddar cheese, medium 30 
Cucumber, lettuce Free 
Orange juice, unsweetened 231 
Snack 
Rice pudding, canned (not light) 231 
Apple (weighed with core) 144 
Dinner 
White spaghetti, boiled 277 
Home-made sauce: 
Tomatoes, carrots, peppers Free 
Sunflower oil 28 
Beef mince, not lean (for sauce) 139 (raw) 
Cheddar cheese, medium 28 
Snack 
Orange juice, unsweetened 231 
Apple (weighed with core) 144 
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Actual Notes 
amount, g 
Please eat and drink everything that has been prescribed for the three days of the 
typical Western diet. Please refrain from exercise on these three days and do not eat 
or drink anything else (except water). 
Table 5.3 An example of the prescribed typical Western diet. It was consumed 
for three days. 
High-carbohydrate diet 
Total energy: 12.0 MJ 
CHO FAT 
70% : IS % : 
Breakfast 
Corn flakes 
Semi-skimmed milk 
Sugar 
Raisins 
Apple (weighed with core) 
White bread 
PROTEIN 
15 % 
Amount,g 
61 
319 
12 
37 
153 
98 
Honey (or jam-not reduced sugar) 45 (49) 
Snack 
Banana (weighed flesh only) 123 
Raisins 49 
Lunch 
White bread 147 
Butter 11 
Ham 74 
Cucumber, lettuce Free 
Low-fat yogurt, fruit (-lg fat/lOOg) 184 
Banana (weighed flesh only) 123 
Orange juice, unsweetened 200 
Dinner 
White rice, easy cook, boiled 294 
Sweetcorn, no sugar/salt added 123 
Lean turkey breast, fried 147 (raw) 
Corn oil 17 
Orange juice, unsweetened 241 
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Actual Notes 
amount,g 
Please eat and drink everything that has been prescribed for the three days of the 
high-carbohydrate diet. Please refrain from exercise on these three days and do not 
eat or drink anything else (except water). 
Table 5.4 An example of the prescribed high-carbohydrate diet. It was con-
sumed for three days. 
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5.2.5 Exercise sessions 
During the high-carbohydrate diet plus exercise intervention, subjects ran or walked 
(1 subject) on the treadmill at 60 % V02max for 30 minutes daily. As discussed in 
section 3.8.2, exercise at this intensity is considered as moderate by most classifica-
tions. All exercise sessions were performed in the laboratory between 13:00-17:00 
hours. Expired air samples were collected every 15 minutes using Douglas bags and 
V02, and Ve02 were calculated as described in section 3.4. Heart rate was moni-
tored using short-range telemetry (section 3.5) and ratings of perceived exertion us-
ing the Borg scale (section 3.6). 
5.2.6 Test meal protocol 
Full details of the test meal protocol were given in section 3.9. Briefly, subjects ar-
rived at the laboratory after a 12-hour fast at approximately 08:00 hours. A cannula 
was introduced into a forearm or antecubital vein and the subject rested quietly in a 
supine position for 10 minutes, after which a baseline blood sample was obtained 
(details on blood sampling are given in section 3.10). The test meal (described in 
section 3.9.1) was then consumed. It was given according to body mass (per kg of 
body mass: 1.2 g fat, 1.1 g carbohydrate, 0.2 g protein). For these subjects this meant 
(mean ± SD) 95 ± 8 g fat, 86 ± 7 g carbohydrate, 14 ± 1 gprotein and 5.14 ± 0.14 MJ 
of energy, 69 % of which came from fat. Further blood samples were obtained (with 
subjects in the supine position) 15, 30, 45, 60 and 90 minutes after completion of the 
meal, and then hourly until 6 hours. Expired air samples were collected for 6-minute 
periods in the fasted state and postprandially (every hour), using Douglas bag tech-
niques, for measurement ofV02 and Ve02 (section 3.4). Subjects rested or worked 
quietly during the observation period and consumed only water. This was provided 
ad libitum on the first trial and replicated during subsequent trials. 
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5.2.7 Diet analysis 
Weighed food inventories were analysed for energy and major nutrients using a 
computerised version (Comp-Eat 5.0, Nutrition Systems, London) ofUK food com-
position tables (Holland et al. 1991). 
5.2.8 Analytical methods 
At each sampling point in the fasted and postprandial states, blood samples for 
plasma preparation were separated within 15 minutes of collection, divided into ali-
quots and were stored at _200 C. At most time points, separate samples were col-
lected for serum preparation. These were allowed to clot at room temperature before 
separation and were stored at _700 C. Plasma samples were analysed for total and 
HDL-cholesterol (fasted and 6-h samples only), TAG, non-esterified fatty acids 
(NEFA), glucose and lactate, and serum samples for 3-hydroxybutyrate (all by en-
zymatic, colorimetric methods). Serum samples were also analysed for insulin using 
a solid-phase 1251 radioimmunassay. Details of these analyses have been given in 
section 3.11. Phenotypes of apolipoprotein E were determined by isoelectric focus-
ing, using Western blot techniques. 
5.2.9 Calculations and statistics 
Plasma and serum concentrations measured in the fasted state were compared using 
one-way ANOVA for repeated measures. Total postprandial responses were calcu-
lated as the AUC using the trapezoidaI rule. These summary measures (section 3.12) 
were compared among interventions using one-way ANOV A for repeated measures. 
In addition, the interaction effect of intervention and time was determined using 
two-way ANOVA for repeated measures. As TAG concentrations and AUC for 
TAG were not normally distributed, logarithmic transformation was performed be-
fore statistical testing (section 3.12). If significant differences were identified by 
ANOV A, Tukey post hoc comparisons were performed to determine where these 
differences occurred. Carbohydrate and fat utilisation rates and energy expenditure 
were calculated using indirect calorimetry, as described in section 3.3. LDL choles-
terol concentration in the fasted state was estimated using the Friedewald formula 
(Friedewald et al. 1972). A 5 % level of significance was adopted throughout. Sta-
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tistical procedures were performed using Statistica for Windows, version 5.0 (Tulsa, 
OK, USA). 
5.3 Results 
5.3.1 Experimental diets and test meal 
Both experimental diets were well tolerated, aside from a common complaint by the 
subjects offee1ing excessively full during the high-carbohydrate diet. Compliance, 
assessed by food inventories and detailed discussions with subjects, was high. The 
test meal was also well tolerated by all subjects without any sign of nausea or other 
gastrointestinal discomfort. It was consumed over a median of 11 (range 9 - 14) 
minutes. 
5.3.2 Cardiorespiratory and metabolic responses during exercise sessions 
The average V02 during exercise for the 3 days was 33 ± 5 mL/kg/min (mean ± SD) 
and represented 61 ± 3 % ofV02 max. This was achieved by numing on the flat at 
2.6 ± 0.4 mls (8 subjects). One subject walked at 2.1 mlsup a 4 % gradient. Average 
values for heart rate and respiratory exchange ratio were 145 ± 19 beat/min and 0.94 
± 0.03 respectively. Ratings of perceived exertion were 12 ± 1 corresponding to the 
description "fairly hard". The gross energy expenditure was 1.58 ± 0.36 MJ, 81 ± 10 
% from carbohydrate and 19 ± 10 % from fat. On average, 60 ± 35 g of carbohydrate 
and 7 ± 4 g offat were oxidized daily during treadmill numing / walking. 
5.3.3 Plasma and serum concentrations in the fasted state 
Fasting plasma concentrations of TAG, total, HDL- and LDL-cholesterol, NEFA, 
glucose, lactate and serum concentrations of insulin and 3-hydroxybutyrate are pre-
sented in Table 5.5. Triacylglycerol concentration was significantly higher after the 
high-carbohydrate diet than after the Western diet (P = 0.03). The addition of exer-
cise to the high-carbohydrate did not significantly reduce TAG concentration (P = 
0.19 vs high-carbohydrate diet). LDL-cholesterol concentrations were significantly 
lower after both the high-carbohydrate and the high-carbohydrate plus exercise in-
terventions than after the Western diet. There were no significant differences among 
interventions in any of the other parameters. 
Western High-CHO High-CHO-Ex Pvalue l 
TAG,mmollL 0.83 ± 0.10 1.15 ± 0.16~ 1.02 ± 0.24 0.03 
Total cholesterol, mmollL 4.15± 0.27 4.04 ± 0.27 3.95 ± 0.26 0.08 
HDL-cholestero~ mmollL 1.05 ± 0.08 0.95 ±0.04 0.98± 0.06 0.28 
LDL-cholesterol, mmollL 2.75 ±0.25 2.56 ± 0.2~ 2.54 ± 0.25' 0.01 
Non-esterified fatty acids, mmollL 0.26 ± 0.04 0.24 ± 0.05 0.31 ± 0.04 0.37 
3-Hydroxybutyrate, mmollL 0.04± 0.01 0.04 ± 0.01 0.04± 0.01 0.86 
Insulin, IlIU/mJ 
Glucose, mmollL 
Lactate, mmollL 
Table 5.5 
8.1 ± 0.8 8.4 ± 1.3 7.7± 0.9 0.74 
5.35 ± 0.17 5.29 ± 0.16 5.22 ± 0.13 0.17 
0.76 ± 0.07 0.91 ± 0.10 0.81 ± 0.06 0.17 
Plasma or serum concentrations measured in the fasted state after three days on a typical Western diet 
(Western), after three days on a high-carbohydrate diet (High-CHO) and after three days on the same 
high-carbohydrate diet with the addition of 30 minutes daily moderate intensity exercise (High-CHO-
Ex). Each diet was consumed for three days. n = 9 men, Mean ± SEM. 
1 Significance of differences among interventions by one-way ANOV A for repeated measures. 
Y Significantly different from Western diet (Tukey post hoc test): P < 0.05. 
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5.3.4 Postprandial responses 
Plasma TAG concentrations after the test meal are shown in Figure 5.1, with sum-
mary measures (AVCs) of these responses in Table 5.6. The AVC was 35 % greater 
after the high-carbohydrate diet than after the Western diet (P < 0.01). The addition 
of daily exercise to the high-carbohydrate diet significantly reduced this response, 
almost to the level observed after the Western diet (P = 0.01 vs high-carbohydrate 
diet). The pattern of change over time in TAG concentration differed among inter-
ventions (interaction P < 0.01). Peak concentration occurred later after the high-
carbohydrate diet, both with and without exercise (5 ± 1 h for both interventions) 
(mean ± SEM), than after the Western diet (3 ± 1 h, P < 0.01). 
Postprandial concentrations of insulin, NEF A and 3-hydroxybutyrate, glucose and 
lactate are shown in Figure 5.2, 5.3 and 5.4 (respectively) and surmnary measures 
(AVCs) are given in Table 5.6. None of the AVCs differed among interventions, 
except 3-hydroxybutyrate. The change in plasma concentrations of glucose over 
time differed among interventions (interaction of intervention x time, P < 0.01). 
The ADC for 3-hydroxybutyrate was significantly lower after the high-carbohydrate 
diet than after the Western diet, with a much smaller rise between two and six hours 
postprandially (interaction of intervention x time, P < 0.01). The addition of exer-
cise to the high-carbohydrate diet did not have a significant effect on the A VC for 
3-hydroxybutyrate. Neither total nor HDL-cholesterol changed over the postpran-
dial period in any of the interventions. 
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hours following consumption of a high-fat mixed meal after three 
days on a typical Western diet (Western), after three days on a high-
carbohydrate diet (High-CHO) and after three days on the same 
high-carbohydrate diet with 30 minutes daily of moderate exercise 
(High-CHO-Ex). n = 9 men. Mean ± SEM. 
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--Western 
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-0- High-CHO-Ex 
0 1 2 3 4 5 6 
Time,h 
Plasma non-esterified fatty acids (NEFA) and serum 3-
hydroxybutyrate concentrations in the fasted state (0 hour) and for 
six hours following consumption of a high-fat mixed meal after three 
days on a typical Western diet (Western), after three days on a high-
carbohydrate diet (High-CHO) and after three days on the same 
high-carbohydrate diet with 30 minutes daily of moderate exercise 
(High-CHO-Ex). n = 9 men. Mean ± SEM. 
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Plasma glucose and lactate concentrations in the fasted state (0 hour) 
and for six hours following consumption of a high-fat mixed meal 
after three days on a typical Western diet (Western). after three days 
on a high-carbohydrate diet (High-CHQ) and after three days on the 
same high-carbohydrate diet with 30 minutes daily of moderate ex-
ercise (High-CHQ-Ex). n = 9 men. Mean ± SEM. 
Western High-CHO High-CHO-Ex Pvalue' 
TAG, rnrnollL x h 9.30± 1.30 12.54 ± 2.07§ 9.95 ± 1.94T 0.004 
Non-esterified fatty acids, rnrnollL x h 2.07 ± 0.18 1.74 ± 0.17 1.97 ± 0.15 0.20 
3-Hydroxybutyrate, rnrnollL x h 0.42± 0.07 0.26 ± 0.Q7~ 0.31 ± 0.07 0.004 
Insulin, ,1lU/rnL x h 126 ± 15 135 ± 16 116 ± 16 0.18 
Glucose, rnrnollL x h 34.1 ± 0.9 33.2 ± 1.0 33.4 ± 1.1 0.28 
Lactate, rnrnollL x h 5.51 ± 0.26 5.78 ± 0.45 5.70± 0.44 0.67 
Table 5.6 Six-hour areas under the plasma or serum concentration vs time curves for TAG, non-esterified fatty acids, 3-hydroxybutyrate, 
insulin, glucose and lactate after three days on a typical Western diet (Western), after three days on a high-carbohydrate diet 
(High-CHO) and after three days on the same high-carbohydrate diet with 30 minutes daily of moderate exercise (High-CHO-
Ex). n = 9 men. Mean ± SEM. 
, Significance of differences among interventions by one-way ANOVA for repeated measures. 
§.' Significantly different from Western diet (Tukey post hoc test): §p < 0.01, ~P < 0.05. 
t Significantly different from High-CHO diet (Tukey post hoc test): P < 0.05. 
-N 
..... 
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5.3.5 Indirect calorimetry 
Fasting and postprandial respiratory exchange ratio (RER) values are presented in 
Figure 5.5. Neither the high-carbohydrate intervention, nor the high-carbohydrate 
plus exercise intervention, significantly affected fasting or postprandial energy ex-
penditure or substrate utilisation. More details are given below. 
In the fasted state, respiratory exchange ratio values were numerically lower after 
the Western intervention (0.78 ± 0.01) than after both the High-CHO (0.83 ± 0.03) 
and the High-CHO-Ex (0.80 ± 0.02) interventions but they were not significantly 
different. Calculated rates off at utilisation were 0.09 ± 0.01 glmin (Western), 0.08 
± 0.01 glmin (High-CHO) and 0.09 ± 0.01 glmin (High-CHO-Ex) and were not sig-
nificantly different among interventions. The same was the case for rates of carbo-
hydrate utilisation, which were 0.10 ± 0.03 glmin (Western), 0.15 ± 0.04 glmin 
(High-CHO) and 0.12 ± 0.03 glmin (High-CHO-Ex). Therefore, calculated resting 
metabolic rate did not differ significantly among interventions: 5.18 ± 0.22 kJ/min 
(Western), 5.51 ± 0.38 kJ/min (High-CHO) and 5.34 ± 0.26 kJ/min (High-CHO-
Ex). 
In the postprandial state, calculated energy expenditure over the 6-hour observation 
period was not significantly different among interventions: 2.15 ± 0.08 MJ (West-
ern), 2.09 ± 0.10 MJ (High-CHO) and 2.06 ± 0.08 MJ (High-CHO-Ex). The amount 
of fat utilised during the 6-h postprandial period was 37 ± 1 g (Western), 33 ± 2 g 
(High-CHO) and 36 ± 1 g (High-CHO-Ex) (NS). Corresponding values for the 
amount of carbohydrate utilised postprandially were 41 ± 5 g, 53 ± 8 g and 44 ± 5 g 
(NS). 
Figure 5.5 
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Respiratory exchange ratio (RER) values in the fasted state (0 hour) 
and for six hours following consumption of a high-fat mixed meal 
after three days on a typical Western diet (Western), after three days 
on a high-carbohydrate diet (High-CHO) and after three days on the 
same high-carbohydrate diet with 30 minutes daily of moderate ex-
ercise (High-CHO-Ex). n = 9 men. Mean ± SEM. 
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5.4 Discussion 
The main purpose of the present study was to investigate whether the addition of 
daily moderate intensity exercise can oppose the exaggeration in postprandial 
plasma TAG response attributable to a high-carbohydrate diet. The exaggeration in 
postprandial lipaemia was examined by comparing the postprandial TAG response 
after a high-carbohydrate diet with that after a typical Western diet. 
As expected (Chen et a1. 1993; Jeppesen et al. 1997), the high-carbohydrate diet 
augmented postprandial lipaemia compared to the Western diet. However, in line 
with the hypothesis in the present study, this carbohydrate-induced increase was ne-
gated by 30 minutes of daily moderate intensity exercise. Previous studies have 
shown that such exercise reduces postprandial lipaemia (Aldred et al. 1994; Tset-
sonis et at. 1997; Gill and Hardrnan 2000) but, without exception, these studies 
were undertaken with the subjects' background diets ('nonnal' Western diets) held 
constant. These are the first data to demonstrate that the TAG-lowering effect of 
moderate exercise is sufficiently potent to offset the augmentation of postprandial 
lipaemia which develops when subjects change from a typical Western diet to a 
low-fat, high-carbohydrate diet. 
Other studies have shown that physical activity can ameliorate fasting hypertriacyl-
glycerolaernia associated with a high-carbohydrate diet (Liebman et al. 1983; Ull-
rich and Albrink 1986; Szostak and Cybulska 1987; Thompson et al. 1988). Inter-
estingly, in the present study, there was no significant effect on fasting TAG con-
centrations of adding exercise to the high-carbohydrate diet. By contrast, when the 
TAG metabolic capacity was challenged in the postprandial state the nonnalising 
effect of exercise was clearly revealed, showing the importance of studying humans 
in the fed state. 
There are a number of possible explanations for the carbohydrate-induced exag-
geration in postprandial lipaemia. Whilst the higher plasma TAG concentrations ob-
served in the fasted state after the high-carbohydrate diet would have contributed 
(Brunzell et al. 1973; Karpe and Hultin 1995; Bjorkegren et al. 1996), the high-
carbohydrate diet probably also affected postprandial events per se. As discussed in 
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detail in chapter 4, although the same test meal was consumed on each occasion, the 
effect on lipaemia of the carbohydrate in the meal could have been magnified after 
the high-carbohydrate diet. Carbohydrate in a meal accentuates fat-induced post-
prandial lipaemia, possibly due to stimulation of endogenous TAG secretion (Cohen 
and Scha1l1988; Jeppesen et al. 1995). High-carbohydrate diets prime the liver to 
secrete more VLDL-TAG, at least partly, by suppressing hepatic oxidation offatty 
acids and so diverting a greater proportion of the m towards hepatic TAG synthesis 
(Sidossis and Mittenddorfer 1999; McGarry and Foster 1980). It may be therefore 
that the response to the carbohydrate in the meal was amplified after the high-
carbohydrate diet, priming the liver to secrete more VLDL-TAG postprandially. 
The lower postprandial 3-hydroxybutyrate response after the high-carbohydrate diet 
(Table 5.4, Figure 5.3) than after the typical Western diet may indicate a suppres-
sive effect of the former diet on hepatic fatty acid oxidation. 
An additional explanation for the augmented postprandiallipemia after the high-
carbohydrate diet may be an effect of this diet on the activity ofLPL. For example, 
a 56 % reduction in skeletal muscle LPL activity has been reported in sedentary 
men who consumed a high-carbohydrate diet for three days (Lithell et al. 1982). 
Furthermore, at a whole-body level, a reduction in (heparin releasable) LPL activity 
and capacity for clearance of TAG has often been observed after high-carbohydrate 
diets (Thompson et al. 1984; Parks et al. 1999). The above alterations would lead to 
increases in plasma TAG concentrations, especially in the postprandial state, when 
the number of circulating TAG-rich lipoproteins increases dramatically. 
The addition of exercise to the high-carbohydrate diet prevented the exaggeration in 
plasma postprandial TAG response that was observed with the high-carbohydrate 
diet alone. Although there were no significant differences in the fasted state, it may 
be that the moderate reductions in fasting TAG concentrations observed in the ma-
jority of subjects contributed to lower responses during the postprandial state. Exer-
cise could also have opposed the suppressive effects of high-carbohydrate diets on 
LPL activity that often occur with this type of diet (Lithell et at. 1982; Thompson et 
al. 1984). Short-term exercise increases muscle LPL activity (Seip et al. 1997), an 
effect opposite to that seen after a short-term high-carbohydrate diet (Lithell et al. 
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1982). Furthennore, both a single exercise session (Sady et al. 1986) and exercise 
training (Thompson et al. 1988) increase (heparin releasable) LPL activity and the 
capacity for intravenous fat clearance. All these exercise-induced changes may have 
affected postprandial TAG metabolism, when exercise was combined with the high-
carbohydrate diet. 
Exercise may have also ameliorated the carbohydrate-induced augmentation in 
postprandial lipernia by affecting VLDL-TAG production. It has been reported that 
both high-carbohydrate diets (Sidossis and Mittenddorfer 1999) and increased acute 
glucose availability to the liver (Sidossis et al. 1998) increase VLDL-TAG secre-
tion, possibly by increasing hepatic glycolytic rate and therefore inhibiting hepatic 
fatty acid oxidation. If this were the case during the high-carbohydrate diet, one 
might speculate that the exercise diverted a considerable amount of carbohydrate to 
muscles for use as an energy source and for glycogen replenishment. This would 
reduce the amount of carbohydrate that needed to be disposed of by the liver. This, 
in turn, might have attenuated the increase in hepatic glycolytic rate and the de-
crease in hepatic fatty acid oxidation due to the high-carbohydrate diet, decreasing 
VLDL-TAG secretion. In line with this thinking, the reduction in the postprandial 
3-hydroxybutyrate response by the high-carbohydrate diet was somewhat attenuated 
by exercise, although this difference was not significant. 
As expected (Mensink and Katan 1992), the low-carbohydrate diet reduced LDL-
cholesterol concentration, although the addition of exercise did not reduce this fur-
ther. Interestingly, the interventions employed did not alter HDL-cholesterol, despite 
the fact that both low-carbohydrate diets (Katan 1998) and exercise (Durstine and 
Haskell 1994) have been reported to influence this. HDL-cholesterol concentrations 
are dependent on the rate of transfer to HDL of surface lipids from chylomicron and 
VLDL remnants fonned during lipolysis (patsch et al. 1987). It may be, therefore, 
that the initial effect of a high-carbohydrate diet or of exercise is to alter postpran-
dial TG metabolism and that changes in HDL-cholesterol concentration develop 
later. 
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The present model can not show whether the prevention of carbohydrate-induced 
augmentation in postprandial lipaemia was due to the effect of the last session of 
exercise per se or to the accumulated effects of the three exercise sessions, or both. 
However, the first possibility seems unlikely because exercise oflonger duration and 
greater energy expenditure did not significantly decrease postprandiailipaemia 
(Tsetsonis and Hardman 1996b). 
A case has recently been made out for replacing saturated fat in the diet with mono-
unsaturated fatty acids as a strategy to reduce the risk of coronary heart disease 
(Katan 1997). This would reduce LDL-cholesterol without the adverse effects on 
TAG and HDL-cholesterol concentrations seen when fat is replaced with carbohy-
drate. The present findings show that a further attractive alternative may be the 
adoption of a physically active lifestyle alongside a low-fat, high-carbohydrate diet. 
However, it should be noted that a short-term intervention model was employed in 
order to examine the influence of exercise on the development ofhypertriacylglyc-
erolaemia during the initial period of a change to a high-carbohydrate diet. There is 
no evidence, therefore, on the long-term efficacy of exercise in this regard but this is 
an issue which justifies further investigation. 
In conclusion, daily moderate intensity exercise prevented the augmentation of 
postprandial lipaemia resulting from the short-term consumption of a low-fat, high-
carbohydrate diet. Moreover, a diet was employed in which 70 % of energy came 
from carbohydrate, a more extreme dietary change than that recommended for the 
popUlation at large. Nonetheless, a modest amount of exercise, attainable by most 
people, was sufficient to negate carbohydrate-induced hypertriacylglycerolaemia. 
Since exercise seems to have such a potent effect on carbohydrate-induced hyper-
triacylg1ycerolaemia, a study examining the qualitative effects on postprandial TAG 
metabolism of exercise during a low-fat, high-carbohydrate diet is considered in the 
chapter that follows. 
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CHAPTER 6 
POSTPRANDIAL ACCUMULATION OF TRIACYLGLYCEROL-RICH 
LIPOPROTEINS AFTER A LOW-FAT, IDGH-CARBOHYDRATE DIET: 
REVERSAL BY MODERATE EXERCISE 
6.1 Introduction 
The study described in the previous chapter showed that daily moderate intensity 
exercise is sufficient to prevent the augmentation of postprandial lipaemia which 
develops when subjects change from a typical Westem diet to a low-fat, high-
carbohydrate diet. However, a detailed description of the qualitative changes to post-
prandial TRL metabolism elicited by high-carbohydrate diets and exercise is lacking. 
TRL particles are a heterogeneous group of particles including chylomicrons (con-
taining apo B48), VLDL (containing apo BIOO) and their remnants (section 2.3). 
TRL remnants are formed from VLDL and chylomicrons after partial removal of 
their TG by the action of LPL. The remnants have a reduced TG content but are en-
riched in cholesterol and have been implicated in the development of atherosclerosis 
(section 2.7.1). Determination ofRLP-cholesterol in serum (section 3.11.6) provides 
a marker for TRL remnants and may be useful in the assessment ofCHD risk. Previ-
ous reports showed that CHD patients have increased fasting RLP-cholesterollevels 
(Nakajima et al. 1993; Devaraj et al. 1998). Fasting RLP-cholesterol also predicted 
the development of clinical coronary events in patients with CHD independently of 
other risk factors (Kugiyama et al. 1999) and was associated with common carotid 
artery intima-media thickness in healthy humans independently of plasma TAG and 
LDL-cholesterollevels (Karpe et al. in press). 
The purpose of the present study was to investigate the effect of a high-
carbohydrate diet and exercise on TRL particles of exogenous and endogenous ori-
gin. A further purpose was to provide some indirect evidence for the atherogenic 
potential of carbohydrate-induced changes to TRL metabolism. Postmenopausal 
women were studied as plasma TAG concentration is an important CHD risk factor 
for women (Hokanson and Austin 1996) and CHD risk increases after the meno-
pause (Kannel et al. 1976). In addition, despite the popular perception that CHD is a 
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male disease, it is responsible for 20 % of deaths in women, making it the leading 
cause of female mortality (Office for National Statistics 1998). 
6.2 SUbjects and methods 
6.2.1 Subjects 
Eight healthy postmenopausal (for at least two years) women took part in the study, 
which was approved by the Loughborough University Ethical Advisory Committee. 
All subjects were fully informed of the procedures and risks involved and gave their 
written consent. Some physical characteristics and plasma concentrations of TAG, 
total cholesterol and HDL-cholesterol of subjects as measured after an over-night 
fast on recruitment, whilst subjects were following their habitual lifestyle are pre-
sented in Table 6.1. All subjects were non-smokers and none had any physician-
diagnosed cardiovascular or metabolic disease. Two subjects were on hormone re-
placement therapy and were instructed not to interrupt it during the study. Other than 
this, subjects were not taking drugs known to influence lipid or carbohydrate me-
tabolism. To exclude individuals with extreme dietary practices, only non-vegetarian 
subjects and subjects with habitual fat intakes constituting between 25 % and 45 % 
of energy intake were enrolled. Subjects' habitual diet was assessed by the weighed 
food inventory method over two weekdays and one weekend day, as described in 
section 3.2.1. Information about the energy content and macronutrient composition 
of subjects' habitual diets is presented in Table 6.2. All subjects engaged in activities 
like fast walking or easy cycling at least three times per week. Six subjects pos-
sessed the E3/3 phenotype, one the E4/3, and one the E4/2. 
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Age, year 60±4 
Body mass, kg 69.6± 6.6 
Height, m 1.63 ± 0.04 
BMI, kg/m2 26.4 ± 2.3 
Waist, cm 86.9±4.8 
Waist to hip ratio 0.84± 0.05 
V02 max, mLlkg/min 29±2 
TAG,mmollL 1.11 ± 0.31 
Total cholesterol, mmollL 6.50 ± 0.46 
lIDL cholesterol, mmollL 1.69 ± 0.29 
Table 6.1 Physical characteristics of subjects and plasma concentrations oflipo-
protein Jipids measured in the fasted state. n = 8 women, mean ± SD. 
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6.2.2 Study design 
Each subject consumed a standardised high-fat, mixed meal, with intervals of 13 
days, after three different interventions. These interventions comprised: (i) three 
days on a low-carbohydrate diet (Low-CHO); (ii) three days on a high-carbohydrate 
diet (High-CHO); and (iii) three days on the same high-carbohydrate diet with one 
60-minute session of brisk walking each day (High-CHO-Ex). The order of the in-
terventions was counterbalanced. 
6.2.3 Preliminary exercise testing 
The steady-state relationship between submaximal V02 and treadmill gradient was 
established during a submaximal uphill walking test at a constant speed (section 
3.2.2.1). From this relationship, a linear regression equation was derived, for each 
subject, which was used, together with the estimated V02 max, to calculate the gra-
dient necessary to elicit intensity corresponding to 60 % V02 max. As the subjects 
were women 51-66 years and had not undertaken any clinical exercise stress test to 
ensure no contraindications to maximal exercise, their V02 max was estimated, 
rather than directly measured, by extrapolation of the V02 / heart rate relationship 
obtained during the submaximal exercise test (section 3.2.2.2). 
6.2.4 Experimental diets 
The experimental diets were isoenergetic and their energy value approximated, on an 
individual basis, subjects' previously determined energy intake (sections 3.2.1 and 
3.8.1). The low-carbohydrate diet provided 35 % of energy as carbohydrate, 50 % as 
fat, and 15 % as protein. Corresponding values for the isoenergetic high-
carbohydrate diet were 70 %, 15 % and 15 %. The diets were based on normal foods 
(that were provided by the experimenter), excluding alcohol, and their energy and 
macronutrient contents are shown in Table 6.2. A low-carbohydrate diet, rather than 
a typical Western diet, was employed in order to enhance the chance of observing 
clear differences in the postprandial events. For the same reason and in order to ex-
aggerate the effect of the high-carbohydrate diet on TAG metabolism, the ratio of 
simple sugars to starch in the high-carbohydrate diet employed in the present study 
(67:33) was much higher than in the high-carbohydrate diet employed in the two 
previous studies (50:50). Using diets of more extreme composition than those em-
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ployed in chapter 5 would increase the chance of detecting diet effects on TRL parti-
cles, taking into consideration that analytical imprecision for the TRL detennination 
would be greater than that for simple assays (e.g. plasma TAG concentration). Three 
meals and one or two snacks were consumed each day. Subjects prepared these 
themselves, to a menu agreed with a dietician. The menu included detailed instruc-
tions about the mass of each item to be consumed and methods of preparation and 
cooking (these were also discussed verbally with the dietician). Subjects were in-
structed to follow the experimental diets ''to the gram" and were also asked to weigh 
and record each item consumed. Examples of the prescribed low-carbohydrate diet 
and high-carbohydrate diet are presented in Table 6.3 and Table 6.4, respectively. 
Subjects refrain from exercise during the three-day interventions, except the planned 
exercise session in the High-CHO-Ex intervention. Only activities of daily living and 
slow walking for personal transport were permitted. Caffeine consumption was not 
restricted during the interventions but subjects were instructed to standardise it on 
the day prior to the oral fat tolerance tests. 
During the day prior to the first intervention subjects weighed and recorded all 
food and drink consumed, replicating this prior to subsequent interventions. 
During this day, they also refrained from exercise and from alcohol consump-
tion. Otherwise, subjects returned to their usual lifestyle during the 10-day 
wash-out intervals. 
Habitual Low-carbohydrate High-carbohydrate 
Energy(MJ) 7.41 ± 1.37 7.45 ± 1.39 7.41 ± 1.39 
Carbohydrate, % energy 46±4 35 70 
Simple sugars 21 ± 3 18 47 
Starch 25±4 17 23 
Fat, % energy 37 ± 5 50 15 
Saturated 15 ± 3 20 7 
Monounsaturated 11 ± 3 16 4 
Polyunsaturated 7±2 12 3 
Protein, % energy 17± 3 15 15 
Cholesterol, mg 206± 33 331±131 131 ± 25 
Fibre, g 19± 3 13 ± 3 13±3 
Table 6.2 Energy content and composition of the habitual and experimental (Iow- and high-carbohydrate) diets. Each experimental diet 
was consumed for three days. Mean or Mean ± SD. 
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Low-carbohydrate diet 
Total energy: 8.8 MJ 
CHO FAT 
35 % : 50% 
Breakfast 
Wholemeal bread 
Flora, 70 % vegetable fat 
Whole milk 
Lunch 
Wholemeal bread 
Flora, 70 % vegetable fat 
Cheddar cheese, medium 
Cucumber, lettuce 
Snack 
PROTEIN 
15% 
Amount, 
g 
53 
8 
200 
80 
12 
73 
Free 
Walnuts (weighed without shells) 20 
Apple (weighed with core) 260 
Banana (weighed flesh only) 75 
Dinner 
Quiche Lorraine, Sainsbury's 168 
Oven chips, McCain reduced fat, 73 
baked 
Tomatoes, carrots, peppers Free 
Low-fat yogurt, fruit (-lg 150 
fat/lOOg) 
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Actual Notes 
amount, g 
Please eat and drink everything that has been prescribed for the three days of the 
low-carbohydrate diet. Please refrain from exercise on these three days and do not 
eat or drink anything else (except water). 
Table 6.3 An example of the prescribed low-carbohydrate diet. It was consumed 
for three days. 
High-carbobydrate diet 
Total energy: 8.7 MJ 
eRO FAT 
70% . 15 % . 
Breakfast 
Cornflakes 
Semi-skimmed milk 
Raisins 
Apple (weighed with core) 
Wholemeal bread 
Butter 
Jam (not reduced sugar) 
Lunch 
Wholemeal bread 
Butter 
Lean ham 
Cucumber, lettuce 
Orange juice, unsweetened 
Banana (weighed flesh only) 
Snack 
Digestive biscuits (plain) 
Semi-skimmed milk 
Dinner 
White rice, easy cook, boiled 
Sweetcom, no sugar/salt added 
Lean turkey breast, fried 
Corn oil 
Orange juice, unsweetened 
Snack 
Apple (weighed with core) 
PROTEIN 
15 % 
Amount, 
g 
36 
100 
42 
92 
36 
6 
18 
71 
10 
60 
Free 
339 
240 
13 
200 
119 
60 
110 (raw) 
8 
339 
119 
Boiled sweets (total for the whole 68 
dayl 
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Actual Notes 
amount,g 
Please eat and drink everything that has been prescribed for the three days of the 
high-carbohydrate diet. Please refrain from exercise on these three days and do not 
eat or drink anything else (except water). 
Table 6.4 An example of the prescribed high-carbohydrate diet. It was con-
sumed for three days. 
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6.2.5 Exercise sessions 
During the High-CHO-Ex intervention, subjects walked on the treadmill at 60 % of 
estimated V02 max for 60 minutes each afternoon. The duration of exercise em-
ployed was longer than that in chapter 5 in order to increase the chance of detecting 
an effect of exercise on TRL particles. However, the intensity remained moderate in 
order to be attainable by the population at large. Exercise at this intensity for the 
group of older subjects in the present study meant brisk walking. All exercise ses-
sions were performed in the laboratory between 13 :00-17 :00 hours. Expired air 
samples were collected every 15 minutes using Douglas bags and V02, and VC02 
were calculated as described in section 3.4. Heart rate was monitored using short-
range telemetry (section 3.5) and ratings of perceived exertion using the Borg scale 
(section 3.6). 
6.2.6 Test meal protocol 
Full details of the test meal protocol are given in section 3.9. Briefly, subjects arrived 
at the laboratory after a 12-hour fast at approximately 08:00 hours. A cannula was 
introduced into a forearm or antecubital vein and the subject rested quietly in a su-
pine position for 10 minutes, after which a baseline blood sample was obtained (de-
tails on blood sampling are given in section 3.10). The test meal (described in section 
3.9.1) was then consumed. It was given according to body mass (per kg of body 
mass: 1.0 g fat, 0.9 g carbohydrate, 0.2 g protein). For these subjects this meant 
(mean ± SD) 62 ± 6 g fat, 56 ± 6 g carbohydrate, 9 ± 1 g protein and 3.36 ± 0.35 MJ 
of energy, 69 % of which came from fat. Further blood samples were obtained (with 
subjects in the supine position) 15,30,45,60 and 90 minutes after completion of the 
meal, and then hourly until 6 hours. Expired air samples were collected for 6-minute 
periods in the fasted state and postprandially (every hour), using Douglas bag tech-
niques, for measurement ofV02 and VC02 (section 3.4). Subjects rested or worked 
quietly during the observation period and consumed only water. This was provided 
ad libitum on the first trial and replicated during subsequent trials. 
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6.2.7 Diet analysis 
Weighed food inventories were analysed using a computerised version (Comp-Eat 
5.0, Nutrition Systems, London) ofUK food composition tables.(Holland et al. 
1991) 
6.2.8 Analytical methods 
At each sampling point in the fasted and postprandial states, blood samples for 
plasma preparation were separated within IS minutes of collection, divided into ali-
quots and were stored at _200 C. At most time points, separate samples were col-
lected for serum preparation. These were allowed to clot at room temperature before 
separation and were stored at -700 C. One plasma aliquot was kept overnight on ice, 
until a TRL fraction was separated by preparative ultracentrifugation. To minimise 
proteolytic degradation of apo B in this aliquot, 1.0 ilL per mL plasma of phenyl-
methylsulfonylfluoride (pMSF, Sigma) 10 mM dissolved in iso-propanol and SilL 
per mL plasma of aprotinin (Trasylol, Bayer, Leverkusen, Germany) 1.4 Ilg/L were 
added. Further plasma aliquots were stored at -20' C until analysed for total choles-
terol, HDL-cholesterol (fasted samples only), glucose and NEFA by enzymatic, col-
orimetric methods (section 3.11.1). Concentrations of TAG in plasma and the TRL 
fraction were measured enzymatically, with correction for free glycerol, (Humphreys 
et at. 1990) in samples obtained at all time points (total TAG in frozen samples) or at 
0,2,4 and 6 hours (TRL-TAG in fresh samples). Serum aliquots were stored at-
70'C, until analysed for insulin (section 3.11.2), RLP-cholesterol (section 3.11.6) and 
3-hydroxybutyrate (3.11.1). Apart from TAG analysis in the TRL fraction, all sam-
ples from each subject were analysed in the same batch. Accuracy and precision 
were maintained using quality-control sera (Roche Diagnostics Ltd.). Phenotypes of 
apolipoprotein E were determined by isoelectric focusing using Western blot tech-
niques (section 3.11.3). 
6.2.9 TRL fractionation 
The TRL fraction (Sf> 20) was separated by preparative ultracentrifugation (section 
3.11.4) in an Optima TLX ultracentrifuge (Beckman Instruments Ltd., High Wy-
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combe, Bucks, UK) in a fixed-angle rotor (Beckman, TLA 100·4). The TRL fraction 
was separated by slicing the tube. 
6.2.10 Determination ofTRL apo B48 and apo BI00 and serum RPL-
cholesterol concentrations 
TRL apo B48 and B I 00 concentrations were used as specific markers for the con-
centration ofTRL particles of intestinal and hepatic origin, respectively. TRL apo 
B48 and B I 00 concentrations were quantified using analytical sodium dodecyl sul-
fate polyacrylamide gel electrophoresis (SDS-PAGE) (section 3.11.5). RLP-
cholesterol was determined in serum samples obtained in the basal state and 4 h 
postprandially using a novel immunoseparation kit technique (Jimro-II) made avail-
able from Japanese Immunoresearch Laboratories Company (section 3.11.6). 
6.2.11 Calculations and statistics 
Plasma or serum concentrations measured in the fasted state and summary measures 
of postprandial responses (AUCs) were compared using one-way ANOV A for re-
peated measures. When significant differences were identified, Tukey post hoc 
comparisons were performed. For RLP-cholesterol concentrations, intervention and 
time effects were determined using two-way ANOVA for repeated measures. For 
the calculation of mol apo E per apo BIOO-containing TRL particle and mol TAG 
per apo Bl OO-containing TRL particle in the fasted state, fasting TRL concentrations 
of TAG, apo E and apo B 100 were converted to mollL units. The molecular weights 
of apo BIOO and apo E were taken as 512 kO and 34 kO, respectively. For both cal-
culations, the presence of a small number of apo B48-containing TRL particles in 
the fasted state was disregarded as these particles represent a very small proportion 
of the TRL pool and are relatively TAG-poor (Sf < 400) compared to "normal" 
chylomicrons (Karpe and Hamsten 1994). The mol TAG per apo BI OO-containing 
TRL particle in the fasted state was used as a measure ofVLDL particle size. The 
proportion ofTRL particles which was of endogenous origin (apo BlOO-containing) 
was calculated from the concentrations (mgIL) of apo B I 00 and apo B48 in the TRL 
fraction using the formula: [apo BI00] / [apo BI00] + [apo B48] /0.48 (Karpe 
1999). LDL cholesterol concentration in the fasted state was estimated using the 
Friedewald formula (Friedewald et al. 1972). Data for mol apo E per apo BIOO-
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containing TRL particle and mol TAG per apo BIOO-containing TRL particle were 
not normally distributed and, therefore, they were transformed to their naturalloga-
ritbm before statistical testing. Rates of whole body carbohydrate and fat utilisation 
and energy expenditure were calculated using indirect calorimetry, as described in 
section 3.3. A 5 % level of significance was adopted throughout. Statistical proce-
dures were performed using Statistica for Windows, version 5.0 (Tulsa, OK, USA). 
6.3 Results 
6.3.1 Experimental diets and test meal 
Both experimental diets were well tolerated, aside from a common complaint by the 
subjects of feeling excessively full during the high-carbohydrate diet. Compliance, 
assessed by food inventories and detailed discussions with subjects, was high. The 
test meal was also well tolerated by all subjects without any sign of nausea or other 
gastrointestinal discomfort. It was consumed over a median of 13 (range 11 - 15) 
minutes. 
6.3.2 Cardiorespiratory and metabolic responses during exercise sessions 
During the Hi-CHO-Ex intervention, subjects walked at 1.5 ± 0.1 mls (mean ± SD) 
up a 3 ± I % gradient, with an average \T02 of 17.7 ± 1.1 mLlkglmin, which repre-
sented 61 ± 3 % of estimated \T02 max. Heart rate averaged 128 ± 8 beat/min and 
ratings of perceived exertion 12 ± 2 (on a scale from 6 to 20), corresponding to 
"fairly hard". Gross energy expenditure per session was 1.46 ± 0.10 MJ, 65 ± 10 % 
from carbohydrate and 35 ± 10 % from fat. On average, 56 ± 11 g of carbohydrate 
and 13 ± 3 g of fat were oxidized daily during treadmill walking. 
6.3.3 Plasma, TRL and serum concentrations in the fasted state 
Plasma TAG and TRL-TAG concentrations were significantly higher after the High-
CHO intervention than after the Low-CRO intervention, as were TRL-apo B48, apo 
BIOO and apo E concentrations (Table 6.5). Because concentrations of both TRL-
TAG and TRL apo BlOO were similarly affected by the High-CRO intervention, the 
number of TAG molecules per apo BlO0-containing TRL particle did not differ be-
tween the Hi-CHO and the Low-CHO intervention (Table 6.5). Thus, the High-CHO 
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intervention did not seem to have affected the size ofVLDL particles. The VLDL 
particles constituted a very large proportion of the total pool of lRL after both the 
Low-eHO (98 %) and the High-eHO (97 %) interventions. The High-eHO inter-
vention increased the apo E content ofVLDL particles (Table 6.5) as well as the se-
rum RLP-cholesterol concentration (Table 6.8). Although total cholesterol concen-
tration was not significantly affected by the High-eHO intervention, HDL-
cholesterol was reduced (Table 6.5). 
The addition of exercise to the High-eHO diet significantly attenuated the diet-
induced increases in plasma TAG, lRL-TAG and lRL concentrations of apo B48, 
apo B 1 00 and apo E (Table 6.5). The addition of exercise also seemed to reduce 
fasting serum RLP-cholesterol concentration but this did not reach statistical signifi-
cance (P = 0.09). Exercise had no statistically significant effect on plasma HDL-
cholesterol concentration when compared with the Hi-eHO intervention (Table 6.5). 
Overall there were no significant differences between the High-eRO-Ex and the 
Low-eRO interventions in any of the above parameters except HDL-cholesterol, 
which was significantly higher after the Low-eRO intervention. 
The fasting plasma NEFA concentration was not different among interventions but 
3-hydroxybutyrate concentration was somewhat lower after the Righ-eRO than after 
the Low-eRO intervention (P < 0.07) (Table 6.6). Plasma glucose was significantly 
lower after the High-eRO than after the Low-eHO intervention. Serum insulin was 
lower after the High-eRO-Ex than after the Righ-eRO intervention (Table 6.6). 
Low-eHO High-eHO High-eHO-Ex Pvalue 
I 
TAG,mmollL 0.96±0.12 1.58 ± 0.19§ 1.21 ± O.lOt <0.01 
TRL-TAG, mmollL 0.37 ± 0.08 0.85 ± 0.14§ 0.55 ± 0.09; <0.01 
TRL-apo B48, mg/L 0.08± 0.05 0.44 ± 0.12§ 0.23 ± 0.09t <0.01 
TRL-apo BI00, mg/L 9.36 ± 2.27 27.84 ± 5.31 § 17.63 ± 3.49t <0.01 
TRL-apo E, mg/L 3.97 ± 1.33 21.59 ± 6.12§ 10.30 ± 3.06t <0.01 
mol apo E per apo BlOO-containing TRL particle 5.43 ± 0.92 12.74 ± 4.11' 10.47 ± 3.16 0.02 
mol TAG per apo BlOO-containing TRL particle 25,369 ± 5,315 16,676 ± 1,815 22,510 ± 8,991 0.42 
Total cholesterol, mmollL 6.37 ± 0.22 6.37 ± 0.23 6.23 ± 0.18 0.44 
LDL-cholesterol, mmollL 4.50± 0.09 4.37 ± 0.17 4.36 ± 0.15 0.34 
HDL-cholesterol, mmollL 1.39 ± 0.09 1.25 ± 0.08§ 1.29± 0.08' <0.01 
Table 6.5 Plasma and TRL fraction concentrations of lipids and apolipoproteins measured in the fasted state after the low-
carbohydrate diet (Low-eHO), after the high-carbohydrate diet (High-eHO), and after the high-carbohydrate diet with 
the addition of 60 minutes daily moderate intensity exercise (High-eHO-Ex). n = 8 women, mean ± SEM. 
I Overall significance of differences among the three interventions by one-way ANOVA for repeated measures. 
§ P < 0.01 vs Low-eHO, , P < 0.05 vs Low-eHO by Tukey post hoc test. 
; P < 0.01 vs High-eHO, t P < 0.05 vs High-eHO by Tukey post hoc test. 
Low-CHO High-CHO High-CHO-Ex Pvalue 
I 
Non-esterified fatty acids, mmolJL 0.51 ± 0.05 0.49 ± 0.04 0.57 ± 0.04 0.18 
3-Hydroxybutyrate, mmollL 0.10± 0.02 0.07 ± 0.01 0.10 ± 0.01 0.06 
Insulin, J.lIU/mL 
Glucose, mmollL 
Table 6.6 
10.8 ± 1.3 12.3 ± 1.9 9.8±l.l t 0.04 
5.25 ± 0.18 5.04 ± O.W 5.06 ± 0.15 0.03 
Plasma non-esterified fatty acids and glucose and serum 3-hydroxybutyrate and insulin concentrations 
measured in the fasted state after three days on a low-carbohydrate diet (Low-CHO), after three days on a 
high-carbohydrate diet (High-CHO), and after three days on the same high-carbohydrate diet with the addi-
tion of 60 minutes daily moderate intensity exercise (High-CHO-Ex). n = 8 women, mean ± SEM. 
1 Overall significance of differences among the three interventions by one-way ANOV A for repeated measures. 
, P < 0.05 vs Low-CHO by Tukey post hoc test. 
t P < 0.05 vs Hi-CHO by Tukey post hoc test. 
Low-CRO High-CRO Righ-CHO-Ex Pvalue 
[ 
Plasma TAG, mmollL x h 10.12 ± 1.15 13.74 ± 1.57§ 10.54 ± 1.08* <0.01 
TRL-TAG, mmollL x h 8.68 ± 1.31 11.49 ± 1.26§ 8.86 ± 1.09~ <0.01 
TRL-apo B48, mg/L x h 2.88 ± 1.11 5.39 ± 1.41' 2.97 ± 0.66t 0.02 
TRL-apo BlOO, mg/L x h 127 ± 29 216±47§ 143 ± 28t <0.01 
TRL-apo E, mg/L x h 120 ± 36 246 ± 69§ 128 ± 32~ <0.01 
Non-esterified fatty acids, mmollL x h 3.15 ± 0.24 2.66± 0.16 2.95 ± 0.25 0.06 
3-Rydroxybutyrate, mmollL x h 0.89 ± 0.12 0.57 ± 0.08' 0.72 ± 0.10 0.03 
Insulin, J.lIU/mL x h 194 ± 31 202 ± 32 159 ± 22,t 0.01 
Glucose, mmollL x h 33.3 ± 1.3 33.7 ± 1.07 33.08 ± 1.27 0.42 
Table 6.7 Six-hour areas under the plasma, 1RL fraction or serum concentration vs time curves after three days on a low-
carbohydrate diet (Low-CRO), after three days on a high-carbohydrate diet (High-CRO), and after three days on the 
same high-carbohydrate diet with the addition of 60 minutes daily moderate intensity exercise (High-CRO-Ex). n = 8 
women, mean ± SEM. 
I Overall significance of differences among the three interventions by one-way ANOV A for repeated measures. 
§ P < 0.01 vs Low-CRO, ~ P < 0.05 vs Low-CHO by Tukey post hoc test. 
l P < 0.01 vs Ri-CRO, t P < 0.05 vs Hi-CRO by Tukey post hoc test. 
RLP-cholesterol 
Oh,mmol/L 
4h,mmol/L 
Low-CHO 
0.26± 0.02 
0.38 ± 0.04 
High-CHO 
0.41 ± 0.Q7~ 
0.55 ± 0.06§ 
High-CHO-Ex 
0.29 ± 0.02 
0.41 ± 0.04t 
1 
Pvalue 
0.04 
<0.01 
Table 6.8 Remnant-like lipoprotein particle (RLP) cholesterol concentration in the fasted state (0 h) and at 4 h after the 
consumption of the test meal after three days on a low-carbohydrate diet (Low-CHO), after three days on a 
high-carbohydrate diet (High-CHO), and after three days on the same high-carbohydrate diet with the addi-
tion of 60 minutes daily moderate intensity exercise (High-CHO-Ex). n = 8 women, mean ± SEM. 
I Overall significance of differences among the three interventions by one-way ANOV A for repeated measures. 
§ P < 0.01 vs Low-CHO,' P < 0.05 vs Low-CHO by Tukey post hoc test. 
t P < 0.05 vs Hi-CHO by Tukey post hoc test. 
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6.3.4 Postprandial responses 
Plasma TAG and TRL-TAG concentrations after the high-fat, mixed meal are shown 
in Figure 6.1. The AUCs for postprandial plasma TAG and TRL-TAG were 36 % 
and 32 % (respectively) greater after the High-CHO than after the Low-CHO inter-
vention (Table 6.7). However, the addition of daily exercise to the High-CHO inter-
vention significantly reduced both AUCs, almost to the level observed after the Low-
CHO intervention (Table 6.7). 
Postprandial concentrations of apo B48, apo B 1 00 and apo E in the TRL fraction 
are shown in Figure 6.2. As in the fasted state, the apo B lOO-containing particles 
constituted a very large proportion of the TRL particles (for example, at 4 h post-
prandially, 94 - 95 % after both diet-only interventions). The AUCs for all meas-
ured apolipoproteins were significantly higher after the High-CHO than after the 
Low-CHO intervention (Table 6.7). After the High-CHO-Ex intervention the AUCs 
for all three apolipoproteins were significantly lower than after the High-CHO in-
tervention (Figure 6.2, Table 6.7). 
RLP-cholesterol concentration increased postprandially (main effect of time: P < 
0.01) (Table 6.8). The Hi-CHO intervention led to 50 % higher postprandial con-
centrations than the Low-CHO intervention, but exercise prevented this increase. 
The RLP-cholesterol concentrations were highly related to the plasma TAG concen-
trations (r = 0.88, P < 0.01). 
The insulin and glucose, NEF A and 3-hydroxybutyrate responses are shown in Fig-
ure 6.3 and 6.4, respectively. Their surmnary measures (AUCs) are given in Table 
6.7. 
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Plasma TAG and TRL-TAG concentrations in the fasting state (0 hour) and 
for six hours following consumption of a high-fat mixed meal after three 
days on a low-carbohydrate diet (Low-CHO), after three days on a high-
carbohydrate diet (High-CHQ) and after three days on the same high-
carbohydrate diet with the addition of 60 minutes daily moderate intensity 
exercise (Hlgh-CHO-Ex). n = 8 women. Mean ± SEM. 
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TRL-apo B48 and BI00 concentrations in the fasted state (0 hour) and 
for six hours following consumption of a high-fat mixed meal after 
three days on a low-carbohydrate diet (Low-CHO), after three days on 
a high-carbohydrate diet (High-CHO) and after three days on the same 
high-carbohydrate diet with the addition of 60 minutes daily moderate 
intensity exercise (High-CHO-Ex). n = 8 women. Mean ± SEM. 
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TRL-apo E concentrations in the fasted state (0 hour) and for six 
hours following consumption of a high-fat mixed meal after three 
days on a Iow-carbohydrate diet (Low-CHO), after three days on a 
high-carbohydrate diet (High-CHO) and after three days on the same 
high-carbohydrate diet with the addition of 60 minutes daily moder-
ate intensity exercise (High-CHO-Ex). n = 8 women. Mean ± SEM. 
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Figure 6.4 Serum insulin and plasma glucose concentrations in the fasted state 
(0 hour) and for six hours following consumption of a high-fat mixed 
meal after three days on a low-carbohydrate diet (Low-eRO), after 
three days on a high-carbohydrate diet (High-eRO) and after three 
days on the same high-carbohydrate diet with the addition of 60 
minutes daily moderate intensity exercise (High-eRO-Ex). n = 8 
women. Mean ± SEM. 
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Time, h 
Plasma non-esterified fatty acids (NEFA) and serum 3-
hydroxybutyrate concentrations in the fasted state (0 hour) and for 
six hours following consumption of a high-fat mixed meal after three 
days on a low-carbohydrate diet (Low-CHO), after three days on a 
high-carbohydrate diet (High-CHO) and after three days on the same 
high-carbohydrate diet with the addition of 60 minutes daily moder-
ate intensity exercise (High-CHO-Ex). n = 8 women. Mean ± SEM. 
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6.3.5 Indirect calorimetry 
Fasting and postprandial respiratory exchange ratio (RER) values are presented in 
Figure 6.6. Neither the High-CHO nor the High-CHO-Ex intervention significantly 
affected fasting or postprandial energy expenditure and substrate oxidation. Details 
are given below. 
In the fasted state, RER values were similar after the three different interventions: 
0.82 ± 0.03 (Low-CHO), 0.83 ± 0.03 (High-CHO) and 0.82 ± 0.02 (High-CHO-Ex). 
Calculated rates offat utilisation were 0.06 ± 0.01 glmin (Low-CHO), 0.05 ± 0.02 
glmin (High-CHO) and 0.05 ± 0.02 glmin (High-CHO-Ex) and were not signifi-
cantly different among interventions. The same was the case for rates of carbohy-
drate utilisation, which were 0.11 ± 0.03 glmin (Low-CHO), 0.16 ± 0.05 glmin 
(High-CHO) and 0.14 ± 0.06 glmin (High-CHO-Ex). Therefore, calculated resting 
metabolic rate did not differ significantly among interventions: 4.04 ± 0.57 kJ/min 
(Low-CHO), 4.49 ± 0.64 kJ/min (High-CHO) and 4.22 ± 0.61 kJ/min (High-CHO-
Ex). 
In the postprandial state, calculated energy expenditure over the 6-hour observation 
period was not significantly different among interventions: 1.69 ± 0.04 MJ (Low-
CHO), 1.61 ± 0.04 MJ (High-CHO) and 1.75 ± 0.06 MJ (High-CHO-Ex). The 
amount offat utilised during the 6-h postprandial period was 32 ± 3 g (Low-CHO), 
30 ± 4 g (High-CHO) and 33 ± 2 g (High-CHO-Ex) (NS). Corresponding values for 
the amount of carbohydrate utilised postprandially were 27 ± 5 g, 26 ± 7 g and 21 ± 
4 g(NS). 
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Respiratory exchange ratio (RER) values in the fasted state (0 hour) 
and for six hours following consumption of a high-fat mixed meal 
after three days on a low-carbohydrate diet (Low-CHO), after three 
days on a high-carbohydrate diet (High-CHO) and after three days 
on the same high-carbohydrate diet with the addition of 60 minutes 
daily moderate intensity exercise (High-CHO-Ex). n = 8 women. 
Mean±SEM. 
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6.4 Discussion 
The fmdings of the present study confirmed the potential of daily moderate intensity 
exercise to prevent the augmentation of postprandial lipaemia attributable to a low-
fat, high-carbohydrate diet. More importantly, it was demonstrated that this type of 
exercise can exert its beneficial effect on TAG metabolism in the population of 
postmenopausal women which is at a higher risk for CHD (Hokanson and Austin 
1996; Kannel et al. 1976) than the population of young men studied in the previous 
study (chapter 5). In the present study, direct quantifications of TRL-apo B48, TRL-
apo B 1 00 and serum remnant lipoproteins were performed after high-carbohydrate 
diet and exercise interventions. The data suggest that daily moderate intensity exer-
cise can reverse the increases in fasting and postprandial concentrations of TRL apo 
B48 and apo B 1 00 and in serum remnant lipoproteins induced by a short-term high-
carbohydrate diet. 
In the fasted state, the high-carbohydrate diet resulted in higher plasma TAG and 
TRL-TAG concentrations compared to the low-carbohydrate diet. It has been sug-
gested that both elevated TAG synthesis and inadequate or reduced TAG clearance 
could contribute to carbohydrate-induced hypertriacylglycerolaemia (parks and 
Hellerstein 2000). In the present study increases in fasting TRL-TAG concentrations 
after the high-carbohydrate diet were accompanied by increases in apo B 1 00 con-
centrations, indicating the presence of more, rather than bigger, VLDL particles 
(Table 6.5). An interesting observation was the increased presence of apo B48-
containing TRL particles in the l2-hour fasted state after the high-carbohydrate diet. 
This was surprising, taking into consideration the very small amount offat the sub-
jects had consumed the day before (-35 g). These particles may constitute a certain 
subpopulation of chylomicron remnants with a very slow turnover (Karpe et al. 
1997a; Welty et al. 1999). A prolongation of their residence time in the circulation 
could also have resulted from increased competition with VLDL particles that were 
elevated 3-fold in the fasted state after the high-carbohydrate diet. 
In the postprandial state, the high-carbohydrate diet resulted in plasma TAG and 
TRL-TAGresponses that were more than one third greater than after the low-
carbohydrate diet. Additionally, after the high-carbohydrate diet, the responses of 
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apo B48 and apo B I 00 in the TRL fraction were 87 % and 70 % higher, respec-
tively. The removal of TAG from chylomicrons and VLDL is achieved by the same 
enzymatic pathway (BrunzeJl et al. 1973; Bjorkegren et al. 1996). Thus, increases in 
the concentration ofTRL particles in the fasted state, especiaJly ofVLDL particles, 
which are much more numerous than apo B48-containing particles, could increase 
competition for LPL dramaticaJly, when newly synthesised chylomicrons appear 
postprandially. This will impede degradation of both species ofTRL particles and 
lead to their accumulation. To exacerbate the situation further, (heparin releasable) 
LPL activity has been reported to be significantly reduced by high-carbohydrate di-
ets (Campos et al. 1995). Thus, after the high-carbohydrate diet more TRL particles 
could have been competing postprandially for a "less active" lipolytic pathway. 
The high-carbohydrate diet led to more apo E-enriched VLDL particles in the fasted 
state and an exaggerated and protracted apo E postprandial response compared to the 
low-carbohydrate diet. In the postprandial state, a transient increase in apo E con-
centration in the TRL fraction is expected because of the redistribution of apo E 
from HDL to the TRL fraction (Blum 1982). Apo E allows for the uptake and rec-
ognition ofTRL remnants by a receptor-dependent process in the liver (Beisiegel 
1995) and as a result, apo E levels decrease again. According to this reasoning, the 
high postprandial apo E concentrations after the high-carbohydrate diet, especially at 
the late time points, probably reflect sustained levels of TRL remnants that were not 
taken up efficiently by the liver and, therefore, had increased residence time in the 
circulation. This interpretation is supported by the 40 % higher RLP-cholesterol 
concentration at 4 hours postprandially after the high- than the low-carbohydrate 
diet, suggesting higher levels of cholesteryl-ester-enriched remnant lipoproteins. 
The observed carbohydrate-induced alterations to TAG and TRL metabolism are 
potentially atherogenic. First, high fasting (Hokanson and Austin 1996) and post-
prandial (Patsch et al. 1992) TAG concentrations have been recognised as an inde-
pendent risk marker of CHD. Therefore, the observed carbohydrate-induced eleva-
tions may indicate a potentially atherogenic impairment in lipid metabolism. Sec-
ond, the observed, diet-induced increases in the number ofapo BIOO-containing 
TRL particles (VLDL), especially in the postprandial state, could also confer a high 
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atherogenic risk. VLDL particles (as well as chylomicrons, although much fewer in 
number) become particularly enriched in cholesterol postprandially and this may 
increase their atherogenic potential (Bjorkegren et al. 1998). Indeed, in a previous 
study comparing the pattern ofTRL particles in the postprandial state in subjects 
with and without manifest coronary atherosclerosis, the postprandial accumulation 
oflarge VLDL was the most pronounced discriminator between the groups (Karpe 
et al. 1999). Furthermore, cholesterol and apo E-enriched VLDL particles have been 
isolated from human atherosclerotic plaque (Rapp et al. 1994). Another potentially 
adverse effect of the high-carbohydrate diet in relation to the risk of CHD is the ele-
vation in RLP-cholesterol concentration. RLP-cholesterol has been found to be in-
creased in normolipidaemic men with CHD (Devaraj et al. 1998) and may be useful 
in the assessment of CHD risk. In the present study the high-carbohydrate diet in-
creased the RLP-cholesterollevels by almost 60 % in the fasted state and 40 % post-
prandially compared with the low-carbohydrate diet. These increases probably indi-
cate higher levels of cholesteryl-ester-enriched TRL remnants after the high-
carbohydrate diet that are potentially atherogenic. 
If all the above carbohydrate-induced alterations to lipoprotein metabolism confer a 
high atherogenic risk, then the addition of exercise largely offsets this. Exercise pre-
vented the augmentation of postprandial lipaemia and the accumulation ofTRL par-
ticles both in the fasted and postprandial states. Exercise could oppose the overpro-
duction ofVLDL-TAG (Sidossis and Mittenddorfer 1999) andlor the suppressive 
effects on LPL activity (Campos et al. 1995) of a diet high in carbohydrate. Both 
these potential mechanisms have been discussed in chapter 5. These exercise-
induced changes could have decreased the competition between VLDL and chylo-
microns and improved the capacity for hydrolysis of their TAG content. The addi-
tion of exercise to the high-carbohydrate diet did not reduce the enrichment of 
VLDL with apo E in the fasted state but it did prevent the exaggerated and pro-
tracted postprandial apo E response observed with the high-carbohydrate diet. The 
latter effect possibly reflects an effective clearance ofTRL remnants, which is sup-
ported by the lower postprandial RLP-cholesterollevels. 
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Whether low-fat, high-carbohydrate diets provide a net benefit with respect to CHD 
risk is a key and unresolved public health issue (Parks and Hellerstein 2000). In the 
present study, fasting hypertriacylglycerolaemia and exaggerated postprandial 
lipaemia were observed after exchanging dietary fat with carbohydrate. These ef-
fects were associated with increases in the numbers of circulating TRL particles and 
their potentially atherogenic remnants but were abolished by daily, moderate exer-
cise. These fmdings strongly suggest that regular exercise during the consumption 
of a low-fat, high-carbohydrate diet may optimise CHD risk reduction. 
CHAPTER 7 
GENERAL DISCUSSION 
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Coronary heart disease is the leading cause of death in the affluent Western societies 
(Murray and Lopez 1997). There is a general agreement that diets with a high pro-
portion of saturated fatty acids raise LDL-cholesterollevels and consequently, in-
crease the risk of CHD. However, what macronutrient should replace saturated fatty 
acids in the diet remains controversial. Whilst some scientists stress that the type of 
fat, rather than the total amount, is of prime importance in CHD risk (Katan 1997), 
some others advocate a reduction in total fat with replacement from carbohydrate 
(Connor and Connor 1997). Most public health recommendations have focused on 
low-fat, high-carbohydrate diets because populations with low intakes of saturated 
and total fat tend to be at low risk and, also, because these diets effectively decrease 
total and LDL-cholesterollevels (Gnmdy et al. 1982). However, low-fat, high-
carbohydrate diets also raise fasting TAG and reduce HDL-cholesterol concentra-
tions (Mensink and Katan 1992). As high TAG and low HDL-cholestero1 concen-
, 
trations independently increase the risk (Hokanson and Austin 1996), the value of 
replacing fat with carbohydrates has been questioned (Roche 2000). One theoretical 
argument in favour of the anti-atherogenic utility of high-carbohydrate diets has 
been that postprandial lipaemia will be lower during these diets as the amount of in-
gested dietary fat is reduced (Connor and Connor 1997). 
Postprandial lipaemia is transient hypertriacylglycerolaemia, which affects the 
physical characteristics and particle composition of all major plasma lipoproteins in 
a way that it may contribute to the initiation and progression of atherosclerosis. In 
fact, the magnitude of postprandial lipaemia may be critical as it seems to determine, 
at least partly, fasting TAG (Griffin 1997) and HDL-cholesterol (Lechleitner et al. 
1990) levels, as well as the size of population of small dense LDL particles (Karpe 
et at. 1993b) that are potentially atherogenic (Griffm 1999). In addition, TRL parti-
cles may directly enhance atherosclerosis, taking into consideration the composi-
tional characteristics they attain postprandially (Bjorkegren et al. 1997; Bjorkegren 
et al. 1998) and that TRL particles have been isolated from human atherosclerotic 
plaque (Rapp et al. 1994). 
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In the preceding three chapters of this thesis, a series of investigations have been 
presented examining the effect of low-fat, high-carbohydrate diets on postprandial 
lipaemia. In an attempt to isolate the effects of the interventions from the acute ef-
fects of macronutrients in the test meal on postprandial lipaemia, an identical test 
meal was employed after each intervention. As opposed to the theoretical argument 
in favour of the anti-atherogenic utility of high-carbohydrate diets (Connor and 
Connor 1997), it was fonnd that high-carbohydrate diets were associated with fast-
ing hypertriacylglycerolaemia and augmented postprandial lipaemia compared to 
isoenergetic diets lower in carbohydrate and higher in fat. Specifically, a 68 % car-
bohydrate diet increased postprandial lipaemia (TAG-AUC) by 90 % compared with 
a 15 % carbohydrate diet in healthy men (chapter 4). Almost the same diet (70 % 
carbohydrate) increased postprandial lipaemia by 35 % compared with a 46 % car-
bohydrate diet in men (chapter 5) or compared with a 35 % carbohydrate diet in 
healthy postmenopausal women (chapter 6). In the study described in chapter 6, the 
qualitative changes to postprandial TAG metabolism elicited by high-carbohydrate 
diets were also investigated. It was observed that exchanging dietary fat with carbo-
hydrate was associated with increases in the numbers of circulating apo B48- and 
apo B lOO-containing TRL particles and their remnants in both the fasted and post-
prandial states. Specifically, the 70 % carbohydrate diet was associated with in-
creases in the postprandial responses (AUC) ofTRL apo B48- and apoBl00-
containing lipoproteins by 87 % and 70 %, respectively. 
The potential mechanisms by which high-carbohydrate diets cause hypertriacylglyc-
erolaemia and postprandial accumulation ofTRL particles have been discussed in 
section 2.8.4 and chapters 4, 5 and 6. An overview of these mechanisms is provided 
here. Carbohydrate-induced fasting hypertriacylglycerolaemia appears to result from 
overproduction of both VLDL-TAG and VLDL particles (Parks and Hellerstein 
2000); clearance ofVLDL could also be impaired (parks et al. 1999). Accumulation 
ofVLDL particles in the fasted state probably increases the competition with chy-
10microns for hydrolysis by LPL postprandially (Brunzell et al. 1973; Karpe and 
Hultin 1995; Bjorkegren et at. 1996), leading to postprandial accumulation of both 
TRL species and their remnants. The latter was clearly indicated in chapter 6 by the 
exaggerated and delayed postprandial response ofTRL apo E and high levels of 
RLP-cholesterol after the high-carbohydrate diet. 
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Hepatic de novo lipogenesis per se is not likely to be a primary factor of carbohy-
drate-induced hypertriacylglycerolaemia. However, as discussed in section 2.8.4.1 
and chapters 4 and 5, de novo lipogenesis could provide a signal within the hepato-
cyte to shift more plasma-derived fatty acids from oxidation toward esterification 
and TAG synthesis. According to studies in rats, this effect on hepatic fat oxidation 
seems to be linked to an inhibition of carnitine acyl-transferase I, located on the 
outer side of the mitochondrial inner membrane, by malonyl CoA, the first commit-
ted intermediate of lipogenesis (McGarry and Foster 1980). However, a variation of 
malonyl CoA concentration is not always responsible for the decrease in hepatic 
fatty acid oxidation when lipogenic rate increases (Decaux et al. 1988). It may in-
volve, in addition, a decrease in carnitine acyltransferase I activity and an increase in 
the sensitivity of this enzyme to malonyl CoA. Whatever the mechanism is, hepatic 
fat oxidation would be decreased and more fatty acids would be shunted toward 
VLDL production. The present thesis provided some evidence, albeit indirect, for a 
reduced hepatic fatty acid p-oxidation after high-carbohydrate diets by demonstrat-
ing lower serum 3-hydroxybutyrate concentrations in the fasted (chapter 4) and 
postprandial states (chapters 4, 5 and 6) after the high-carbohydrate diet than after 
diets lower in carbohydrate. 
Certainly, a defect in TRL-TAG hydrolysis can also constitute a mechanism for the 
observed carbohydrate-induced hypertriacylglycerolaemia and kinetic studies have 
provided evidence for this (Parks et al. 1999; Chen et al. 1995). However, the 
mechanism for this defect is less clear as is the exact contribution ofLPL, taking 
into consideration that a reduction in VLDL-TAG fractional catabolic rate after a 
high-carbohydrate diet has been found to be accompanied by a significant increase 
in postheparin plasma LPL activity (Chen et al. 1995). Theoretically, the degree of 
activity ofLPL in postheparin plasma indicates the upper limit for the rate ofhy-
drolysis ofTRL-TAG in plasma. Previous studies (Karpe 1992; Karpe et al. 1993a), 
however, provided little evidence that this measure is metabolically important. No 
significant relations were found between postheparin plasma LPL activity and AUC-
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TAG measurements in the Sf> 400, Sf 60-400 and Sf 20-60. Furthennore, only weak 
negative correlation coefficients were obtained between postheparin plasma LPL 
activity and the AUCs for Sf 60-400 apo B48 and apo BlOO. Concerning the Sf 20-
60 fraction, no significant relations with AUCs for apo B48 and apo B I 00 and post-
heparin plasma LPL activity were noted. There is currently no way to assess LPL 
activity in vivo without the use of heparin, which, as discussed above, may not pro-
vide physiologically relevant results. The mechanisms responsible for reduced TRL-
TAG or/and VLDL-TAG overproduction on low-fat, high-carbohydrate diets await 
further study. 
Taken together with clinical data, the changes in lipoprotein metabolism induced by 
euenergetic high-carbohydrate diets appear to support concerns about the athero-
genic potential of these diets. In the studies described in this thesis, it was found that 
the high-carbohydrate diets were associated with fasting hypertriacylglycerolaemia 
and exaggerated postprandial lipaemia. These effects were accompanied by in-
creases in the number of circulating TRL particles of both exogenous and endoge-
nous origin. Fasting TAG concentration is an independent risk factor for CHD 
(Hokanson and Austin 1996) while there is also accumulated evidence that elevated 
postprandial levels of plasma TAG and TRL particles are closely related to the risk 
ofCHD and early atherosclerosis (Karpe 1999). As discussed in chapter 6, the car-
bohydrate-induced increases in the number ofapo BIOO-containing TRL particles 
(VLDL), especially in the postprandial state, could confer a high atherogenic risk. 
VLDL particles (as well as chylomicrons, although much fewer in number) become 
particularly enriched in cholesterol postprandially and this may increase their ath-
erogenic potential (Bjllrkegren et al. 1998). Another potentially adverse effect of 
high-carbohydrate diets is the accumulation of renmant lipoproteins as was indicated 
by the elevation in RLP-cholesterol concentration (chapter 6). There is considerable 
evidence linking TRL renmant particles with the risk or progression of atherosclero-
sis (Hodis and Mack 1998; Hodis 1999). Collectively, these observations lead to the 
concern that, at least in some individuals, the beneficial LDL-cholesterollowering 
effect of high-carbohydrate diets may be offset by adverse changes in other circu-
lating lipoprotein fractions (Baum and Brown 2000). 
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Probably, the most striking fmding of the research in this thesis was the potential of 
exercise to abolish the effects of high-carbohydrate diets on TAG metabolism. It 
was clearly demonstrated that the TAG-lowering effect of exercise (Aldred et al. 
1994; Tsetsonis et al. 1997; Gill and Hardman 2000) is sufficiently potent to offset 
the augmentation of postprandial lipaemia, which develops when subjects change to 
a low-fat, high-carbohydrate diet. Thirty minutes of daily moderate exercise was 
sufficient to negate the carbohydrate-induced augmentation of postprandiallipae-
mia, although not the increase in fasting TAG levels, in healthy young men (chapter 
5). This study showed the importance of studying humans in the fed state and the 
dissociation that may exist between fasting and postprandial TAG concentrations. 
Furthermore, one hour of daily exercise entirely prevented the accumulation of 
TAG, TRL particles and their remnants in both the fasted and postprandial states in 
healthy postmenopausal women (chapter 6). Importantly, the exercise in both stud-
ies (chapters 5 and 6) was prescribed at a "relative exercise intensity" of 60 % V02 
max, which is considered as moderate by most classifications. Thus, each individual 
exercised at a speed and gradient, which he/she could manage comfortably. As the 
exercise was prescribed according to individual ability and fitness, the least fit sub-
jects performed less exercise in absolute terms than their fitter counterparts but even 
these subjects experienced substantial reductions in plasma TAG concentrations. 
Interestingly, the dietary change that was employed was more extreme in the pro-
portion of dietary energy from carbohydrate (70 % carbohydrate) than that recom-
mended to the population at large (e.g. > 55 % carbohydrate, National Cholesterol 
Education Program Step I diet). Nonetheless, one hour and even 30 minutes of 
moderate intensity exercise daily was sufficient to negate the carbohydrate-induced 
augmentation of postprandial lipaemia. A smaller amount of exercise is, therefore, 
likely to offset the effects of a more modest dietary change. 
The potential mechanisms by which exercise prevented the effects of carbohydrate-
rich diets on TAG metabolism have been discussed in chapters 5 and 6 and an over-
view is given here. One possible explanation may be that exercise opposed the re-
duction in the capacity for clearance of TAG that has been demonstrated after a 
high-carbohydrate diet (Parks et al. 1999). This exercise effect may have been me-
diated by increases in the activity of LPL located at the endothelial surface of cap-
illaries, which can be measured with the use of heparin. Taking into consideration 
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the already discussed concerns on whether heparin-releasable LPL activity provides 
physiologically relevant results, both a single exercise session (Kantor et al. 1987) 
and exercise conditioning (Weintraub et al. 1989) increase postheparin plasma LPL 
activity. In addition, they both enhance the capacity for intravenous fat clearance 
(Sady et al. 1986; Thompson et al. 1988). These exercise-induced changes may 
have affected postprandial TAG metabolism, when exercise was combined with the 
high-carbohydrate diet. It should be noted, however, that in all four studies just re-
ferred to, the intensity of exercise was higher than in the studies described in this 
thesis. Specifically, exercise was either at 80 % maximum heart rate (> 60 % \702 
max) (Kantor et al. 1987; Weintraub et al. 1989; Thompson et al. 1988), or intense 
and prolonged (marathon running) (Sady et al. 1986). To what extent one hour or 
even 30 minutes of daily exercise at 60 % \702 max affected TAG clearance capac-
ity is unclear. It may be that it was enough to oppose a reduction due to the carbo-
hydrate-rich diet. 
Another possible explanation for the TAG-lowering effect of exercise in the fasted 
and postprandial state may be a suppressive effect on carbohydrate-induced VLDL 
overproduction. Studies in rats have shown that exercise decreases hepatic VLDL 
production (Simonelli and Eaton 1978; Mondon et al. 1984; Fukuda et al. 1991) 
even during long-term carbohydrate feeding (Zavaroni et al. 1981). The causative 
factors for the lowering effect of exercise on VLDL-TAG-production could be, at 
least partly, an alteration in the hepatic partitioning of long-chain fatty acids be-
tween esterification and oxidation (Fukuda et al. 1991). High-carbohydrate diets 
(Sidossis and Mittenddorfer 1999) and increased acute glucose availability (Sidossis 
et al. 1998) decrease hepatic fatty acid oxidation, possibly by direct inhibition of 
long-chain fatty acid entry into the mitochondria via carnitine acyl-transferase I 
(section 2.8.4.1). Hypothetically, exercise could reduce or oppose this effect by di-
verting a considerable amount of carbohydrate to muscles for use as an energy 
source and for glycogen replenishment in the post-exercise state (Hamilton et al. 
1996). In this way, the amount of carbohydrate that needs to be disposed of by the 
liver would be reduced, possibly reducing malonyl CoA production. This, in turn, 
may relieve the inhibition on carnitine acyl-transferase I, thereby allowing the flow 
of long-chain fatty acids into the mitochondria for p-oxidation and decreasing the 
availability of fatty acids for TAG synthesis. There is some evidence from the re-
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search in this thesis (chapters 5 and 6) for an exercise-induced increase in hepatic 
fatty acid ~-oxidation. The 3-hydroxybutyrate response (AUC) to the test meal was 
higher when the high-carbohydrate diet was combined with exercise than after the 
high-carbohydrate diet alone, however, this increase did not reach statistical signifi-
cance. Whether exercise attenuates VLDL-TAG secretion in humans on a high-
carbohydrate diet and to what extent this is determined by an effect on the hepatic 
partitioning oflong-chain fatty acids between esterification and oxidation requires 
investigation. 
The present work demonstrated that daily moderate exercise can offset, in the short 
term, the potentially detrimental effects of high-carbohydrate diets on postprandial 
TAG and TRL metabolism. Certainly, intervention studies over a longer time-scale 
are needed to examine whether exercise exerts the same effect in the long term. Hy-
pothetically, a normalisation ofTRL metabolism by exercise during low-fat, high-
carbohydrate diets could also prevent the effects of these diets in other lipoprotein 
species such as the LDL particles. Previous reports have shown that more than a 
third of men who manifested a LDL subclass phenotype A (large, buoyant LDL) 
while consuming a high-fat diet converted to phenotype B (small, dense LDL) with 
a reduction in fat to 20-24 % of energy and a concomitant increase in carbohydrate 
(Dreon et al. 1994; Krauss and Dreon 1995). A subsequent study by the same group 
(Dreon et al. 1999) demonstrated that an additional 32 % of men who had stable 
phenotype A during the low-fat, high-carbohydrate converted to phenotype B after 
consumption of a very-low-fat (10 % fat), high-carbohydrate diet. Several studies 
have shown that risk of CHD is significantly greater in individuals with a predomi-
nance of small, dense LDL particles (Austin et al. 1988; Griffm 1994; Gardner et al. 
1996). Thus, it seems that low-fat, high-carbohydrate diets can increase the risk for 
CHD in individuals who are considered at low risk while consuming their usual di-
ets. It was also noted (Dreon et al. 1999) that after the consumption of the high-
carbohydrate diet increases in concentration of dense LDL-llI and reductions in 
buoyant LDL-I particles were inversely correlated with increases in fasting TAG 
concentrations. Furthermore, these subjects whose LDL phenotype changed from A 
to B after the high-carbohydrate diet had two-fold higher concentrations of plasma 
fasting TAG and higher concentrations of all VLDL subclasses, particularly the 
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largest VLDL particles, compared with the stable A group. With regard to the meta-
bolic basis for the shift in LDL subclass phenotype from A to B, these authors 
speculated that the carbohydrate-induced increases in TAG and TRL concentrations 
may have resulted in TAG enrichment ofLDL particles by the action ofCETP and 
their subsequent remodeling and conversion to small dense LDL by hepatic lipase, 
however, some genetic influence was probably also involved. The magnitude of 
postprandial lipaemia has been positively associated with the levels of small dense 
LDL in the fasted state (Karpe et al. 1993b). Although no postprandial investiga-
tions were conducted in the above mentioned studies, it may be that an exaggeration 
in postprandial TAG and TRL concentrations due to the high-carbohydrate (as can 
be predicted by high fasting levels) particularly triggered the formation of small 
dense LDL particles during this diet. The research in this thesis showed that exercise 
during a high-carbohydrate diet prevents increases in fasting and postprandial TAG 
and TRL concentrations and, therefore, exercise might provide one means for at-
tenuating the potentially deleterious effects of this type of diet on LDL subclasses. 
In the study presented in chapter 6, one hour of daily moderate intensity exercise 
did not prevent the reduction in HDL-cholesterol concentration associated with the 
high-carbohydrate diet, although it did decrease fasting and postprandial TAG and 
TRL concentrations. There are several explanations for this. First, it has been sug-
gested that a high level of physical activity leads to higher plasma HDL-cholesterol 
concentration by increasing TAG metabolic capacity (Wood and HaskeIl1979). It 
may be that the initial effect of exercise was to enhance postprandial TAG metabo-
lism and that changes in HDL-cholesterol concentration would develop later. In this 
way, the duration of the intervention might have been too short for the exercise to 
exert an effect on HDL-cholesterollevels. Second, as discussed in section 2.7.2, 
there may be a dissociation of postprandial TAG metabolism and fasting HDL-
cholesterol concentration at low or normal levels of postprandial lipaemia. Cohen 
and Grundy (1992) reported similar postprandial lipaemia in two groups of normo-
Iipidaemic men with distinctly different HDL-cholesterollevels (-0.8 mmollL vs 
-1.2 mmollL). Thus, it may be that the similar postprandial TRL particle concen-
tration and magnitude of lipaemia after the low-carbohydrate intervention and after 
the high-carbohydrate diet plus exercise intervention in the present work would not 
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necessarily confer similar HDL-cholesterol concentrations. Finally, it has recently 
been demonstrated that the decrease in HDL-cholesterol during an euenergetic low-
fat, high-carbohydrate diet (National Cholesterol Education Program Step 11 diet) 
paralleled the reduction in apo AI (major apolipoprotein component ofHDL parti-
cle) secretion rate (Velez-Carrasco et al. 1999). It was, therefore, suggested that the 
requirement for HDL-mediated cholesterol removal may be less at lower intakes of 
dietary fat and cholesterol and so the carbohydrate-induced reduction in HDL-
cholesterol levels should not be interpreted as a negative outcome with regard to 
CHD (Velez-Carrasco et al. 1999). If this holds true, then the HDL-cholesterol-
lowering effect of high-carbohydrate diets could indeed be independent of the effect 
of these diets on postprandial TAG metabolism. In contrast, a diet high in fat has 
been shown to increase apo AI secretion rate and HDL-cholesterol concentration 
compared with a low fat diet in transgenic mice expressing human apo AI (Hayek et 
al. 1993). It was suggested that the HDL-cholesterol-raising effect of high-fat diets 
represents a defensive response which along with higher secretion rates of apo AI 
may be a protective mechanism against the deleterious effects of elevated levels of 
apo B-containing particles on the arterial wall (Wolf 1996; Hayek et al. 1993). 
Interventions of longer duration (> three weeks) than the three-day model used in the 
present work have provided some evidence that regular exercise may offset the re-
ductions in HDL-cholesterol concentration attributable to high-carbohydrate diets. A 
recent meta-analysis (Yu-Poth et al. 1999) found that regular exercise attenuated the 
lowering effect oflow-fat, high-carbohydrate diets (National Cholesterol Education 
Program Step I and Step 11 diets) on HDL-cholesterol concentration by inducing a 
10-fold smaller decrease than the non-exercise interventions. It was speculated that 
the attenuating effect of exercise may be mediated by the weight loss which usually 
occurs with exercise regimens. This speculation is confirmed by a study in older 
glucose intolerant subjects (Hughes et al. 1994). This study demonstrated that a 
combination of a high-carbohydrate diet and moderate exercise for 12 weeks without 
significant changes in body composition and only small (-I kg) changes in body 
weight was not effective in preventing the decrease in HDL-cholesterol that oc-
curred with the high-carbohydrate diet. In contrast, the addition of weight loss (-10 
kg) to the American Heart Association Step I diet « 30 % fat) prevented the de-
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crease in HDL-cholesterol seen with the same diet intervention alone in obese men 
(Dengel et al. 1995). Using a weight-reducing National Cholesterol Education Pro-
gram Step I diet for one year in overweight men, Wood et al. (1991) found that, al-
though the diet alone did not affect HDL-cholesterol concentration, the addition of 
aerobic exercise induced a significant elevation in HDL-cholesterol concentration 
which was accompanied by a greater weight loss (-9 kg) than the weight-reducing 
diet alone (~5 kg). However, a study by Nieman et al. (1990) showed that, despite a 
similar weight loss (-6 kg) after a five-week low-fat (30 % fat) diet and after the 
same diet combined with moderate exercise, the exercise prevented the decrease in 
HDL-cholesterol concentration induced by the low-fat diet alone. Clearly, more re-
search is needed to clarify whether the exercise-induced attenuation in the reduction 
in HDL-cholesterol concentration due to low-fat, high-carbohydrate diets is depend-
ent on changes in body weight (and composition) or not. 
In the research of this thesis, postprandial investigations were conducted in subjects 
who had fasted for 12 hours overnight and consumed a single, standardised mixed 
meal containing large amounts of fat that ranged from 60 to 95 g. A similar model 
has been used in a number of postprandial studies as it provides some advantages. 
First, it defmes the fasted state as a 12 hour overnight fast, minimising effects of 
previous meals on the "baseline" TAG concentration. Second, high fat doses exag-
gerate the metabolic sequelae of the postprandial response allowing better under-
standing of the biochemical basis of the postprandial TAG and TRL response. How-
ever, recently, some criticisms have been expressed that this approach for investiga-
tion of postprandial TAG metabolism may not provide results relevant to a free-
living situation (Roche and Gibney 2000). Specifically, it has been reported (De 
Castro 1987) that the mean fat intake at each eating occasion throughout the day in 
free-living individuals is between 12 and 30 g, the fat dose being low in the early 
morning and higher in the early evening. These data may challenge the physiological 
relevance of some postprandial investigations because (i) the quantities of fat con-
sumed as part of a habitual diet are much lower than those used in postprandial in-
vestigations, including these in the present work (ii) individuals consume dietary fat 
as part of three to six occasions rather than as one bolus, and (Hi) most postprandial 
investigations begin in early morning, a stage in the circadian rhythm when fat in-
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take tends to be low. Postprandial investigations using large fat loads are important 
in examining the mechanisms behind postprandial TAG metabolism. However, they 
may need to be complemented by investigations using more realistic models, before 
extrapolating any results to free-living situations. Different but complementary 
models could collectively provide a body of evidence which will progress knowl-
edge on postprandial lipoprotein metabolism and lead to changes in public health 
policy and recommendations. 
The fmdings of the present research regarding the effects of high-carbohydrate diets 
on TAG metabolism do not necessarily speak against current population recommen-
dations for some substitution of energy from fat with carbohydrate, not least because 
the carbohydrate-rich diets employed were euenergetic, extreme and contained large 
amounts of sugars. High-carbohydrate foods exert a strong, positive effect on satiety 
(Blundell et al. 1994) and in free-living conditions may therefore aid weight reduc-
tion. Indeed, most of the subjects in the present thesis experienced some difficulty 
eating all the food prescribed for the isonergetic, high-carbohydrate diet. Given a 
choice, they would have consumed less food, possibly resulting in energy deficit and 
speculatively, in the long term, in weight loss. In line with this reasoning, several 
experimental studies have demonstrated significant weight loss during the consump-
tion of ad libitum low-fat, high-carbohydrate diets (Schaefer et al. 1995; Turley et 
al. 1998; Kasim-Karakas et al. 2000). As discussed in section 2.8.3.1, the weight 
loss occurring with an ad libitum low-fat, high-carbohydrate diet often prevents 
fasting hypertriacylglycerolaemia. However, whether this is the case for the post-
prandial state as well has not been fully investigated. Another point for consideration 
is how long this weight loss lasts for. The two-year Women's Trial Feasibility Study 
(Sheppard et al. 1991) showed that the intervention group that received intensive in-
struction in maintaining a low-fat, high-carbohydrate diet lost 3.0 kg in the first year. 
However, body weight gradually rose thereafter so that more than a third of the ini-
tial weight loss was lost by the end of the second year. 
Epidemiologic studies have shown that some populations who consume very-low-fat 
diets have a low incidence of CHD, however, these populations also have a very low 
incidence of overweight and obesity and a high level of physical activity (Roberts 
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1988; Kagan et al. 1974). The levels of physical activity may be important in deter-
mining CHD risk during the conswnption of low-fat diets. For example, physical in-
activity among the USA population is now widespread so that one in four adults 
have sedentary lifestyles (Nlli Consensus Conference 1996). At the same time, de-
spite a decline in the intake of energy from fat (Stephen et al. 1995), obesity stands 
out as being increasingly prevalent in the United States (Grundy 1998). Thus, re-
stricting fat intake in free living populations does not necessarily result in weight re-
duction, especially in affluent Western societies where the population is largely sed-
entary and the typical low-fat food items are often high in energy. 
In conclusion, perhaps the most important and unambiguous generalisation that can 
be made from the findings of the studies described in this thesis is that daily moder-
ate intensity exercise is sufficient to prevent the augmentation of postprandiallipae-
mia and accumulation ofTRL particles attributable to a short-term low-fat, high-
carbohydrate diet in men and women. High-carbohydrate diets are recommended by 
various scientific bodies for the prevention or treatment of CHD. However, whether 
these diets provide a net benefit with respect to CHO risk (Connor and Connor 
1997) or actually increase the risk (Baum and Brown 2000) is an important public 
health issue. The present thesis demonstrated that the effects of high-carbohydrate 
diets on CHD risk factors, such as TAG metabolic capacity, could be strongly af-
fected and beneficially altered by regular exercise. The programme of moderate ex-
ercise used in this thesis was acceptable to and generally enjoyed by the majority of 
subjects and it appears to be realistic for a large proportion of sedentary and maybe 
overweight people. Regular exercise may provide one means for allaying current 
anxieties about high-carbohydrate diets. However, studies oflonger duration are 
necessary to evaluate the role and importance of exercise as an adjunct to dietary 
advice to the population to replace fat with carbohydrate. 
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APPENDICES 
Appendix A: Information for volunteers, questionnaires, forms, food inventory, 
instructions for diet recording. 
Appendix B: Plasma and TRL-TAG assay, serum insulin assay. 
APPENDIX Al 
LOUGHBOROUGH UNIVERSITY, DEPARTMENT OF PHYSICAL 
EDUCATION, SPORTS SCIENCE AND RECREATION MANAGEMENT 
INFORMATION FOR VOLUNTEERS 
Influence of exercise on the hypertriglyceridaemic effect of a low-fat, high-
carbohydrate diet: a study in the postprandial state. 
BACKGROUND 
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Work in the Muscle Metabolism Research Group in this Department is looking at the 
effects of different types of diet and exercise on the body's ability to cope with fat 
contained in food. This capacity has important implications in determining one's risk of 
developing coronary heart disease. After eating a meal, blood vessel walls are exposed to 
particles carrying fat (triglycerides) from the food (exogenous triglycerides) as well as 
triglycerides produced from the body (endogenous triglycerides) that may facilitate the 
build-up of fatty deposits on the artery surface. High blood triglyceride responses to 
meals could accelerate this process. 
A short-term high-carbohydrate diet has been shown to augment blood triglyceride 
responses to a meal possibly by promoting the production of endogenous triglycerides 
and/or by reducing the body's capacity to clear triglycerides from the circulation. 
Moderate exercise has been shown to reduce blood triglyceride responses to a meal, when 
participants are on a typical-UK diet, but the effect is unclear when participants are on a 
high-carbohydrate diet. 
The first aim of this study is to compare the blood triglyceride response to a high fat meal 
following a 3-day high carbohydrate diet with that after a 3-day Western diet. The 
second, and more important, aim is to examine blood triglyceride responses after a 3-day 
high carbohydrate diet with participants also performing 30 minutes of exercise each day, 
to determine whether exercising while consuming a high carbohydrate diet provides a 
favourable alteration to triglyceride metabolism. 
STUDY DESIGN 
All volunteers will undertake a series oftests during the study. 
These tests involve the evaluation of: 
• Fitness, by exercise tests. 
• Body composition. 
• Blood triglyceride responses to a test meal after 3 days on a typical-Western diet 
while refraining from exercise (Western intervention). 
• Blood triglyceride responses to a test meal after 3 days on a high-carbohydrate diet 
while refraining from exercise (high-carbohydrate intervention). 
• Blood triglyceride responses to a test meal after 3 days on a high-carbohydrate diet, 
with 30 minutes of treadmill jogging on each day (high-carbohydrate plus exercise 
intervention). 
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PRELThfiNARYPROCEDURES 
Before enrolling in the study, you will be asked to attend the laboratory for a preparatory 
session during which we will: 
• Ask you to record everything you eat and drink for 2 weekdays and 1 weekend day. 
• Measure your blood pressure. 
• Discuss and complete with you confidential questionnaires regarding your health and 
physical activity. 
• Provide an opportunity for you to ask questions. 
We will also ask you to come to the laboratory before breakfast one morning so we can 
take a small blood sample to check the triglyceride and cholesterol levels in your blood. 
EXPERlMENTALPROCEDURES 
A. Preliminary Exercise Tests 
A submaximal and a maximal exercise test will be undertaken on the treadmill at 
Loughborough University. Heart rate will be monitored and recorded throughout using a 
heart rate monitor and expired air will be collected at intervals using a mouthpiece and 
respiratory valve. 
• The first test will be sub-maximal and last for 16 mins. The speed will be increased at 
the end of each 4-min period. This test is designed to familiarise you with running on a 
treadmill. 
• The second test will be maximal. The gradient will increase every three minutes and 
the test will end when you decide that you are able to run for just one further minute. 
This test is designed to determine your body's ability to use oxygen and enables us to 
fmd the correct speed for you to run at during the high-carbohydrate plus exercise 
intervention. 
B. Body Composition 
The amount and distribution of your body fat will be determined by measuring body girths 
and by using callipers to measure skin fold thickness at four different sites (a sophisticated 
version of "pinch an inch"). Your height and weight will also be recorded. You will need to 
wear only underclothing for these measurements, which will be made in private. 
C. Diet Recording 
You will be asked to weigh and record everything that you eat and drink for two weekdays 
and one weekend day. You will be given detailed instructions how to do this. According to 
your daily energy intake, the experimenters will prescribe a typical Western diet and a 
high-carbohydrate diet for you. You will be asked to follow the typical Western diet during 
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the Western intervention. You will be asked to follow the high-carbohydrate diet during 
the high-carbohydrate and the high-carbohydrate plus exercise interventions. 
We will provide you with a set of scales to do this easily. 
D. Main Interventions 
These will be conducted in random order. 
• Western intervention - You will be asked to refrain from physical activity (other than 
'everyday activities') and consume a prescribed typical Western diet for three days 
before attending the lab for an oral fat tolerance test (described below). 
• High-carbohydrate intervention - You will be asked to refrain from physical activity and 
consume a prescribed high-carbohydrate diet for three days before attending the lab for 
an oral fat tolerance test. 
• High-carbohydrate plus exercise intervention - You will be asked to perform a 60-
minute bout of moderate exercise (treadmill walking) each day for 3 days while 
following a high-carbohydrate diet. The next day you will attend the lab for an oral fat 
tolerance test. 
You will be asked to follow a prescribed diet for the three days prior each intervention and 
to refrain from exercise and alcohol. 
E. Blood Triglyceride Responses to a Test Meal (Oral fat tolerance test) 
You will be asked to come to the laboratory after an overnight fast (Le. having eaten 
nothing for 12 hours) and eat a test meal consisting of cereal, bananas, apples, nuts, 
sultanas, coconut, chocolate and cream. If you are allergic to nuts, they will be omitted 
from the meal. In order to determine triglyceride concentrations in the blood, we will take 
small blood samples in the fasted state and at intervals over a period of 6 hours after the 
meal. About 450 ml of blood will be removed in total over the three trials (about the 
volume withdrawn if one volunteers to donate blood). To minimise any discomfort the 
samples will be obtained via a cannula (tiny plastic tube) placed (under local anaesthetic) 
in a forearm vein. Just before the meal and hourly for the next 6 hours we will take 
expired air samples. For 6 hours following the meal, you will not be able to eat or drink 
anything, except water. You will just be resting, watching TV, reading or working. After 
this time we will provide you with a meal and then you can go home. 
These tests will be done at your convenience. 
HOW MUCH TIME WILL THE TESTS TAKE? 
• Fitness tests: For the exercise test at the University you will be in the laboratory for no 
more than 40 minutes on each occasion. 
• Body composition: The procedure requires only a few minutes and will take place on 
the same visit as one of the exercise tests. 
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• High-carbohydrate plus exercise intervention: The treadmill jogging will take 30 
minutes each of the three days. 
• Blood triglyceride responses to a fat meal: These tests will take place over a period of 
about 7 hours. 
PossmLE RISKS AND DISCOMFORT 
• Exercise testing will be at sub-maximal and maximal level and the possibility exists 
that, very occasionally, certain changes may occur during or shortly after the tests. 
They include abnormal blood pressure, fainting or a change in the normal rhythm of 
the heartbeat. 
• Blood sampling via the cannula may cause minor bruising, an inflammation of the 
vein or haematoma (a small accumulation of blood under the skin). There is also a 
exceedingly small risk of a tiny piece of plastic or an air bubble entering the 
bloodstream if the cannula is incorrectly placed. Good practice, however, minimises 
this risk and only experienced and trained staffwill deal with blood sampling. 
The preliminary procedures before the start of the study are designed to minimise possible 
risks. All tests will be contacted and closely monitored by trained and experienced staff 
and in addition, only those at little risk from the procedures will be accepted into the 
study. 
BENEFITS OF THE STUDY 
The fmdings will be published in the scientific and medical literature so that 
understanding of the way in which diet and exercise influences the risk of heart disease 
can be increased. 
We will provide you with feedback about the group fmdings and also about your own 
results and would be delighted to explain results and discuss the implications with you. 
CONFIDENTIALITY 
Although information will be stored on computer, each subject will be entered as a 
number rather than by name and will not be identifiable. This is in accordance with the 
Data Protection Act. 
Any questions about the procedures used in this study are encouraged. If you have any 
doubts or questions, please ask for further explanations by contacting Christina Koutsari 
on 01509 228183 (Office), 222277 (Home), C.Koutsari@lboro.ac.uk (e-mail) or Prof. 
Adrianne Hardman on 01509 223265. 
APPENDIXA2 
STATEMENT OF INFORMED CONSENT 
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LOUGHBOROUGH UNIVERSITY, DEPARTMENT OF PHYSICAL EDUCATION, 
SPORTS SCIENCE AND RECREA nON MANAGEMENT 
Influence of exercise on the hypertriglyceridaemic effect of a low-fat, high-
carbohydrate diet: a study in the postprandial state. 
Statement ofinformed consent: 
Your permission to take part in this study is voluntary. You are free to deny consent or to 
withdraw from the study at any point and without explanation, if you so desire. 
I have read the information regarding this study and had the opportunity to ask questions 
of the investigators. I understand the procedures involved and consent to participate in 
this study. 
Signature of subject: Date: 
Signature of witness: 
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APPENDlXA3 
HEALTH mSTORY QUESTIONNAIRE FOR STUDY VOLUNTEERS 
CONFIDENTIAL 
NAME DATE 
DATE OF BIRTH 
ADDRESS 
TELEPHONE 
It is important that volunteers participating in research studies are ClDTently in good health and have had no 
significant medical problems in the past. This is to ensure (i) their own continuing well-being and (ii) to 
avoid the possibility ofindividual health issues confounding study outcomes. 
Please complete this brief questionnaire to confirm fitness to participate: 
I. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise ........................................ Yes D 
(b) attending your general practitioner ............................................... Yes D 
(c) on a hospital waiting lisL ............................................................. Yes D 
2. In the past two years, have you had any illness which require you to: 
(a) consult your GP .......................................................................... Yes D 
(b) attend a hospital outpatient department ........................................ Yes D 
(c) be admitted to hospital ............................................................... Yes D 
3. Have you ever had any of the following: 
(a) Nut allergy .................................................................................... Yes D 
(b) Convulsions/epilepsy ................................................................... Yes D 
(c) Diabetes ........................................................................................ Yes D 
(d) A blood disorder ........................................................................... Yes D 
(e) Digestive problems ....................................................................... Yes D 
(f) Heart problems ............................................................................. Yes D 
(g) Thyroid problems ......................................................................... Yes D 
(h) High blood pressure ..................................................................... Yes 0 
(i) Kidney or liver problems .............................................................. Yes D 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
G) Asthma ......................................................................................... Yes 0 
(1<) Eczema ......................................................................................... Yes 0 
(I) Head injury ................................................................................... Yes 0 
(m) Problems with bones or joints ...................................................... Yes 0 
(n) Disturbance ofbalance!coordination ............................................ Yes 0 
(0) Numbness in hands or feet ........................................................... Yes 0 
(P) Disturbance of vision ................................................................... Yes 0 
(q) Earlhearing problems ................................................................... Yes 0 
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NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
If YES to any question, please describe briefly if you wish (e.g. to confirm problem was!is short-lived, 
insignificant or well controlled.) .................................................................................................................................... .. 
5. Additional questions for female participants 
(a) Are you taking hormone replacement therapy? ............................ Yes 0 
(b) For how longbave you been on menopause? ............................... Yes 0 
NoD 
NoD 
Name and address of GP .................................................................................................. .. 
Thank you for your co-operation 
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APPENDIXA4 
PHYSICAL ACTIVITY QUESTIONNAIRE 
During one week, how many times on average do you do the following kinds of exercise 
for more than 15 minutes? 
(a) Strenuous Exercise (heart beats rapidly) 
For example; running, jogging, squash, hockey, 
football, basketball, vigorous swimming, 
vigorous long distance cycling. 
_____ times per week. 
(b) Moderate Exercise (not exhausting) 
For example; fast walking, tennis, easy cycling, 
badminton, easy swimming, dancing. 
_____ times per week. 
(c) Mild Exercise (minimal effort) 
For example; yoga, archery, fishing, bowling, 
golf, easy walking. 
_____ times per week. 
APPENDIXA5 
FOOD INVENTORY FORM 
Nam~e ________________________ __ 
1. Time/Place 2. Description of food/drink 
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Date.e ____________ _ 
3. Weight of 4. Weight of 
food/drink leftovers (g) 
(e) 
APPENDIXA6 
FOOD INVENTORY INSTRUCTIONS 
It is important that you weigh and record everything that you eat and drink (except 
water) for two week days and one weekend day. 
Please (i) start a separate page for each day 
(ii) start a separate line for each item. 
Column 1 
Record meal and time and place of eating. 
Column 2 
Describe each item as accurately as possible, starting where relevant: 
(i) type and brand 
(ii) whether food is fresh, dried, canned, frozen, salted, smoked, etc. 
(iii)whether food is cooked, if so give method of cooking e.g. fried, baked, etc. 
Column 3 
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Record the weight of each item preferably after cooking (fried chicken-lean meat, baked 
potatoes, lasagne, chicken curry, boiled rice etc.): 
(i) place scales on a level surface 
(ii)place plate or container on top of scales 
(iii) press 'ONlReset' button to turn on scales 
(iv) once zero appears, add first item of food 
(v) record weight displayed 
(vi) press reset button before weighing next item 
Record weights in grams. If this is not possible, record weights in household measures 
(e.g. sugar or jam in teaspoons, stating whether level, rounded, or heaped). 
If you are going to cook a food following a special recipe (very different from the 
common one in terms of the kind and quantity of the ingredients): 
(i) weigh and record each of the ingredients raw (do not forget to weigh and 
record the water) 
(ii) weigh and record the whole food cooked 
(Hi) weigh and record your portion 
e.g.: meat and tomato (pasta) sauce: 
Raw ingredients: 200 gr lean beef mince 
350 g peeled plum tomatoes in tomato juice (no sugar) 
50 g green peppers 
15 g olive oil 
30 g red onion 
10 g parsley 
20 gwater 
JO g sugar 
3 g salt, 2 g pepper 
Whole food cooked: 550g 
Your portion: 230 g 
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Column 4 
Record the weight of any leftovers, such as food remaining on plate, weight of container 
in which food has been weighed, apple cores, etc. 
If food consists of several items, please list each on a separate line i.e. instead of writing 
'one cheese sandwich', record separately the weights of bread, margarine, cheese, etc. 
Eating out: If you eat foods away from home, please do not forget to record these as well. 
Take your diary and scales with you where it is possible. If this is too inconvenient, just 
record the types offood eaten with an estimated weight-but please specify when a weight 
has been estimated. 
Please try to be as accurate as possible and try to choose fairly representative days to 
record your food intake. For instance do not record days when you are involved in 
activities that would alter your normal diet (e.g. illness, holiday). 
An example is shown overleaf. 
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FOOD INVENTORY 
Name~ ________________________ __ Date~ ____________ _ 
1. TimelPlace 2. Description of food/drink 3. Weight of 4. Weight of 
food/drink leftovers (g) 
(g) 
Breakfast Corn flakes (Kellogs) 30 
8:30am Milk (Sainsbury's virtually fat-free) 218 
Home White bread (Mothers Pride, toasted) 73 
Flora spread, 70 % fat, PUF A 8 
Robertson strawberry jam 17 
Milk (whole pasteurised) 10 
Coffee (instant) 2 
Lunch White bread 88 
1:00pm Cheese (Cheddar, extra mature) 37 
Pub Butter 6 
Ham 51 
Banana 197 32 (skin) 
Orange Tan~~ can 
Snack Coffee (instant) 2 
3:30pm Milk (semi-skimmed, pasteurised) 15 
office Mars bar 35 
Apple (Grann~ Smith) 76 10 (core) 
Dinner Turkey fillet (grilled) 123 
7:00pm Old potatoes, boiled 228 42 (leftover) 
Home Peas (Birds Eye, frozen, boiled) 52 
Heinz tomato ketchup 14 
Yogurt (MUlIer thick and creamy) 139 
Snack Potato crisps (Walkers) 30 
9:00pm Sorbet, lemon 80 
Home 
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APPENDIXBl 
DETERMINATION OF PLASMA AND TRL-TAG CONCENTRATION WITH 
CORRECTION FOR FREE GLYCEROL 
TAG concentration is chapters 5 and 6 were detennined using the method by Humphreys 
et al. (1990) with correction for free glycerol. 
Test principle 
Lipoprotein lipase 
1. TAG Glycerol + Fatty Acids 
Glycerokinase 
2. Glycerol + ATP -------l~~ Glycerol-3-phosphate + ADP 
Glycerol·3-phosphate dehydrogenase 
3. Glycerol-3-phosphate + NAD+ _________ ~~ 
Diaphorase 
Dihydroxyacetone phosphate 
+ NADH + W 
4.NADH +W + INT ----------~~ NAD + fonnazan 
TAG was hydrolysed by lipoprotein lipase to yield glycerol and fatty acids. The glycerol 
was then phosphorylated (glycerokinase) to glycerol-3-phosphate. This was oxidised with 
glycerol-3-phosphate dehydrogenase to dihydroxyacetone phosphate and NADH + H,+ 
and finally, a coloured fonnazan was fonned by reduction of 2-( 4-iodophenyl)-3-( 4-
nitrophenyl)-5-phenyltetrazolium chloride (INT). 
The coloured fonnazan end product shows an absorbance maximum at 500 nm. The 
increase in absorbance at 500 nm is, therefore, directly proportional to the TAG 
concentration of the sample For the determination of free glycerol, the reaction was 
repeated with omission oflipoprotein lipase (step 1). TAG concentration was calculated 
from the difference between total and free glycerol. 
Reagents 
Trizma base (Sigma Diagnostics, Poole, UK), cholic acid, sodium salt (Sigma 
Diagnostics, Poole, UK), albumin, bovine, fatty acid free, 99 % (Sigma Diagnostics, 
Poole, UK), Triton X-lOO (Sigma Diagnostics, Poole, UK), magnesium chloride, 
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hexahydrate (Merck, Pooie, UK), NAD, grade IT (Roche Diagnostics Ltd., Lewes, UK), 
adenosine-5-triphosphate, di -sodium salt (Roche Diagnostics Ltd., Lewes, UK), 
glycerokinase,5 mg/mL (Roche Diagnostics Ltd., Lewes, UK), glycerol-3-phosphate 
dehydrogenase, 10 mg/mL (Roche Diagnostics Ltd., Lewes, UK), diaphorase, 200 U 
(Roche Diagnostics Ltd., Lewes, UK), NADH:dye oxidoreductase (Roche Diagnostics 
Ltd., Lewes, UK), lipase, type XIII, 1000 U (Sigma Diagnostics, Poole, UK), of2-(4-
iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride (INT) (Merck, Poole, UK), 
Na2HP04 (anhydrous) and Na2HPO ... 2H20 (Merck, Poole, UK). 
Solutions 
0.1 mollL Trizma, pH 7.9 
For 500 mL, the following amounts were weighed: 
6.055 g Trizma base 
0.75 gsodiumchoiate 
5 g albumin, bovine, fatty acid free 
These were dissolve in about 100 mL of distilled water and then 0.75 g Triton X-lOO was 
added. They were mixed until dissolved. The pH was adjusted to 7.9 with approximately 
5 mollL HCL Distilled water was then added to make up to 500 mL. The fInal solution 
was stored at 4' C. 
0.1 mollL sodium phosphate buffer, pH 7.0 
For 500 mL, the following amounts were weighed: 
4.33 g Na2HP04 (anhydrous) or 5.43 g Na2HPO ... 2H20 
3.04 g Na2HPO",2H20 
These were dissolved in about 400 mL distilled water. The pH was checked (7.0) and 
adjusted ifnecessary. Distilled water was then added to make up to 500 mL. The fInal 
solution was stored at 4'C. 
0.1 mollL magnesium chloride 
2.03 g ofMgCl:z.6H20 was dissolved into 100 mL distilled water. The solution was stored 
, 
at 4C. 
217 
I%NAD 
100 mg NAD was dissolved in distilled water (to make up to 10 rnL). The solution was 
stored in aliquots at -20'C. 
0.1 mollL ATP 
603 mg ATP was dissolved in distilled water (to make up to 10 rnL). The solution was 
stored in aliquots at -20'C. 
12 mmollL INT 
60 mg INT was dissolved in distilled water (to make up to 10 rnL). The solution was 
stored in aliquots at 4' C. 
Diaphorase 
200 U diaphorase was dissolved in IrnL of 0.1 mollL sodium phosphate buffer pH 7.0. 
The solution was stored at 4'C in the bottle that diaphorase was supplied in (stable for 6 
weeks). 
Lipase 
1000 U lipase was dissolved in 1.4 mL of 0.1 mollL sodium phosphate buffer pH 7.0. The 
solution was stored at 4'C in the bottle that lipase was supplied in. 
Glycerokinase and glycerol-3-phosphate dehydrogenase 
These were used as supplied after mixing well. They were stored at 4'C. 
Working reagent for free glycerol assay 
The following proportions were mixed: 
10 rnL 0.1 mollL Trizma pH 7.9 
1 rnL 0.1 mollL MgClz.6H20 
1 rnL 1 %NAD 
0.5 mL 0.1 mollL ATP 
20 J.lL glycerokinase 
100 J.lL glycerol-3-phosphate dehydrogenase 
200 J.lL diaphorase 
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For each 1 mL of the above working reagent, 100 J.1L 12 mmollL INT was added just 
before the analysis (the INT has to be added as late as possible because it turns pink in the 
light). The working reagent was ready for use. 
Working reagent for total glycerol assay 
The following proportions were mixed: 
10 mL 0.1 mollL Trizma pH 7.9 
1 mL 0.1 mollL MgCh-6H20 
1 mL 1 %NAD 
0.5 mL 0.1 moIlL ATP 
20 J.1L glycerokinase 
100 J.1L glycerol-3-phosphate dehydrogenase 
200 J.1L diaphorase 
100 J.1L lipase 
For each 1 mL of the above working reagent, 100 J.1L 12 mmollL INT was added just 
before the analysis. The working reagent was ready for use. 
Samples were analysed in duplicate for total and free glycerol on an automated analyser 
(Cobas Mira Plus, Roche Diagnostic Systems, Hertfordshire, UK). For calibration, three 
calibrators were prepared from a commercially available 2290 J.1ffiollL glycerol solution 
(Roche Diagnostics Ltd., Lewes, UK). This calibrator was serially diluted with distiI\ed 
water to produce calibrators appropriate for the assay range. For plasma and TRL free 
glycerol assay, these were 143 J.1mollL, 286 J.1ffiollL and 572 J.1mollL. For plasma total 
glycerol assay, calibrators of 572 J.1ffiollL, 1145 J.1ffiollL and 2290 J.1ffiollL were used. 
Corresponding values for TRL total glycerol assay were 286 J.1mollL, 572 J.1mollL and 
1145 J.1moIIL. For plasma total and free glycerol, 4 J.1L of sample as required for each 
analysis. For TRL total and free glycerol assay, 20 J.1L and 30 J.1L were required, 
respectively. For all assays, 110 J.1L of working reagent was required per measurement. 
APPENDIXB2 
DETERMINATION OF SERUM INSULIN CONCENTRATION 
Concentrations of serum insulin were determined using a solid-phase 125Iodine 
radioimmunoassay (COAT-A-COUNT; Diagnostic Products, Los Angeles, CA, USA). 
Radioactivity was measured using an automated ganuna counting system (Cobra n, 
Packard Instrument, Downers Grove, IL). 
Test principle 
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In this procedure, 12sIodine labelled insulin competes with insulin in the sample for sites 
on insulin-specific antibodies which are immobilised on the wall of a polypropylene tube. 
After an incubation period, the antibody bound fraction is achieved by decanting the 
supematent. The radioactivity of the tube is then measured, with the counts being 
inversely related to the amount of insulin present in the serum sample. Serum insulin 
concentration is then determined by comparing the counts to a standard curve. 
Materials and reagents 
• Plain (uncoated) polypropylene tubes for the measurement of total and non-specific 
binding counts. 
• Green polypropylene tubes coated with antibodies to insulin. 
• A concentrated solution of 125Iodine labelled insulin, which was diluted with 100 mL 
distilled water. 
• Lyophilised processed human calibrators were supplied with the kit at insulin 
concentrations of 0, 5,15,50,100,200 and 400 JllU/mL. These were reconstituted 
with distilled water at least 30 minutes before use. 
• A three-level, human-serum based, quality control was used (CON6, Diagnostic 
Products, Los Angeles, CA, USA). 
Procedure 
1. 200 J.lL of the 0 J.lIU/mL calibrator was dispensed into the plain non-specific binding 
tubes. 
2. 200 J.!L of each calibrator, serum sample or quality control was dispensed directly to 
the bottom of each antibody-coated tube. 
3. 1.0 mL of the 12sIodine labelled insulin solution was added to the plain total count 
tubes and each antibody-coated tube, within 40 minutes of dispensing the 
calibrator/sample/quality control. 
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4. Tubes were vortexed and allowed to incubate for 18 to 24 hours at room temperature. 
5. After this incubation period, the contents of each tube (except the total count tubes) 
were decanted using a foam decanting rack. The tubes were allowed to drain for 
about 5 minutes and were then struck sharply on absorbant paper to remove residual 
droplets remaining in the tubes. 
6. The radioactivity of each tube was then counted for 1 minute in the gamma counter. 
7. Insulin concentrations were determined from a spline fit calibration curve calculated 
from the values of the calibrators. 

